JPS6258720B2 - - Google Patents
Info
- Publication number
- JPS6258720B2 JPS6258720B2 JP620684A JP620684A JPS6258720B2 JP S6258720 B2 JPS6258720 B2 JP S6258720B2 JP 620684 A JP620684 A JP 620684A JP 620684 A JP620684 A JP 620684A JP S6258720 B2 JPS6258720 B2 JP S6258720B2
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dopamine
- enzyme
- norepinephrine
- epinephrine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 claims description 53
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 39
- 150000001875 compounds Chemical class 0.000 claims description 37
- 108090000790 Enzymes Proteins 0.000 claims description 36
- 102000004190 Enzymes Human genes 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 34
- 108020002739 Catechol O-methyltransferase Proteins 0.000 claims description 32
- 239000003960 organic solvent Substances 0.000 claims description 32
- 239000002904 solvent Substances 0.000 claims description 32
- 238000011534 incubation Methods 0.000 claims description 29
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 28
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 25
- 230000003647 oxidation Effects 0.000 claims description 25
- 238000007254 oxidation reaction Methods 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 24
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 24
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 24
- 235000012141 vanillin Nutrition 0.000 claims description 24
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 23
- 229910001424 calcium ion Inorganic materials 0.000 claims description 23
- 229930182837 (R)-adrenaline Natural products 0.000 claims description 22
- 229960005139 epinephrine Drugs 0.000 claims description 22
- 210000001519 tissue Anatomy 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 20
- 150000001768 cations Chemical class 0.000 claims description 20
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 claims description 19
- 229960002748 norepinephrine Drugs 0.000 claims description 19
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 210000002966 serum Anatomy 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 15
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical group OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 15
- 239000000741 silica gel Substances 0.000 claims description 15
- 229910002027 silica gel Inorganic materials 0.000 claims description 15
- 239000008346 aqueous phase Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 claims description 13
- 229960003638 dopamine Drugs 0.000 claims description 13
- 230000002255 enzymatic effect Effects 0.000 claims description 13
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 12
- 229910052749 magnesium Inorganic materials 0.000 claims description 12
- 239000011777 magnesium Substances 0.000 claims description 12
- 229910052722 tritium Inorganic materials 0.000 claims description 12
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 claims description 11
- 238000006911 enzymatic reaction Methods 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 239000013060 biological fluid Substances 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- 239000003112 inhibitor Substances 0.000 claims description 9
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims description 9
- 230000005855 radiation Effects 0.000 claims description 8
- 108010024636 Glutathione Proteins 0.000 claims description 7
- 230000002378 acidificating effect Effects 0.000 claims description 7
- 229960003180 glutathione Drugs 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 238000004809 thin layer chromatography Methods 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 6
- 229910017052 cobalt Inorganic materials 0.000 claims description 6
- 239000010941 cobalt Substances 0.000 claims description 6
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 6
- -1 methyl ( 3 H) dopamine Chemical compound 0.000 claims description 6
- XYEOALKITRFCJJ-UHFFFAOYSA-N o-benzylhydroxylamine Chemical group NOCC1=CC=CC=C1 XYEOALKITRFCJJ-UHFFFAOYSA-N 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 230000002452 interceptive effect Effects 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- 102000006378 Catechol O-methyltransferase Human genes 0.000 claims 4
- 210000005228 liver tissue Anatomy 0.000 claims 4
- GXVUZYLYWKWJIM-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanamine Chemical compound NCCOCCN GXVUZYLYWKWJIM-UHFFFAOYSA-N 0.000 claims 1
- SFLSHLFXELFNJZ-CMIMLBRMSA-N 4-[(1r)-2-amino-1-hydroxy-1-tritioethyl]benzene-1,2-diol Chemical compound NC[C@@](O)([3H])C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-CMIMLBRMSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229910002804 graphite Inorganic materials 0.000 claims 1
- 239000010439 graphite Substances 0.000 claims 1
- 150000003943 catecholamines Chemical class 0.000 description 67
- 238000004458 analytical method Methods 0.000 description 51
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 39
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 29
- 239000000523 sample Substances 0.000 description 27
- 102100040999 Catechol O-methyltransferase Human genes 0.000 description 26
- 239000007788 liquid Substances 0.000 description 19
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- 238000000926 separation method Methods 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 230000035945 sensitivity Effects 0.000 description 13
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229960000583 acetic acid Drugs 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- 239000012074 organic phase Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 235000011054 acetic acid Nutrition 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000002955 isolation Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 230000000087 stabilizing effect Effects 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 230000002285 radioactive effect Effects 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 241000124008 Mammalia Species 0.000 description 6
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
- 239000000908 ammonium hydroxide Substances 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 238000007069 methylation reaction Methods 0.000 description 5
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000003463 adsorbent Substances 0.000 description 4
- 150000001412 amines Chemical group 0.000 description 4
- 210000005013 brain tissue Anatomy 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000700 radioactive tracer Substances 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 239000012089 stop solution Substances 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- JWJCTZKFYGDABJ-UHFFFAOYSA-N Metanephrine Chemical compound CNCC(O)C1=CC=C(O)C(OC)=C1 JWJCTZKFYGDABJ-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 229960001570 ademetionine Drugs 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000012496 blank sample Substances 0.000 description 3
- 239000003729 cation exchange resin Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000010908 decantation Methods 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 2
- DIVQKHQLANKJQO-UHFFFAOYSA-N 3-methoxytyramine Chemical compound COC1=CC(CCN)=CC=C1O DIVQKHQLANKJQO-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- YNYAYWLBAHXHLL-UHFFFAOYSA-N Normetanephrine Chemical compound COC1=CC(C(O)CN)=CC=C1O YNYAYWLBAHXHLL-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920006328 Styrofoam Polymers 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- KSRGADMGIRTXAF-UHFFFAOYSA-N a-Methyldopamine Chemical compound CC(N)CC1=CC=C(O)C(O)=C1 KSRGADMGIRTXAF-UHFFFAOYSA-N 0.000 description 2
- 239000011260 aqueous acid Substances 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000005277 cation exchange chromatography Methods 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000011210 chromatographic step Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 239000008261 styrofoam Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 150000003738 xylenes Chemical class 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- GEFQWZLICWMTKF-CDUCUWFYSA-N (-)-alpha-Methylnoradrenaline Chemical compound C[C@H](N)[C@H](O)C1=CC=C(O)C(O)=C1 GEFQWZLICWMTKF-CDUCUWFYSA-N 0.000 description 1
- XJKSTNDFUHDPQJ-UHFFFAOYSA-N 1,4-diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=C(C=2C=CC=CC=2)C=C1 XJKSTNDFUHDPQJ-UHFFFAOYSA-N 0.000 description 1
- JHFAEUICJHBVHB-UHFFFAOYSA-N 1h-indol-2-ol Chemical class C1=CC=C2NC(O)=CC2=C1 JHFAEUICJHBVHB-UHFFFAOYSA-N 0.000 description 1
- VBWFMAYZSJVLMJ-UHFFFAOYSA-N 1h-indole-2,3,4-triol Chemical class C1=CC(O)=C2C(O)=C(O)NC2=C1 VBWFMAYZSJVLMJ-UHFFFAOYSA-N 0.000 description 1
- PGNRLPTYNKQQDY-UHFFFAOYSA-N 2,3-dihydroxyindole Chemical compound C1=CC=C2C(O)=C(O)NC2=C1 PGNRLPTYNKQQDY-UHFFFAOYSA-N 0.000 description 1
- DCJKUXYSYJBBRD-UHFFFAOYSA-N 2,5-diphenyl-1,3,4-oxadiazole Chemical compound C1=CC=CC=C1C1=NN=C(C=2C=CC=CC=2)O1 DCJKUXYSYJBBRD-UHFFFAOYSA-N 0.000 description 1
- CNRNYORZJGVOSY-UHFFFAOYSA-N 2,5-diphenyl-1,3-oxazole Chemical compound C=1N=C(C=2C=CC=CC=2)OC=1C1=CC=CC=C1 CNRNYORZJGVOSY-UHFFFAOYSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- WMAXWOOEPJQXEB-UHFFFAOYSA-N 2-phenyl-5-(4-phenylphenyl)-1,3,4-oxadiazole Chemical compound C1=CC=CC=C1C1=NN=C(C=2C=CC(=CC=2)C=2C=CC=CC=2)O1 WMAXWOOEPJQXEB-UHFFFAOYSA-N 0.000 description 1
- QNWOSJAGFSUDFE-UHFFFAOYSA-N 5-(aminooxymethyl)-2-bromophenol Chemical compound NOCC1=CC=C(Br)C(O)=C1 QNWOSJAGFSUDFE-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- FCKYPQBAHLOOJQ-UHFFFAOYSA-N Cyclohexane-1,2-diaminetetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)C1CCCCC1N(CC(O)=O)CC(O)=O FCKYPQBAHLOOJQ-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- YNYAYWLBAHXHLL-MRVPVSSYSA-N Normetanephrine Natural products COC1=CC([C@H](O)CN)=CC=C1O YNYAYWLBAHXHLL-MRVPVSSYSA-N 0.000 description 1
- MASVCBBIUQRUKL-UHFFFAOYSA-N POPOP Chemical compound C=1N=C(C=2C=CC(=CC=2)C=2OC(=CN=2)C=2C=CC=CC=2)OC=1C1=CC=CC=C1 MASVCBBIUQRUKL-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- CJCSPKMFHVPWAR-JTQLQIEISA-N alpha-methyl-L-dopa Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 CJCSPKMFHVPWAR-JTQLQIEISA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000037086 body physiology Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M isovalerate Chemical compound CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000018791 negative regulation of catalytic activity Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940124643 non-selective drug Drugs 0.000 description 1
- 150000002871 norepinephrines Chemical class 0.000 description 1
- HYDZPXNVHXJHBG-UHFFFAOYSA-N o-benzylhydroxylamine;hydron;chloride Chemical compound Cl.NOCC1=CC=CC=C1 HYDZPXNVHXJHBG-UHFFFAOYSA-N 0.000 description 1
- 229940078552 o-xylene Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229930184652 p-Terphenyl Natural products 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical group NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012260 resinous material Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 1
- 229940039790 sodium oxalate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 150000003649 tritium Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N βâMercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Description
æ¬çºæã¯ãæŸå°èœãå©çšããé
µçŽ ã®æ°èŠåææ¹
æ³ã«é¢ãã詳现ã«ã¯ãã«ãã³ãŒã«ââã¡ãã«åº
è»¢ç§»é µçŽ ã«ããæšèåã¡ãã«åºäŸäžäœããã¡ãã«
åºãã«ãã³ãŒã«ã¢ãã³ã«è»¢ç§»ãããã€ãã§ïŒ¯âã¡
ãã«ïŒ 3HïŒåã«ãã³ãŒã«ã¢ãã³ãåé¢ãã次ã«
æŸå°èœã枬å®ããããšãããªãã«ãã³ãŒã«ã¢ãã³
ã®æ°èŠåææ¹æ³ã«é¢ããã 蚺æãã¹ãã¯å»è ã«ãšãäžå¯æ¬ ãªæŠåšã§ããã
å€ãã®çŸç ãšçç¶ãšã«äŒŽãã®ã身äœççåŠãç¹ã«
ãã®çç¶ã«é¢é£ããååç©ã®æ¿åºŠã®åŸ®åŠãªå€åã§
ãããã«ãã³ãŒã«ã¢ãã³ã¯ãããååç©ã®äžçŸ€ã§
ããããããã¯åŒïŒ ïŒåŒäžãã¯åã ã®ååç©ã®ã¢ãã³å®èœåºã§ã
ãïŒ äžã®ã«ãã³ãŒã«æ žã«ãã確èªããããäœå ã«èªç¶
ã«çºèŠãããéèŠãªã«ãã³ãŒã«ã¢ãã³ã¯ãšããã
ãªã³ïŒäžèšåŒã§ïŒ²ã
æ³ã«é¢ãã詳现ã«ã¯ãã«ãã³ãŒã«ââã¡ãã«åº
è»¢ç§»é µçŽ ã«ããæšèåã¡ãã«åºäŸäžäœããã¡ãã«
åºãã«ãã³ãŒã«ã¢ãã³ã«è»¢ç§»ãããã€ãã§ïŒ¯âã¡
ãã«ïŒ 3HïŒåã«ãã³ãŒã«ã¢ãã³ãåé¢ãã次ã«
æŸå°èœã枬å®ããããšãããªãã«ãã³ãŒã«ã¢ãã³
ã®æ°èŠåææ¹æ³ã«é¢ããã 蚺æãã¹ãã¯å»è ã«ãšãäžå¯æ¬ ãªæŠåšã§ããã
å€ãã®çŸç ãšçç¶ãšã«äŒŽãã®ã身äœççåŠãç¹ã«
ãã®çç¶ã«é¢é£ããååç©ã®æ¿åºŠã®åŸ®åŠãªå€åã§
ãããã«ãã³ãŒã«ã¢ãã³ã¯ãããååç©ã®äžçŸ€ã§
ããããããã¯åŒïŒ ïŒåŒäžãã¯åã ã®ååç©ã®ã¢ãã³å®èœåºã§ã
ãïŒ äžã®ã«ãã³ãŒã«æ žã«ãã確èªããããäœå ã«èªç¶
ã«çºèŠãããéèŠãªã«ãã³ãŒã«ã¢ãã³ã¯ãšããã
ãªã³ïŒäžèšåŒã§ïŒ²ã
ãåŒãã§ãã
ååç©ã以åŸïŒ¥ãšç§°ãïŒã
ãã«ãšããããªã³ïŒäžèšåŒã§ïŒ²ã
ãåŒãã§ããååç©ã以åŸNEãšç§°ãïŒã
åã³ããŒããã³ïŒäžèšåŒã§ïŒ²ãâCH2CH2NH2
ã§ããååç©ã以åŸDAãšç§°ãïŒã§ãããããã
ã®ã«ãã³ãŒã«ã¢ãã³ã¯ããšãããè¡æ¶²ãå°¿ãé«æ¶²
åã³è³çµç¹ãå«ãèªäœã®æ§ã ãªçµç¹äžã«èŠãåºã
ããããããååç©ã®éã¯æ¥µåºŠã«å°ãªããäŸã
ã°ãè¡æž äžã«ïŒ¥ãšNEãšã¯pgïŒ10-12ïœïŒåäœã®é
ã§ååšããã æè¿ã§ã¯åºä¹³åç©ç³»äžã®ã«ãã³ãŒã«ã¢ãã³éã
枬å®ããããšã«çžåœã®èå³ããããã«ãã³ãŒã«ã¢
ãã³éã¯å¥œã¯ããŒã æ§çŽ°èè «ãååšããæã«ã¯æ
æã«å¢å ããããã®ã«ãã³ãŒã«ã¢ãã³éã¯ãäžæ¢
ç¥çµç³»ã«åœ±é¿ãäžããä»è «çãäŸãã°ç¥çµèœçŽ°è
è «ãã®åœ±é¿ãåãããã«ãã³ãŒã«ã¢ãã³éãç¥ã
ããšã¯ãé«è¡å§çãå ç¶åèçŸæ£ãçå¿çãæ¥æ§
å¿çæ¢å¡çåã³çæ§ç³å°¿ç ã®èšºæåã³åŠçœ®ã«ãã
ãŠææ矩ã§ããããµããã¯ãïœåã«éããã«å å
ã«æåæ§ã§ãããåºä¹³åç©ç³»äžã®ã«ãã³ãŒã«ã¢ã
ã³éã枬å®ããããã®åæã®æ¹æ³ã¯Von Eulerãš
Flodingãšã®èå åå åææ³ïŒActa Physiol.
Scand.33ïŒå¢è£çïŒ118ïŒ1955幎ïŒã§ãã€ããã
ã®åææ³ã¯ãé«èå çºå æ§ã®ãã«ã¢ãã¬ãã«ãã³
åã¯ã¢ãã¬ãã«ãã³ãã¢ã«ã«ãªæ§æº¶æ¶²äžã«ãããŠ
çæãã察å¿ããªããããã·ã€ã³ããŒã«ã«NEå
ã³ïŒåã¯ïŒ¥ããããšãªã·ã¢ããåã¯ãšãŠçŽ ãçšã
ãŠé žåããããšã«åºã¥ãããã®åæãè¡ãåã«ã
NEåã¯ïŒ¥ããåºä¹³åç©ç³»ãäŸãã°è¡æž åã¯è¡
挿ãè±èçœçµç¹åç質åã¯é«æ¶²ããããŸãåé¢ã
ãªããã°ãªããªããDAããšãŠçŽ ã«ããé žåããŠ
ãžããããã·ã€ã³ããŒã«ã圢æããããã®ããã
ãã·ã€ã³ããŒã«ã®èªå°äœã®èå å£ã¯NEåã¯ïŒ¥ã®
èªå°äœã®èå å£ãšã¯ç°ããèå åæã®åºç€ã§ãã
ïŒCarlsonãšWaldeckã®å ±èãActa.Physinol.
Scand.44ïŒ293ïŒ1958幎ïŒãNEåã³ïŒ¥ãšåæ§ã«ã
DAãåãã®åæã«å ç«ã€ãŠåºä¹³åç©ç³»ããåé¢
ãããªããã°ãªããªãã è±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž ãè¡æŒ¿åã¯ç
ç©åŠçæµåäœããã®ã«ãã³ãŒã«ã¢ãã³ã®åé¢ã¯äž
è¬ã«ãïŒã€ã®æè¡ã®ãã¡ã®ïŒã€ã«ããè¡ãããã
第ïŒã®ãæãå¹ åºã䜿çšãããŠããåé¢æè¡ã¯ã
ã«ãã³ãŒã«ã¢ãã³ãPH8.4ã8.6ã®äžæ§ã¢ã«ããã«
åžçãããããšã§ãããã«ãã³ãŒã«å«æååç©ã¯
ã¢ã«ããã«ããåžçãããéã«ãã³ãŒã«ååç©ã¯
æšãŠããããã«ãã³ãŒã«ã¯é žã«ãã溶åºã«ããã
ã®ã¢ã«ããããåãåºãããã 第ïŒã®åé¢æè¡ã§ã¯ã«ããªã³äº€æã¯ãããã°ã©
ãã€ãŒãçšãããNEïŒïŒ¥åã³DAã¯é žæ§PHã§ã¯ã€
ãªã³åããã®ã§äº€ææš¹èã«çµåãããã€ãã§é žåŒ·
床ãé«ããããšã«ããåªå 溶åºãããããšãã§ã
ãã ãããåé¢æ³ã¯å ±ã«æ¥µããŠé·æéããããåç¹
å®ã«ãã³ãŒã«ã¢ãã³ã«å¯ŸããŠç§»ç°çãªãã©ã¯ã·ãš
ã³ãäžè¬ã«ã¯çæããªãããã®äžãèå åå åæ
ç³»ã¯ç 究è ã®èŠæ±åºŠããèããã°æ¯èŒçã«éæå
æ§ã§ãããNEãšïŒ¥ãšã®å Žåã«ã¯çŽ50ã500nïœã®
æ床ãåŸãããããã®æ¹æ³ã®æ¹è¯ã«ããïŒã3n
ïœãšããå°éã«å¯ŸããŠãæåæ§ã§ããæè¡ãéçº
ããããããã®æ床ã¬ãã«ã§ã®åæ粟床ã¯æªã
ãEngelmançèâAm.J.Med.Sci.âïŒ255ïŒ259
ïŒ1962幎ïŒãåç §ããããããDAã®å Žåã®æ床ã¯
çŽ500nïœã§ããããã®åææ³ã¯æ¯èŒçã«éæå
æ§ã§ã¯ããããïŒç®æãé€ãã°å šãŠã®åæ¥çæ€æ»
宀ã§ã¯ãã«ãã³ãŒã«ã¢ãã³ã枬å®ããããã«ãã®
èå åææ³åã¯ãã®æ¹è¯æ³ã䜿çšããŠããã åæ¥çã«ã«ãã³ãŒã«ã¢ãã³éã枬å®ããããã®
ããïŒã€ã®æ¹æ³ãããããå©çšå¯èœã§ããã AxelrodãšTomchickãšã«ããåããŠå ±åã
ããç¹æ§åãããã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»
é µçŽ ïŒä»¥åŸCOMTãšç§°ãïŒã¯ãã¡ãã«åºããã®
äŸäžäœååããã«ãã³ãŒã«æ žã«è»¢ç§»ããããã«ã
ãã次åŒã«ãã瀺ãããïŒâã¡ããã·ååç©ã圢
æããé µçŽ ã§ããã ïŒåŒäžãã¯ã¢ãã³å®èœåºã§ããïŒ æŸå°æ§ãã¬ãŒãµãŒãšãã¯ãããã°ã©ãã€ãŒçã®
ä»æè¡ãšã䜿çšããåŸã®ç 究è ã¯ãã¡ã¿ãããªã³
ïŒä»¥åŸMNãšç§°ãïŒããã«ã¡ã¿ãããªã³ïŒä»¥åŸNMN
ãšç§°ãïŒåã³ã¡ããã·ãã©ãã³ïŒä»¥åŸMEOTãš
称ãïŒã®æŸå°æ§æšèåéããåºä¹³åç©ç³»äžã®ïŒ¥ã
NEåã³DAã®åæéã«é¢é£ã¥ãããMNïŒNMNå
ã³METOã®ååŠæ§é ã次ã«ç€ºãã 1968幎ãEngelmançã¯COMTãçšããäºéåž
éèªå°äœæ³ïŒdouble isotope dilution derivative
technigueïŒãå©çšããŠçç©åŠçæ€äœäžã®ã«ãã³
ãŒã«ã¢ãã³ãå³ã¡ãšããããªã³ãšãã«ãšããããª
ã³ããåæãããå åå ãã¬ãŒãµãŒã§ããïŒâ
3Hâãã«ãšããããªã³ãã¡ãã«åºäŸäžäœãšããŠ
ã®ïŒ³âã¢ããã·ã«ââã¡ããªãã³ã¡ãã«â14C
ãšå ±ã«çšãããåæã«å ç«ã€ãŠå°¿ãµã³ãã«ãšè¡æ¶²
ãµã³ãã«ãšãååŠçããŠã«ãã³ãŒã«ã¢ãã³ãåé¢
ãããå°¿ãµã³ãã«ã¯ã¢ã«ããã§ã¯ãããã°ã©ãã€
ãŒããè¡æ¶²ãµã³ãã«ã¯ã«ããªã³äº€ææš¹èã§ã¯ãã
ãã°ã©ãã€ãŒãããã¯ãããã°ã©ãã€ãŒããããµ
ã³ãã«ãé µçŽ ç³»äžã§ã€ã³ããŠããŒã·ãšã³ããåŸã«
ã€ã³ããŠããŒã·ãšã³ãåæ¢ãããçæ溶液ãåŠç
ããã«ããªã³äº€ææš¹èã§ã¯ãããã°ã©ãã€ãŒã
ããã¡ã¿ãããªã³ã溶åºãããéãšãŠçŽ é žå¡©ã§ã
ããªã³ã«é žåããããã®ãããªã³ãæœåºãã粟補
ãã液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªäžã§èšæ°ãããã«
ãã³ãŒã«ã¢ãã³ã®ååšéãå€æãããã®ã«ã¯å žå
çãªè€éãªããã«ã¢ã€ãœããŒã枬å®ãèšç®ãšãå¿
èŠã ã€ãã Engelmannã¯åœŒã®åæã®ç 究ãç¶ãããã®çµ
æãå¥ã®åè¡ç©ã§ããEngelmannçè
âCirculation Researchâ26ïŒ53ïŒ1970幎ïŒã«çº
è¡šããã圌ã®åæã®ç 究ã®æ¹è¯ã«ããä»ããïŒã
10mlã®äººè¡æŒ¿ã®åäžãµã³ãã«äžã®ïŒ¥ãšNEãšã®ç€º
å·®ç枬å®ãå¯èœã«ãªã€ããNHãšNMNãšãèå±€ã¯
ãããã°ã©ãã€ãŒã«ããåé¢ããããšããç¹ãé€
ããŠã¯åèšåè¡ç©èšèŒã®ãã®ãšåäžã®äºéåžéæ³
ãçšãããããªããŠã æšèåãã¬ãŒãµãŒéã®ïŒ¥ãš
NEãšã100ÎŒïœã®MNãšNMNãšå ±ã«å ãããåæ
ã«å ç«ã€ãŠãè¡æŒ¿ãµã³ãã«ãšå°¿ãµã³ãã«ãšã¯å ±
ã«ãã«ããªã³äº€ææš¹èã¯ãããã°ã©ãã€ãŒãã
ããã¯ãããã°ã©ãã€ãŒå·¥çšã«å ç«ã€ãŠãšãã¬ã³
ãžã¢ãã³åé ¢å¡©ãè¡æŒ¿ãµã³ãã«ã«å ããããã®å
æã®æ床ã¯ã空詊éšå€ã®ïŒåã®å€ã«ãã枬å®ãã
ãšããã§ã¯250pïœã ã€ããè¡æŒ¿ïŒ¥å€ã¯æ£åžžåã®
äžéå€ã§ã¯ããã»ã©æ£ç¢ºã«ã¯æž¬å®ã§ããªãã€ãã PassonãšPeulerãšã®å ±èâAnalytical
BiochemistryâïŒ51ïŒ618ïŒ1973幎ïŒã«ãããŠ
ã¯ããšNEãšããCOMTã䜿çšããã€ãã§MN
ãšNMNãšãã¯ãããã°ã©ãã€ãŒã«ããåé¢ãã
ãã®åŸã«ãããªã³ã«é žåããããšã«ããåæãã
ãŠãããè¡æž åã¯è¡æŒ¿ã¯ããã®åæã«å ç«ã€ãŠã¯
ãããã°ã©ãã€ãŒã«ä»ãããããšãªãçŽæ¥ã«äœ¿çš
ããããåªïŒã€ã®ã¢ã€ãœããŒããšããŠïŒ³âã¢ãã
ã·ã«âã¡ããªãã³ïŒ 3HïŒã¡ãã«ã䜿çšãããã
ããªããŠã åã¡ãã«åºäŸäžäœãéæŸå°æ§ã¡ãã«åº
äŸäžäœã§åžéããããã¬ãŒãµãŒãšããŠæšèå 14C
ååç©ãè©Šçšããããåºè³ªã§ããã«ãã³ãŒã«ã¢ã
ã³ã®æ£ç¢ºãªååççã«ä¿ãåé¡ç¹ãå°ãããã®ã«
ã¯åœ¹ç«ããªãã€ããéæŸå°æ§ïŒ³âã¢ããã·ã«ã¡ã
ãªãã³ã®æ¿åºŠã10ÎŒïŒããäœããšãã©ã³ã¯ã瀺ã
ãµã³ãã«ãå®è³ªäžå¢å ããããã®ä»ã®ç¹ã§ã¯åæ
æè¡ã¯Engelmançåã³ä»ã®è ã«ãã䜿çšããã
æè¡ã«äŒŒãŠãããåææ床NEãšïŒ¥ã®å Žåã«170p
ïœã§ããããã®ããïŒmlæªæºã®äººè¡æž äžã®NEãš
ãšã枬å®ã§ãããšäž»åŒµãããã CoyleãšHenryãšã¯COMTãšïŒ³âã¢ããã·ã«â
ã¡ããªãã³ïŒ 3HïŒã¡ãã«ãšã䜿çšããããšã«ã
ãè±èçœè³çµç¹åç質ã«ãããŠãã«ãšããããªã³
ãããŒããã³ããåé¢ããããJ.of
NeurocheistryïŒ21ïŒ61ïŒ1973幎ïŒããéæŸå°ç·æ§
æ äœéã®NMNãšMEOTãšãæ·»å ããåŸã«ã€ã³ã
ãŠããŒãïŒã€ã³ããŠããŒã·ãšã³æ··åç©ïŒãææ©æº¶
液ã«ããæœåºããæœåºç©ãå¡©é žæ°Žæº¶æ¶²äžã«ååé
ããããæ°Žçžãåèšãšåäžã®ææ©æº¶åªã§æŽã€ãã
ãããªã³âïŒ 3HïŒãNMNâïŒ 3HïŒã®éãšãŠçŽ
é žå¡©éè£ã«ããçæããããããªã³âïŒ 3HïŒã
ææ©æº¶åªäžã«æœåºããæåŸã«æ¶²äœã·ã³ãã¬ãŒã·ãš
ã³åªè³ªäžã§èšæ°ãããMEOTãç·©è¡å€ã§ããã
ãŠé žå¡©ãšïŒïŒïŒïŒïœïŒïœïŒãã«ãšã³ïŒã€ãœã¢ãã«
ã¢ã«ã³ãŒã«æº¶åªç³»ãšãçšããŠéãšãŠçŽ é žå¡©æ°Žæº¶æ¶²
çžããæœåºãã液äœã·ã³ãã¬ãŒã¿ãŒãçšããŠèšæ°
ããã Christensenã¯COMTæ³ãå©çšããäºéåžéæ³
ã«ããè¡æŒ¿äžã®DAéã枬å®ãããScand.J.Clin.
Lad.Invest.ïŒ31ïŒ343ïŒ1973幎ïŒããé µçŽ äœçšã«ã
ãã¡ãã«åºè»¢ç§»åã«ãã¢ã«ãããŠã ãå©çšããŠã«
ãã³ãŒã«ã¢ãã³ãè¡æŒ¿ããåé¢ãããCOMTãš
被æ€ãµã³ãã«ãšãâã¢ããã·ã«ã¡ããªãã³âã¡
ãã«ïŒ 14CïŒãšãã¬ãŒãµãŒéã®ããªããŠã æšèå
DAãšå ±ã«ã€ã³ããŠããŒã·ãšã³ãããNMãšNMN
ãšãéãšãŠçŽ é žå¡©ã§ãããªã³ã«é žåããåŸã«
MEOTãåé¢ãã液äœã·ã³ãã¬ãŒã¿ãŒäžã§åæ
ãããDAæ¿åºŠã 14Cãš 3Hãšã®èšæ°ããã³ã³ã
ãŠãŒã¿ã§èšç®ããã Cuelloã¯1973幎ãNEã®ååšäžã§è±èçœè³çµç¹
æœåºç©äžã®DAãåæãããCOMTãšããªããŠã
æšèåâã¢ããã·ã«ã¡ããªãã³ãéæŸå°æ§ïŒ³â
ã¢ããã·ã«ã¡ããã³å㯠14CSâã¢ããã·ã«ã¡ã
ãªãã³ãšå ±ã«æ··åãããã€ã³ããŠããŒããææ©æº¶
åªã§æœåºããåŸã«ãã®ææ©æº¶åªãå¡©é žäžã«éæœåº
ããã€ãã§ã¯ãããã°ã©ãã€ãŒããã 1975幎ã«å±±å£çã¯è¡æ¶²äžã®å å æ§ã«ãã³ãŒã«ã¢
ãã³ãããšãã¬ã³ã°ãªã³ãŒã«ãã¹âïŒã¢ãããšã
ã«ãšãŒãã«ïŒâïŒNâ²âåé ¢é žïŒä»¥åŸEGTAãšç§°
ãïŒãã€ã³ããŠããŒã·ãšã³æ··åç©äžã«ååšãããŠ
åæãããCirculation ResearchïŒ36ïŒ662
ïŒ1975幎ïŒãã Champlainçã¯ãAxelrodãšTomchikãšã«ãã
ãªãããç 究ããã«ã«ã·ãŠã ã€ãªã³ãCOMTã®
åå¿ãé»æ¢ããããšãç¥ãããããšã
Circulation ResearchïŒ38ïŒ109ïŒ1976幎ïŒã«é
瀺ãããEGTAã¯ãã°ãã·ãŠã ã§ã¯ãªãã«ã«ã·ãŠ
ã ã®éžæçãã¬ãŒãå€ã§ãããé µçŽ ã®æŽ»æ§ãå埩
ãããããããããã®åŸã®åè¡ç©ã§ãã
WeinshilboumçèâBiochemical
PharmacolcgyâïŒ25ïŒ573ïŒ1976ïŒã«ã¯ãã«ã«ã·
ãŠã ã€ãªã³ä»¥å€ã®ã«ããªã³ãæé©æ¿åºŠã®ãã°ãã·
ãŠã ã®ååšäžã§COMTåå¿ãé»æ¢ããå¯èœæ§ã¯
ä»æ¥ãŸã§ç 究ãããŠããªããšè¿°ã¹ãããŠããã åŸæ¥ã®å¡©åºæ§COMTç³»ãå©çšãããã«ãã³ãŒ
ã«ã¢ãã³ãåæããããã®æ°èŠãªç³»ãä»ãéçºã
ãããåºä¹³åç©ç³»ã®ã«ãã³ãŒã«ã¢ãã³å«éã¯ä»
ããNEãšïŒ¥ã®å Žåã§5pïœã®ãDAã®å Žåã§12pïœ
ã®æ床ã«ãŸã§åæã§ããããã®åæã¯ç²Ÿç¢ºã§ã
ããåç°åžžã«éžæçã§ãããæŽã«ããã®åææ³ã¯
æå°ã®é«çæè¡èšç·Žãåããæ€æ»å¡ã«ããæ¥éã«
å±¥è¡ã§ããããã®åææ³ã¯çŸåšãã¢ãããžãšã³ã«
ã³ãããŒã®æ€æ»æ¹æ³éšéã«ããåæ¥çããŒã¹ã§æ
åããŠäœ¿çšãããŠããã æ¬çºæã«ããã ïœ è±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž åã¯è¡æŒ¿ã
åã¯çç©åŠçæµåäœã®ã¢ãªã³ãŒãããã«ãã³ãŒ
ã«ââã¡ãã«åºè»¢ç§»é µçŽ ãæªæšèåã¡ãã«åº
äŸäžäœãå®è³ªäžå«ãŸãªãããªããŠã æšèåã¡ã
ã«åºäŸäžäœã§ããâã¢ããã·ã«ââã¡ããª
ãã³ïŒ 3HïŒã¡ãã«ã該ã¡ãã«åºè»¢ç§»ãé²è¡ã
ããé žåæ°ïŒïŒã®ã«ããªã³ãé µçŽ âåºè³ªç³»ãå®
å®åãããååç©ãåã³é µçŽ åå¿ã劚害ãããª
ãããã«ã«ã«ã·ãŠã ã€ãªã³ãåªå çã«é€å»ãã
è¬å€ãšäžç·ã«ãïŒ ïœ å®è³ªäžå šãŠã®ãšããããªã³ãšãã«ãšããããª
ã³ãšãâã¡ãã«ïŒ 3HïŒåããã®ã«å åãªæ
éãšæž©åºŠãšPHã§âïœâã®æåãäžç·ã«ã€ã³ããŠ
ããŒã·ãšã³ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããããšããããªã³ãš
ãã«ãšããããªã³ãšãåªå çã«æº¶è§£ããææ©æº¶
åªã§ãâã¡ãã«ïŒ 3HïŒåããããšããããª
ã³ãšãã«ãšããããªã³ãšãæœåºãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããããšããããªã³ãš
ãã«ãšããããªã³ãšãããããã«ãããã³ãäŸ
äžããã®ã«å åãªåŒ·åºŠã®é žã®æ°Žæº¶æ¶²äžã«ååé
ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããããšããããªã³ãš
ãã«ãšããããªã³ãšããããªã³â 3Hã«é žå
ãïŒ ïœ ãããªã³â 3Hãåªå çã«æº¶è§£ããææ©æº¶åª
ã§ãããªã³â 3Hã氎溶液ããæœåºãïŒ ïœ ãããªã³â 3HããæŸåºãããæŸå°ç·ãèšæ°
ããïŒ ããšãããªããè±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž
åã¯è¡æŒ¿ãåã³çç©åŠçæµåäœãããªã矀ããéž
æãããåºä¹³åç©ç³»äžã®å å æ§ã®æªç€ºå·®åãšãã
ããªã³ãšãã«ãšããããªã³ãšã®éãåæãããã
ã®æ¹æ³ãæäŸãããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãäžèšãšåäžã®åæå·¥çš
ããã¯ãããã°ã©ãã€ãŒæ段ã«ããâã¡ãã«å
ãšããããªã³ãšïŒ¯âã¡ãã«åãã«ãšããããªã³ãš
ãåé¢ããããã®è¿œå å·¥çšãšå ±ã«è¡ãããšãããª
ããè±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž åè¡æŒ¿ãå
ã³çç©åŠçæµåäœãããªã矀ããéžæãããåºä¹³
åç©ç³»ããåŸããããšããããªã³åã³ïŒåã¯ãã«
ãšããããªã³ã®éã瀺差çã«åæããããã®æ¹æ³
ã§ããããã®åé¢å·¥çšã¯ãâã¡ãã«ïŒ 3HïŒå
ããããšããããªã³åã³ïŒåã¯ãã«ãšããããªã³
ãååé ãããåŸããããããããªã³â 3Hã«é ž
åããåã«è¡ãã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ã被æ€ãµã³ãã«äžã«ååš
ããããŒããã³éã®åææ¹æ³ã§ãããæªç€ºå·®åãš
ããããªã³ãšãã«ãšããããªã³ãšã®åæã«ãããŠ
ã¯ããããªã³ã®æœåºåŸã«æ®ã€ãæ°Žæ§é žåçžãææ©
溶åªãçšããŠå¡©åºæ§PHã§æœåºããMEOTïŒ 3HïŒ
ãèšæ°ããããšããããªã³ãšãã«ãšããããªã³ãš
ã®ç€ºå·®çåæã«ãããŠã¯ãâã¡ãã«ïŒ 3HïŒå
ãšããããªã³ãšïŒ¯âã¡ãã«ïŒ 3HïŒåãã«ãšãã
ããªã³ãšãåé¢ããã®ã«äœ¿çšããã溶åªç³»ãé žæ§
ã§ããæã«ã¯é瀺差çåææ³ãšåäžã®æ¹æ³ã§ããŒ
ããã³ãåæãããâã¡ãã«ïŒ 3HïŒåãšãã
ããªã³ãâã¡ãã«ïŒ 3HïŒåãã«ãšããããªã³
ããåé¢ããããã®æº¶åªç³»ãå¡©åºæ§ã§ãããªã
ã°ãMEOTïŒ 3HïŒãåã¯ãããã°ã©ãã€ãŒç³»äž
ã«åé¢ããããMEOTïŒ 3HïŒã溶åºããèšæ°ã
ãã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãCOMTé µçŽ åå¿ã劚
害ãããªãããã«ã«ã«ã·ãŠã ã€ãªã³ãéžæé€å»ã
ãè¬å€ã®äœ¿çšã§ããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãEGTAãCOMTãšçµ
ã¿åããŠäœ¿çšããããšã«ããCOMTã®åºæ掻æ§
ãé«ããæ¹æ³ã§ããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãç¡«é žã¢ã³ã¢ããŠã åå¥
æ³ãå©çšããŠã©ããèCOMTã粟補ããæ¹æ³ã§
ããããã®ç²Ÿè£œã«ããåŸãããæ°èŠãªCOMTçµ
æç©ã¯æ¬çºæã®å¥ã®æ æ§ã§ããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãé žæŽæ¶²ãçšããŠã®ã·ã³
ãã¬ãŒã·ãšã³ãã€ã¢ã«å ã®ãããªã³â 3Hã®ç²Ÿè£œ
ãšãããããã€ã¢ã«ã§ãã®æŸå°èœãåæããæ¹æ³
ãšã§ããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãã·ãªã«ã²ã«ã®ååšäžã§
éãšãŠçŽ é žå¡©ãçšããŠã¡ã¿ãããªã³â 3Hã«é žå
ããããšãšããããã®æåãããªãçµæç©ãšã§ã
ãã æ¬çºæã®ç¬¬10ã®æ æ§ã¯ãèå±€ã¯ãããã°ã©ãã€
ãŒã§äœ¿çšãããæ°èŠãªå¡©åºæ§æº¶åªç³»ã§ããã æ¬çºæã®ç¬¬11ã®æ æ§ã¯ãè³éŠæâã¢ãã³é žã
ç¹ã«DOPAã§ãããã«ã«ããã·ã«åºåè§£é µçŽ ã®é µ
çŽ æŽ»æ§ã®é»æ¢å€ãã€ã³ããŠããŒãäžã«ååšããã
ãšã§ããããã®ã¿ã€ãã®ååç©ã¯ãã®ã€ã³ããŠã
ãŒã·ãšã³æéäžã®ããŒããã³ã®çæãé»æ¢ããã æ¬çºæã®ç¬¬12ã®æ æ§ã¯ãåæå¿ é æåãæ€æ»å¡
ã䜿çšã§ãããããã«éæããããšã§ããã æ¬çºæã®ãã®ä»ã®æ æ§ã¯ãæ¬çºæã«ã€ããŠã®èš
è¿°ãç¶ãã«ã€ããŠæçœã«ãªãã§ãããã ã«ãã³ãŒã«ã¢ãã³ã¯æ§ã ãªåºä¹³åç©ç³»äžã«çºèŠ
ããããåã«è¿°ã¹ãéãããããååç©ã¯ã«ãã³
ãŒã«æ žãšã¢ãã³å®èœåºãšãå ±éããŠæãããã«ã
ã³ãŒã«ã¢ãã³ãåæã§ããæ§ã ãªåºä¹³åç©ã®äŸ
ã¯ã人éã銬ãçãç¬ãç«ãã©ãããããŠã¹ããŠ
ãµã®ãåã³è¡æ¶²åŸªç°åé¡ãšå¿çåé¡ãšã®ç 究ã®ã
ãã«ç§åŠå®éšå®€ã«ãããŠäžè¬ã«äœ¿çšãããä»åç©
ã§ãããã«ãã³ãŒã«ã¢ãã³ã¯åºä¹³åç©ã®æ§ã ãªç³»
äžã«çºèŠãããã埪ç°éã®ã«ãã³ãŒã«ã¢ãã³ãè¡
液äžã«çºèŠããããäœå ã®ä»ã®çç©åŠçæµåäœã
äŸãã°å°¿ãé«æ¶²åã³ãªã³ã液ãåææéã®ã«ãã³
ãŒã«ã¢ãã³ãå«ããåæç³»äžã«çšããããšã®ã§ã
ãçµç¹ãµã³ãã«ã¯ãè¡ç®¡çµç¹ãèèãå¯è åã³è
èã®æ§ãªäº€æç¥çµã®æ¯é ãåããå šãŠã®çµç¹ïŒè³
çµç¹ïŒè «çã®ããçµç¹ïŒçã§ãããçµç¹ãåæã
ãããšããæã«ã¯ãã®ãµã³ãã«ããå質åãçµç¹
ã®å§æŸåã³è¶ é³æ³¢åŠçã®æ§ãªäžè¬æè¡ã®ãããã
ã«ããç²ç ãããåæã«çšããããã®ã¯ãã®åç
質ã®äžæŸã¿ã§ãããç³»ã®çµ±åæ§ãç¶æããããã«
ã¯é žæ§PHãçšããã¹ãã§ãããè¡æ¶²ãã©ã¯ã·ãšã³
ãã®ä»ã®çç©åŠçæµåäœã®æ§ãªæ¶²äœç³»ãçšããæ
ã«ã¯ã¢ã«ããã¯ãããã°ã©ãã€ãŒåã¯ã«ããªã³äº€
æã¯ãããã°ã©ãã€ãŒã®æ§ãªäºååé¢æ³ãçšãã
å¿ èŠã¯å šããªããæµå液äœãµã³ãã«èªäœãçšãã
ããšãã§ããã 被åæãµã³ãã«ã®ãµã€ãºã¯ã«ãã³ãŒã«ã¢ãã³ã®
ååšéã«äŸåããŠçžåœã«å€åãããåææ床ãé«
ãã®ã§10ÎŒãªããããæªæºãšããå°éã®è¡æž å
ã¯è¡æŒ¿ã®ãµã³ãã«ã容æã«åæã§ãããå°¿äžã«å
åšããã«ãã³ãŒã«ã¢ãã³ã®éã¯è¡æ¶²äžã®ååšéã
ããææã«å€ãã®ã§å°¿ãµã³ãã«ã¯äžè¬ã«ã¯åžéã
ãªããã°ãªããªãã奜ã¯ããŒã æ§çŽ°èè «ãå«ãçµ
ç¹ãµã³ãã«ã¯çžåœã«å€éã®ã«ãã³ãŒã«ã¢ãã³ãå«
ããšããããšãç¹èšãããã¹ãã§ããã被åæåº
ä¹³åç©ç³»ã®å®¹éã®äžéã¯ææãªãã°ïŒmlãšå€ããŠ
ããããå¿ èŠå®¹éã¯äžè¬ã«ã¯éåžžã«ããããªã®
ã§ãå°ããªå®éšåç©ãéèŠãªåé¡ãªã容æã«åæ
ã§ãããåãµã³ãã«ã¢ãªã³ãŒãäžã«ååšããã«ã
ã³ãŒã«ã¢ãã³ã®éã¯ãåã¯NEã®é瀺差çåæ
ã«ãããŠçŽ20ã10000pïœãïŒNEåã³DAã®ç€º
å·®çåæã«ãããŠçŽïŒã5000pïœã§ããã被åæ
ç³»ã®äžè¬çãµã³ãã«ã¢ãªã³ãŒãã¯ïœïœæ¿åºŠã«äŸå
ããŠçŽ10ã50ÎŒã§ããã åèšããéããCOMTã¯ã«ãã³ãŒã«æ žãâ
ã¡ãã«åããäžè¬ç掻æ§ãæã€ãæ¬çºæã®åææ³
ã¯å å æ§ã«ãã³ãŒã«ã¢ãã³ã«å¯ŸããŠæ¥µããŠç¹ç°ç
ã§ã¯ãããããã®ã«ãã³ãŒã«æ žãå€å æ§ã®ã«ãã³
ãŒã«æ žããèå¥ããªããäŸãã°ãåºä¹³åç©ãç¹ã«
人éãã«æäžãããå€æ°ã®è¬ç©ã¯ã«ãã³ãŒã«æ žã
æã€ããã«ãã³ãŒã«æ žãæã€ä»£è¬ç£ç©ã®åé§äœã§
ããããããè¬ç©åã³ïŒåã¯ä»£è¬ç£ç©ã®äŸã¯Î±â
ã¡ãã«ãã«ãšããããªã³ãαâã¡ãã«ããŒãã
ã³ãã€ãœãããã¬ããŒã«ãαâã¡ãã«ããŒããå
ã³ä»ã®åé¡ååç©ã§ãããåºä¹³åç©ããããè¬ç©
ã§ã®åŠçœ®ãåããŠãããªãã°ãCOMTãå©çšã
ãåæã®çµæã¯é床ã«é«ããªãã§ããããåŸã€
ãŠããããååç©ãæçšããåºä¹³åç©ã¯äžé©åœãª
被åæ察象ã§ããã é µçŽ COMTã¯æ§ã ãªåºä¹³åç©ã§çºèŠãããã
ãããåºä¹³åç©ã®äŸã¯ã©ãããä¹³çãè±ãããŠ
ã¹ãã¢ã«ã¢ãããç«ããŠãµã®ã人éã§ãããè©²é µ
çŽ ã¯ç³»ãäŸãã°èèãè èãèŸèãå°è žãè³çã
äžã«åºãååžããŠããã奜ãŸããã®ã¯ã©ããã§ã
ããè©²é µçŽ ãåé¢ããã®ã«å¥œãŸããåšå®ã¯èèã§
ããããã®åé¢æ³ã¯åœæ¥çã§ç¥ãããŠãããæŽã«
ç¡«é žã¢ã³ã¢ããŠã åå¥æ³ãçšãããšããç¹ãé€ã
ã°ãè©²é µçŽ ã®åé¢ã«ãããŠã¯æ®éã®å·¥çšãé²è¡ã
ãã該åå¥æ³ã¯ä»è¿åœæ¥çã«ãããŠè¡ãããŠããª
ããã30ã50ïŒ ãªãã55ïŒ ã®ç¡«é žã¢ã³ã¢ããŠã æ²
殿ç©ãç¡«é žã¢ã³ã¢ããŠã 55ïŒ æº¶æ¶²ãšããŠåæžæ¿ã
ããçžãåé¢ãã以åŸã¯æ®éã®åé¢å·¥çšãšããŠé²
è¡ããããã®ã§ããããã®ç¹å¥ã®åå¥å·¥çšã®è¿œå
ã«ãã空詊éšå€ãçžåœã«äœäžããã âã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒã¡ã
ã«ã¯ãé µçŽ ã«ããâã¡ãã«åã§çšããããæšè
åã¡ãã«åºäŸäžäœã§ããããã®ããªããŠã æšèå
ã¡ãã«åºäŸäžäœã¯åœæ¥çã§ç¥ãããŠããæŸå°ååŠ
æ³ã«ãã補é ã§ããåã¢ã¡ãªã«ã®ããŠãŒã€ã³ã°ã©
ã³ãã®ããŠãŒã¯ã¬ã¢ã³ãŒãã¬ãŒã·ãšã³ïŒNuclear
CorpïŒãšã¢ããŒã·ã€ã ãŒãµãŒã¬ïŒAmershamâ
ïŒSearleïŒãšããåžè²©ãããŠãããããªããŠã æš
èã¯ã¡ãã«åºéšäœã«ããããã®ã¡ãã«åºäŸäžäœ
ã¯ãã«ãã³ãŒã«ã¢ãã³ã®æ倧掻æ§ãåŸãåã«ãã³
ãŒã«ã¢ãã³ãâã¡ãã«åé床ã決å®ããæ¿åºŠãš
ããŠç¶æããããã«ã¯çŽïŒÎŒïŒä»¥äžã®æ¿åºŠã§ã€ã³
ããŠããŒã·ãšã³æ··åç©äžã«ååšãããã¹ãã§ãã
ããšãä»ãçºèŠããããããããåææ床ãåŸã
ããã«ã¯ãæšèåã¡ãã«åºäŸäžäœã¯ãæªæšèåé
æŸå°æ§ã¡ãã«åºäŸäžäœã§ããâã¢ããã·ã«â
âã¡ããªãã³ãæ¬è³ªäžå«ãã§ã¯ãªããªããæªæšè
åéæŸå°æ§ã¡ãã«åºäŸäžäœã®æ·»å ã¯ãã«ãã³ãŒã«
ã¢ãã³ã«å¯Ÿããåææ床ãäœããããæ床ã®äœã
åææ³ãææãªãã°ãããã¯ãæªæšèåéæŸå°æ§
âã¢ããã·ã«ââã¡ããªãã³ãåæã€ã³ããŠ
ããŒãã«å ããããšã«ããéæã§ãããæé«åæ
æ床ãåŸãããã«ã¯æ倧æŸå°èœãæã€ããªããŠã
æšèåâã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒ
ã¡ãã«ã補é ãã¹ãã§ãããïŒããŠãªãŒïŒããªã¢
ã«ã«çããããããã倧ããæŸå°èœãçšããããš
ãã§ããã奜ãŸããæŸå°èœã¯çŽ10ã15ããŠãªãŒïŒ
ããªã¢ã«ã§ããã é µçŽ ç³»ã掻æ§ã«ããããã«ã¯ãé žåæ°ãïŒïŒã§
ããå€æ°ã®ã«ããªã³ã®ãã¡ã®å°ããšãïŒçš®ãã€ã³
ããŠããŒãäžã«ååšãããã°ãªããªãã䜿çšã§ã
ãé žåæ°ãïŒïŒã®ã«ããªã³ã¯ãã°ãã·ãŠã ãã³ã
ã«ãåã³ãã³ã¬ã³ã§ããããã°ãã·ãŠã ã奜ãŸã
ãããã®éå±ã¯å¡©ãäŸãã°å¡©åãã°ãã·ãŠã ããš
ããŠååšã§ãããã«ããªã³ã¯çŽ10ã100ããªã¢ã«
ã®ã奜ãŸããã¯çŽ25ã35ããªã¢ã«ã®æ¿åºŠã§ã€ã³ã
ãŠããŒã·ãšã³æ··åç©äžã«ååšããã é µçŽ âåºè³ªç³»ãå®å®åãããååç©ãã€ã³ããŠ
ããŒãäžã«ååšããããã®ååç©ã¯ã«ãã³ãŒã«ã¢
ãã³ã®é žåã劚害ããããšã«ããç³»ã®çµ±åæ§ãç¶
æããåã€ã³ããŠããŒã·ãšã³äžã®é µçŽ 掻æ§ã®æç¶
ãå©ãããé µçŽ âåºè³ªç³»ãå®å®åãããããã«æ
å¹ã«çšããããšã®ã§ããååç©ã¯ã°ã«ã¿ããªã³ã
ãžããªã¹ã¬ã€ããŒã«ãã¢ã¹ã³ã«ãã³é žãã¡ã¿éäº
ç¡«é žãããªãŠã ãã¡ã«ã«ãããšã¿ããŒã«ãã·ã¹ã
ã€ã³çã§ãããã°ã«ã¿ããªã³ã奜ãŸãããã€ã³ã
ãŠããŒãäžã®ãã®å®å®å€ã®æ¿åºŠã¯çŽïŒã10ããªã¢
ã«ã奜ãŸããã¯çŽïŒãïŒããªã¢ã«ã§ãããã¢ã¹ã³
ã«ãã³é žãçšããæã«ã¯ãé µçŽ æŽ»æ§ã®æå¶ãçã
ãããšãããã®ã§ã泚æããŠéå°éã®äœ¿çšãé¿ã
ãªããã°ãªããªãã ã€ã³ããŠããŒãã®å¥ã®æåã¯ãé µçŽ äœçšã«ãã
転åã劚害ãããªãããã«ã«ã«ã·ãŠã ã€ãªã³ãåª
å é€å»ããè¬å€ã§ãããã«ã«ã·ãŠã ã€ãªã³ã¯ãã°
ãã·ãŠã ãã³ãã«ãããã³ã¬ã³ã®æ§ãªè³ŠæŽ»ã€ãªã³
ã®ååšäžã§ã®é µçŽ äœçšã«ããâã¡ãã«åãæå¶
ãããåŸã€ãŠãé µçŽ äœçšã«ãã転ååå¿ã«åå ã
ããªãããã«ã賊掻ã€ãªã³ã§ã¯ãªãã«ã«ã·ãŠã ã€
ãªã³ãéžæé€å»ããè¬å€ãã€ã³ããŠããŒãäžã«å
åšãããããšã極ããŠæçã§ããããã®æ©èœãæ
ããè¬å€ãäŸç€ºãããšEGTAïŒã±ã¬ãã¯ã¹
ChelexïŒãã€ãªã©ã ã©ãã©ããªãŒãº
ïŒBiorad LaboratoriesïŒããåŸãããšã®ã§ããæš¹
èç¶ç©è³ªãïŒèé žãããªãŠã ïŒã«ã«ã·ãŠã ã€ãªã³
ãéžæçã«ãã¬ãŒãããææãäŸãã°ã ã¬ãªãã·
ãïŒMureoxideïŒïŒåã³ä»ã®åé¡è¬å€ã§ã
ããEGTAã奜ãŸããããããè¬å€ã¯è³ŠæŽ»ã€ãªã³
åŠäœã«ãã€ãŠã¯ã«ã«ã·ãŠã ã€ãªã³ã«å¯Ÿããéžææ§
ãç°ãããšãããã®ã§ãç¹å¥ã®è³ŠæŽ»ã€ãªã³ãå¿ èŠ
ãšãããããšããããåå¿ èŠãªãã°æ·»å ãã¹ãã§
ããããããè¬å€ã¯é µçŽ äœçšã«ãã転åãå¯èœãª
éãæ¥éãã€å¹çããé²è¡ãããã®ã«å åãªéã§
ååšããããäŸãã°ãçŽïŒã25ããªã¢ã«ã®æ¿åºŠã§
EGTAãã€ã³ããŠããŒã·ãšãšã³æ··åç©äžã«äœ¿çšã§
ããã EGTAãCOMTã®åºæ掻æ§ã®å¢åŒ·ã®åå ãšãª
ãããšãçºèŠãããã空詊éšã€ã³ããŠããŒããå³
ã¡åºä¹³åç©ç³»ä»¥å€ã®å šæåãå«ãã€ã³ããŠããŒã
ã«æ·»å ããããšEGTAã¯ãâã¡ãã«ïŒ 3HïŒã«
ãã³ãŒã«ã¢ãã³ã®åœ¢æéã«ããå€æãããéãã
COMTã®é µçŽ 掻æ§ãé«ããã ã€ã³ããŠããŒãã®åæåã¯å šãŠãã«ãã³ãŒã«ã¢
ãã³æ¿åºŠãåŸéå åãšãªãéã§ååšããããé µ
çŽ ãã¡ãã«åºäŸäžäœãã«ããªã³ãå®å®åååç©ã
åã³ã«ã«ã·ãŠã ã€ãªã³ãéžæé€å»ããè¬å€ã¯ãã«
ãã³ãŒã«ã¢ãã³ãâã¡ãã«ïŒ 3HïŒåã«ãã³ãŒ
ã«ã¢ãã³ã«é©æ転åããã®ã«å¿ èŠãªéãè¶ éãã
éã§ååšãããã被åæåºä¹³åç©ç³»äžã«ååšãã
ã«ãã³ãŒã«ã¢ãã³ã®å šãŠãªããæ¬è³ªäžå šãŠã¯ã€ã³
ããŠããŒã·ãšã³æéäžã«è»¢åãããã é µçŽ äœçšã«ããã€ã³ããŠããŒã·ãšã³ã¯ãé µçŽ äœ
çšã«ãã転åãå®äºãããæéãšPHãšæž©åºŠã§æšæº
ã®æ€æ»è£ 眮ã§å®æœãããããã®ã€ã³ããŠããŒã·ãš
ã³ã®PHã¯çŽïŒãšçŽ10ãšã®éã«ç¶æãã¹ãã§ããã
奜ãŸããPHåã¯çŽïŒãïŒã§ããããã®ã€ã³ããŠã
ãŒã·ãšã³ã«ãšãé©åœãªç·©è¡å€ã¯äžãªã³é žå¡©åã¯ã°
ãªã·ã³ïŒNaOHã§ãããã€ã³ããŠããŒã·ãšã³æž©åºŠ
ã¯çŽ25ã45âã奜ãŸããã¯çŽ35ã40âã§ãããã€
ã³ããŠããŒã·ãšã³ã¯çŽ15åããçŽïŒæéã奜ãŸã
ãã¯çŽ40ã60åã®éé²è¡ãããã ã€ã³ããŠããŒã·ãšã³ã¯æ§ã ãªæšæºæ段ã®ããã
ã«ãã€ãŠãåæ¢ããããäŸãã°æž©åºŠãäžãããäž
ããåã¯PHãäžãããäžããããšãã§ããã枩床
ãäžãããã€ãã°ãã·ãŠã ãã³ãã«ããåã¯ãã³
ã¬ã³ã®çµåå€ã®æ·»å ã«äŒŽãé«PHã®å°å ¥ã«ããã€ã³
ããŠããŒã·ãšã³ãåæ¢ãããããšã奜ãŸãããçµ
æžçãæéçå åãåã¯å人ç奜ã¿ã«ãããææ
ãªãã°ãâã¡ãã«ïŒ 3HïŒåã«ãã³ãŒã«ã¢ãã³
ãã€ã³ããŠããŒãããéžæé€å»ããåã«ã€ã³ããŠ
ããŒã·ãšã³ãåæ¢ãããå¿ èŠã¯ãªãã åæ¢æ¶²ã«ã¯æ äœéã®MNïŒNMNåã³MEOTã
ãå«ããããšãã§ãããã«ãã³ãŒã«ã¢ãã³ã¯è¢«æ€
ãµã³ãã«äžã«ã¯éåžžã«å°éã§ããååšããªãã®
ã§ããããã®æ äœååç©ãå ããŠãåæäžã®è¢«æ€
ãµã³ãã«äžã®ã«ãã³ãŒã«ã¢ãã³ã®èªèãšåé ãšã
容æã«ãããšæå©ã§ããã該æ äœååç©ã¯äžè¬ç
ã«ã¯ãããå¡©é žä»å å¡©ãšããŠååšããããã®åœ¢ã®
æ¹ãå®å®ã§ããããã§ããã次ã®åæå·¥çšã«ãã
ãŠãã®éé¢å¡©åºã圢æãããã該æ äœååç©ã¯ã€
ã³ããŠããŒãã®ææ©æº¶åªæœåºã«å ç«ã€ãŠåæ¢æ¶²äž
ã«æ·»å ããããšã奜ãŸããããCOMT転移ã«ã
ãã平衡ã«äŸåããŠåãã«ã€ã³ããŠããŒãã«å ã
ãããšãã§ãããã€ã³ããŠããŒã·ãšã³ãåæ¢ããª
ããªãã°æ äœéã®MNïŒNMNåã³MEOTãæŽ
ã«ãåªå çææ©æº¶åªã§ã®æœåºã«å ç«ã€ãŠã€ã³ããŠ
ããŒãã«æ·»å ãã¹ãã§ãããçŽïŒãïŒããªã¢ã«ã®
æ äœæ¿åºŠãçšããããšãã§ããã ä»ããâã¡ãã«ïŒ 3HïŒåã«ãã³ãŒã«ã¢ãã³
ã¯æº¶åªæœåºã«ããã€ã³ããŠããŒãããéžæé€å»ã
ãããMNïŒNMNåã³MEOTãã€ã³ããŠããŒã
ããæœåºããææ©æº¶åªãçšããããã¡ãããâ
ã¡ãã«åã«ãã³ãŒã«ã¢ãã³ãåªå 溶解ãããå³ã¡
ã€ã³ããŠããŒãæåãåå¿å¯çç©ãã®ä»ã®ç°ç©ã®
ã§ããã ãå€ããæ°Žæ§ã€ã³ããŠããŒãäžã«æ®ãæ
æ©æº¶åªã䜿ãããšã奜ãŸãããæ°Žãšã¯å®è³ªäžéæ··
ååæ§ã®ææ©æº¶åªã䜿çšã§ãããçšããããšã®ã§
ããææ©æº¶åªã®äŸã¯ããã¿ããŒã«ãã€ãœã¢ãã«ã¢
ã«ã³ãŒã«ããããµããŒã«ã®æ§ãªé«çŽã¢ã«ã³ãŒã«ïŒ
é ¢é žãšãã«ã®æ§ãªãšã¹ãã«ïŒãžãšãã«ãšãŒãã«ã
ããã©ããããã©ã³ããžãªããµã³ã®æ§ãªãšãŒã
ã«ïŒãã³ãŒã³ããã«ãšã³ããã·ã¬ã³é¡ã®æ§ãªè³éŠ
æååç©ïŒã§ããã奜ãŸããææ©æº¶åªã¯ã€ãœã¢ã
ã«ã¢ã«ã³ãŒã«ããã¿ããŒã«ããã«ãšã³åã³ãã·ã¬
ã³é¡ã§ãããæŽã«å¥œãŸããã®ã¯ææ©æº¶åªã®ç¹å®æ··
åç©ãç¹ã«35ïŒ75vïŒïœïŒ ã®ãã«ãšã³ïŒã€ãœã¢ã
ã«ã¢ã«ã³ãŒã«æ··åç©ã奜ãŸããã¯ã¯50ã65ïŒ ã®ã
ã«ãšã³ãå«ããã«ãšã³ïŒã€ãœã¢ãã«ã¢ã«ã³ãŒã«æ··
åç©ã§ããã ææ©æº¶åªæœåºãããâã¡ãã«ïŒ 3HïŒåã«ã
ã³ãŒã«ã¢ãã³ããã«ãã³ãŒã«ã¢ãã³ã®ã¢ãã³å®èœ
åºã«ãããã³ãä»äžããã®ã«å åãªåŒ·åºŠãæã€é ž
ã®æ°Žæº¶æ¶²äžã«ååé ãããããããé žã®äŸã¯ã®
é žãé ¢é žãããããªã³é žãå¡©é žãç¡«é žããªã³é žç
ã§ãããæªç€ºå·®åãšNEã®åèšéãåæããã
ãã®åæãè¡ãã«ã¯ãããã®é žã®ããããã䜿çš
ã§ããããããããšNEãšã®ç€ºå·®åæãè¡ãæ
ã«ã¯ãæ¯èŒçäœã沞ç¹ãæã¡ããã€èžçºã«éããŠ
æ®æž£ãæ¬è³ªçã«ã¯å šãæ®ããªãé žãäŸãã°ã®é žã
é ¢é žãããããªã³é žã奜ãŸããã¯é ¢é žã䜿çšãã
ããšã奜ãŸããããã®ç€ºå·®åæã§ã¯NMNãMNã
ãåé¢ããããã®ã¯ãããã°ã©ãã€ãŒå·¥çšãå¿ èŠ
ãšããããMNåã¯NMNã®é žä»å å¡©ã®ååšãã
NMNããã®MNã®åé¢ã被æ€ãµã³ãã«äžã®ä»æå
ããã®åã«ãã³ãŒã«ã¢ãã³ã®åé¢ã劚害ãããå
é å¹æãé«ããããã«ååé ãæ°åºŠããè¿ãããš
ãã§ããã æ°Žçžãææ©çžããé«å¯åºŠã§ãããªãã°ãäºçžã®
åé¢ã¯æ°Žçžã®åçµã«ãã容æã«ãªãããšãçºèŠã
ãããåçµã«ããåææéãççž®ãããåæ°Žçžã
ãã®ææ©çžã®åé¢ãäžå±€æçœãã€æ£ç¢ºãšãªãã ãšNEãšã®æªç€ºå·®ååèšéãç¥ãããšãææ
ãªãã°ãMNãNMNããåé¢ããå·¥çšã¯è¡ããª
ãããã®ä»£ããã«é žæ°Žæº¶æ¶²æœåºç©ãåªå çã«ä¹Ÿç¥
ãããå¡©åºæ§æº¶æ¶²ã«å ¥ããMNãšNMNãšããããª
ã³ã«é žåããã ãšNEãšã®ç€ºå·®åææ³ãè¡ãæã«ã¯ãã®æç¹
ã§MNãšNMNããåé¢ãããâã¡ãã«åã«ãã³
ãŒã«ã¢ãã³ãåé¢ããæ®éã®æ段ã¯ã¯ãããã°ã©
ãã€ãŒãäŸãã°ããŒããŒã¯ãããã°ã©ãã€ãŒãšè
å±€ã¯ãããã°ã©ãã€ãŒã§ããã奜ãŸããã¯èå±€ã¯
ãããã°ã©ãã€ãŒã§ãããâã¡ãã«åã«ãã³ãŒ
ã«ã¢ãã³ãå«ãé žæ°Žæº¶æ¶²æœåºç©ã也ç¥ããã95ïŒ
ãšã¿ããŒã«ã®æ§ãªææ©æº¶åªã«æº¶è§£ãããããã®ãš
ã¿ããŒã«æº¶æ¶²ããåžçå€ãäŸãã°çªé žè³ªæãã®è
å±€ã«ãã被ãããã¯ãããã°ã©ãã€ãŒæ¿ã«å¡ãã
åžçå€ã®å±€åã¯åœæ¥çã§äžè¬çã«äœ¿çšãããŠãã
ãã®ã§ãããäŸãã°50ã750ÎŒã奜ãŸããã¯200ã
300ÎŒã§ãããåžçå€ã¯ã·ãªã«ã²ã«ã奜ãŸããã
åé¢ã«äœ¿çšããã溶åªç³»ã¯MNãNMNããåé¢ã
ãããšãç¥ãããŠããç³»ã®ãããã§ãããããã
ããã·ãªã«ã²ã«ãšå ±ã«ã¯ãïœïŒïœïŒ ã§60ã®ã€ãœã
ããã«ã¢ã«ã³ãŒã«ã20ã®ïœâãã¿ããŒã«ã19ã®
æ°Žãåã³ïŒã®ã®é žãšããçµæãæã€æº¶åªç³»ã䜿çš
ããããšã奜ãŸããããã®æº¶åªç³»ã䜿çšããæã«
ã¯MNã¯çŽ0.59ã®Rfå€ãNMNçŽ0.7ã®Rfå€ã瀺
ããMEOTã¯NMNããåé¢ããªããNMNããã®
MNã®åé¢ã¯æ¥éãã€é¡èã«èµ·ãããå¥ã®æº¶åªç³»
ãã·ãªã«ã²ã«ãšçµã¿åããŠäœ¿çšããæã«ã¯
MEOTãNMNããåé¢ãããã容éæ¯ã§ïŒéšã®
ïœâã¢ãã«ã¢ã«ã³ãŒã«ãšïŒéšã®ãã³ãŒã³ãšïŒéšã®
ã¡ãã«ã¢ãã³ãããªãå¡©åºæ§æº¶åªç³»ã¯ã·ãªã«ã²ã«
äžã§MEOTãNMNããåé¢ããããã®å Žåã
MEOTãåç¹ïŒæº¶åªç³»å¡åžå°ç¹ïŒããæãé¢ã
ãŠãããMNãMEOTããã¯åç¹ã«è¿ããNMN
ãåç¹ã«æãè¿ããããã®åŸè ã®æº¶åªç³»ã«ããã
åé¢ãããMEOTã®æŸå°ç·æŸåºãå©çšããŠã®DA
ã®å®¹æãªåæãå¯èœãšãªãã äžèšèå±€ã¯ãããã°ã©ãã€ãŒå·¥çšã§çšãããã
å¡©åºæ§æº¶åªç³»ã¯æ°èŠã§ããããã®ç³»ã®å¿ é æåã¯
容éæ¯ãçŽïŒïŒïŒããçŽïŒïŒïŒã§ããã¢ã«ã³ãŒã«
ãšã¡ãã«ã¢ãã³ãšã§ãããã¡ãã«ã¢ãã³ã¯40ïŒ æ°Ž
溶液ãšããŠäœ¿çšããããã¢ã«ã³ãŒã«ã¯ïœâã¢ãã«
ã¢ã«ã³ãŒã«ãã€ãœã¢ãã«ã¢ã«ã³ãŒã«ãïœâãã¿ã
ãŒã«çã®æ§ãªé«çŽã¢ã«ã³ãŒã«ã§ãããç¡æ¥µæ§ã§èŠª
æ²¹æ§ã®ææ©ååç©ããã®æº¶åªç³»äžã«ååšãããã
ãšãã§ãããããã溶åªã®ååšã«ãã移åé床ãš
ã¹ãããåé¢é床ãšãäžæãããããã¯äžçžæº¶åª
ç³»ãä¹±ããªãéãå€éã«ååšãããããšãã§ã
ããçšããããšãã§ããç¡æ¥µæ§ã»èŠªæ²¹æ§ææ©æº¶åª
ã®äŸã¯ããã³ãŒã³ããã«ãšã³ãïœâãã·ã¬ã³åã³
ïœâãã·ã¬ã³ã§ããã åæã®ãã®æç¹ã§MNãå«ãã¹ããããæ°Žé žå
ã¢ã³ã¢ããŠã ã®æ§ãªæº¶åªãçšããŠã·ãªã«ã²ã«ãã
溶é¢ãããã€ãã§ãã€ã³ããŠããŒãã®æœåºã®ãšã
ãã§æ¢ã«é瀺ããææ©æº¶åªåã¯ææ©æº¶åªç³»ã§æœåº
ããã ã€ãã§æŸå°æ§æšèåååç©ãèšæ°ãããã¯ãã
ãã°ã©ãã€ãŒåé¢ã«ãããŠå¡©åºæ§æº¶åªç³»ã䜿çšã
ãæã«ã¯ãMEOTãšNMNãšã¯åäžæ¹æ³ã§åæã§
ãããããããé žæ§ãå¡©åºæ§ãã®ããããã®æº¶åª
åé¢ç³»ããåŸãããMNãšNMNãšããããªã³ã«é ž
åããããšã奜ãŸãããβâããããã·ã«ãã³ãŒ
ã«ã¢ãã³ã®ã¿ããã®é žåãåããã®ã§ãã®é žåã«
ããåæç¹ç°æ§ã¯å€§ãããªãããã®å·¥çšã«ããã
βâããããã·åºãæããªãä»ã®æšèåã«ãã³ãŒ
ã«æ žååç©ã¯åé¢ããããæŽã«ãé žæ§æº¶åªç³»ã«ã
ããŠã¯ãNMNãšMEOTãšã¯åé¢ãããªãã®ã§ã
NMNããããªã³ã«é žåããããšãå¿ èŠã§ããã
æªç€ºå·®åãšNEãšã®åèšéãåæããã ãã®æ
ã§ããMEOTãMNåã³NMNããåé¢ããã«ã¯
ãã®é žåãå¿ èŠã§ããã βâããããã·ââã¡ãã«åã«ãã³ãŒã«ã¢ã
ã³ã®é žåã¯æšæºã®è©Šè¬ãšæ¡ä»¶ãšãçšããŠéæãã
ããMNåã¯NMNãåžçå€ãã溶é¢ãããåŸã«
MNãšNMNãšããçŽïŒã12ã®PHãçŽïŒã50âã®æž©
床ã§çŽïŒã30åéãã¡ã¿éãšãŠçŽ é žå¡©ãããªãŠã
ã®æ§ãªé žåå€ãšæ¥è§ŠããããMNãšNMNãšã¯ãã
ãªã³ã«å®éçã«é žåãããªããã°ãªããªããåå¿
枩床ã¯çŽïŒã40âã奜ãŸãããåå¿æéã¯ïŒã10
ã奜ãŸããã ä»ããéãšãŠçŽ é žå¡©ã«ããé žåã¯ã·ãªã«ã²ã«ã®
æ¥è§Šååšäžã§å®æœã§ããããšãçºèŠãããããã
ã«ããåæã®æ床ãæ£ç¢ºåºŠã粟床ãé«ãŸããé žå
å·¥çšãåäžå®¹åšå ã§å®æœã§ããããã§ãããMN
åã¯NMNãå«ãã·ãªã«ã²ã«åž¯ãæ¿ããåãã管
ã«å ¥ããMNåã¯NMNãæ°Žé žåã¢ã³ã¢ããŠã ã®æ§
ãªå¡©åºæ§æº¶åªã§æº¶åºããã¡ã¿éãšãŠçŽ é žãããªãŠ
ã ãå ããããããªã³ãžã®é žåã¯ã·ãªã«ã²ã«ã®æ¥
觊ååšäžã§ã¹ã ãŒãºã«ãåäœã®å°é£ããªãèµ·ã
ãã é žåã¯å®äºããããåæ¢ããããåæ¢å€ã¯äžè¬
çã«ã¯ã°ãªã»ããŒã«æº¶æ¶²ã§ãããç³»ã®PHãæªã ïŒ
ãªãããã以äžã§ãªããªãã°ãç³»ã®PHãé žã«ãã
ïŒãªãããã以äžã«äžãããçšããããé žã®æ§è³ª
ã¯é倧ã§ã¯ãªããå¡©é žãç¡«é žããªã³é žãã®é žãé ¢
é žãããããªã³é žãçšããããšã®ã§ããé žã®äŸã§
ããã ãããªã³ããæ°Žæ§ãã©ã¯ã·ãšã³ãšå®è³ªäžéæ··å
æ§ã®ææ©æº¶åªäžã«æœåºããããã®ææ©æº¶åªã¯ãã
ããªã³ãšçžå¯Ÿçã«æ¥µæ§ã®å¯çç©ãšãååã«åé¢ã
ããããã«ã¯çžå¯Ÿçã«ç¡æ¥µæ§ã§ããããšã奜ãŸã
ããããã溶åªã®äŸã瀺ããšãã³ãŒã³ããã«ãš
ã³ãïœâãã·ã¬ã³ãïœâãã·ã¬ã³ããšãã«ãã³ãŒ
ã³ãã€ãœãããã«ãã³ãŒã³ïŒé ¢é žãšãã«ãé ¢é žã€
ãœãããã«ã®æ§ãªãšã¹ãã«ïŒãžãšãã«ãšãŒãã«ã
ïŒïŒïŒâãžãªããµã³ã®æ§ãªãšãŒãã«ïŒã§ãããæ°Ž
çžãææ©çžããé«å¯åºŠã§ããæã«ã¯æ°Žçžãåçµã
ããææ©çžãé€ãããšã«ããïŒçžã®åé¢ã¯å®¹æã«
ãªãã ãããªã³â 3Hãèšæ°ããããã©ã³ã·ãã
ïŒplanchetïŒèšæ°ã®æ§ãªæ§ã ãªæŸå°ç·èšæ°æè¡ã
çšããããšãã§ãããã液äœã·ã³ãã¬ãŒã·ãšã³èš
æ°æè¡ã奜ãŸãããçšããããåã ã®æ¶²äœã·ã³ã
ã¬ãŒã¿ãŒãäœã§ãããã¯ããããããªããŠã ãã
æŸåºãããβç·ã«æé²ãããæã«äžå®éã®å ãæŸ
åºããéãé倧ã§ã¯ãªããé©åœãªã·ã³ãã¬ãŒã¿ãŒ
ã®äŸã¯ïœâãã«ããšãã«ïŒïŒïŒïŒâãžããšãã«ãª
ããµãŸãŒã«ïŒïŒâããšãã«âïŒâïŒïŒâãããšã
ãªã«ïŒâïŒïŒïŒïŒïŒâãªããµãžã¢ãŸãŒã«ïŒïŒïŒïŒ
âãã¹âïŒâïŒïŒâïœâããã«ãã³ãŸããµãŸãª
ã«ïŒâããªããšã³ïŒ2.5âãžããšãã«âïŒïŒïŒïŒ
ïŒâãªããµãžã¢ãŸãŒã«ïŒïŒâïŒ4â²âãããšãã«ïŒ
âïŒâããšãã«ãã³ãŸããµãŸãŒã«ïŒïŒïŒïŒâãã¹
âïŒâïŒïŒâããšãã«ãªããµãŸãªã«ïŒâãã³ãŒ
ã³ïŒã§ããããã®ã·ã³ãã¬ãŒã¿ãŒã¯ææ©æº¶åªã«æº¶
解ããããã·ã³ãã¬ãŒã¿ãŒãšæº¶åªãšã®çµåãã以
åŸã液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªãšåŒã¶ããããªã³
ãå«ãææ©æº¶åªããã®æ¶²äœã·ã³ãã¬ãŒã·ãšã³åªè³ª
ã«å ããèšæ°ããã奜ãŸãããããªã³â3Hæœåº
æ³ã¯ãæœåºçšæº¶åªãšããŠæ¶²äœã·ã³ãã¬ãŒã·ãšã³åª
質ã䜿çšããããšã§ãããåæç¹ç°æ§ã¯ããããª
ã³å«æææ©æº¶åªãé žæ°Žæº¶æ¶²ãšæ¥è§Šãããããã«ã
ã氎溶æ§äžçŽç©ãæŽã«é€å»ããããšã«ããæŽã«é«
ããããšãã§ããããã®æœåºã¯ããããªã³å«ææ
æ©æº¶åªã液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªã«æ·»å ãã以
åã«è¡ãããšãã§ããããé žæ°Žæº¶æ¶²çžã液äœã·ã³
ãã¬ãŒã·ãšã³åªè³ªãšæ¥è§Šãããããšã奜ãŸããã
ãã®æ¹æ³ã«ãããŠåé¢è»¢ç§»ãšçžåé¢ãšã®æ°ãæå°
ã«ãªãããããªã³ã液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªã«
å ããæã«ã¯ãããªã³ã¯ææ©å±€äžã«çãŸããã·ã³
ãã¬ãŒã¿ãŒã«ããèšæ°ããããããããã·ã³ãã¬
ãŒã¿ãŒã¯ææ©çžã«ååšããåããªããŠã ããã®Î²
ç·æŸåºã¯æ°Žçžãšçé¢ãšã«ããåæ¢ãããã®ã§ãé ž
氎溶液çžäžã«æœåºããããããã®ããªããŠã æšè
å借éç©ãèšæ°ãããªãã液äœã·ã³ãã¬ãŒã·ãšã³
åªè³ªã¯ãã·ã³ãã¬ãŒã¿ãŒãæ°Žçžã«ã»ãšãã©ãªãã
å šã溶解ããŠããªããã®ãéžæããªããã°ãªããª
ãã DAãåæ§ã«ããŠåæããããšãææãªãã°ã
éãšãŠçŽ é žå¡©æ°Žæº¶æ¶²çžã®PHãïŒãã倧ããã奜ãŸ
ããã¯9.8ã10.1ã«äžãããããªã³æœåºã§äœ¿çšã
ããæ§ãªææ©æº¶åªã§MEOTãæœåºãããMEOT
â 3Hããã®æŸå°ç·ã®èšæ°ã¯ããããªã³â 3Hã®
å Žåãšåæ§ãªæ¹æ³ã§è¡ãã æªç¥éã®ã«ãã³ãŒã«ã¢ãã³ãå«ãåºä¹³åç©ç³»ãš
åæã«ãåºä¹³åç©ç³»ä»¥å€ã®ã€ã³ããŠããŒãæåã®
å šãŠãå«ã空詊éšãµã³ãã«ãåäžã®æ¹æ³ã§åæã
ãããã®åææ床ã¯ã空詊éšãµã³ãã«ã®èšæ°å€ã®
ïŒåã®å€ã瀺ãã«ãã³ãŒã«éãšããŠå®ãããåæ
æšæºæ²ç·ããæªç¥ãµã³ãã«ã空詊éšãµã³ãã«ãšå ±
ã«æ¢ç¥éã®ïŒ¥ïŒNEåã¯DAãåæããããšã«ãã
åŸããæ¢ç¥æ¿åºŠã®ïŒ¥ïŒNEåã¯DAã§åŸãããèšæ°
å€ããã®æ¿åºŠã«å¯ŸããŠãããããããã€ãã§ãæš
æºæ²ç·ãåç §ããããšã«ãããæªç¥æ¿åºŠã®ã«ãã³
ãŒã«ã¢ãã³ãæŸåºãããæŸå°ç·ã®æ°ããæ±ããã ãã®æ¹æ³ã«ãããŠãã§3pïœïŒNEã§5pïœïŒ
DAã§12pïœãæªç€ºå·®åãšNEãšã®åèšéã§5pïœ
ã®æ床ã«éããããšãã§ããã極ããŠå°ãããµã³
ãã«ãµã€ãºã®åºä¹³åç©ç³»ããå€ç°ä¿æ°ãïŒã12ïŒ
ã§ãããšãã粟床ãåŸããããæšæºæ²ç·ã¯çŽ3p
ïœããå°ããšã3000pïœã®ç¯å²å ã§äžæ¬¡åå¿é床
ã瀺ããæ¬çºæã®åæç³»ã¯å€ç®çã«äœ¿çšã§ããæ¥
éã§ãååæ¥çã«æçšã§ããã 以äžã¯æ¬çºæã®åæç³»ããããå©çšããåææ¹
æ³ã®ç¹å®å®æœäŸã§ãããå®æœäŸã¯æ¬çºæã®æŠå¿µã
äŸç€ºããããšã®ã¿ãç®çãšãããããéå®ããã
ã®ã§ã¯ãªãã å®æœäŸ ïŒ ïŒ¡ ã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ ã®èª¿è£œ ãã®é µçŽ 調補ã¯äžè¬çã«ã¯Axelrodãš
Tomchickãšã®æ¹æ³ïŒJ.Biol.Chem.233ïŒ702ïŒ
1958幎ïŒã«åŸãã ã©ãããç æ§ã«ãããèèãåãåºããå·ç匵
KClïŒ1.15ïŒ ïŒäžã§ãªã³ã¹ããåžåçŽã䜿ã€ãŠä¹Ÿ
ç¥ãããéããéããïŒå容éã®ç匵KClã«å ¥ã
ãŠå質åãããåŸãããåç質ã78000ïœã§30å
éé å¿åé¢æäœã«ä»ãããäžæŸã¿ããã«ã³ããŒã·
ãšã³ã«ããåãåºãããã®PHããæ¹æããªãã
1Né ¢é žã滎äžããããšã«ããPHïŒã«èª¿æŽããã
å·æã«æŸçœ®ããåŸã«é å¿åé¢æäœã«ä»ããŠã圢æ
ãããæµ®é液ãé€å»ããã åŸãããäžæŸã¿ããã«ã³ããŒã·ãšã³ã«ããååº
ããããã«ç¡«é žã¢ã³ã¢ããŠã ïŒAmSO4ïŒããã€ã
ããšå ããŠAmSO4æ¿åºŠã30ïŒ ã«ãããé å¿åé¢
æäœåŸã«äžæŸã¿ããã«ã³ããŒã·ãšã³ã«ããåãåº
ããããã«AmSO4ãå ããŠãã®æ¿åºŠã55ïŒ ã«äž
ãããçæ溶液ãé å¿åé¢æäœã«ä»ããŠ30ã55ïŒ
AmSO4ãã©ã¯ã·ãšã³ãçæããã ãã®30ã55ïŒ AmSO4æ®æž£ãã0.1ããªã¢ã«ã®ãž
ããªã¹ã¬ã€ããŒã«ïŒåã¯0.2ããªã¢ã«ã®ã°ã«ã¿ã
ãªã³ïŒãå«ãPH7.4ã®ïŒããªã¢ã«ãªã³é žå¡©
ïŒPO4ïŒç·©è¡æ¶²ã«æº¶è§£ããã€ãã§AmSO4ãåã³ã
ã€ãããšå ããŠAmSO4æ¿åºŠã55ïŒ ã«ããããã®
è¿œå ã®AmSO4åå¥æ³ã«ãããäœã空詊éšå€ã瀺
ãé µçŽ èª¿è£œç©ãæäŸããããé å¿åé¢æäœåŸã«æ®
枣ãåã³äžèšãšåäžã®PO4ç·©è¡æ¶²ã«æº¶è§£ããåäž
ç·©è¡æ¶²ãïŒåºŠãããŠéæããããã®éæãè¡ãã«
ã¯æ®é14ã18æéããã€ãã é µçŽ èª¿è£œç©ã®æŽ»æ§ã枬å®ãããã®å®¹éããã«ã
ã³ãŒã«ã¢ãã³ã®åæã§æé©ã«äœ¿çšã§ããæ§ã«èª¿æŽ
ãããé µçŽ èª¿è£œç©ã®èçœæ¿åºŠã枬å®ããã ãã®èª¿è£œç©äžã«ã¯è³éŠæâã¢ãã³é žã«ã«ãã
ã·ã«åºåè§£é µçŽ æŽ»æ§ãååšããã®ã§ãå¡©é žãã³ãž
ã«ãªãã·ã¢ãã³åã¯ãªã³é žïŒâããããã·âïŒâ
ããã ãã³ãžã«ãªãã·ã¢ãã³ã®æ§ãªã«ã«ããã·ã«
åºåè§£é µçŽ é»å®³å€ã10-3ã¢ã«æ¿åºŠã§é µçŽ 調補ç©äž
ã«å«ãããã€ã³ããŠããŒãé»å®³å€æ¿åºŠã¯10-3ã
10-5ã¢ã«ã ã€ãã  溶液 以äžã®æº¶æ¶²ã調補ããã ïŒ å®å®å溶液âå šå®¹é0.5ml 10ããªã¢ã«ã®éå æ§ã°ã«ã¿ããªã³ã0.01NHCl
ã«æº¶è§£ããã ïŒ æšæºæº¶æ¶²âå šå®¹é0.5ml ãã«ãšããããªã³ããšããããªã³åã³ããŒãã
ã³ãå®å®å溶液ã«æº¶è§£ããŠåå¡©åºã®æçµæ¿åºŠã
100ÎŒïœïŒmlã«ããã ïŒ ç·©è¡æ¶²âå šå®¹éïŒml 1000ããªã¢ã«ã®ããªã¹ïŒããããã·ã¡ãã«ïŒã¢
ããã¡ã¿ã³ãš100ããªã¢ã«ã®EGTAãš300ããªã¢ã«
ã®å¡©åãã°ãã·ãŠã ãšãå«ã溶液ã ïŒ ïŒ³âã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒã¡
ãã«âå šå®¹é0.4ml ç¹ç°æŽ»æ§ãïŒ8CiïŒããªã¢ã«ã§ããïŒÎŒCiïŒ10
ÎŒã®3Hãåžç¡«é žïŒãšã¿ããŒã«å ¥ããã ïŒ ã©ããèããã®ã«ãã³ãŒã«ââã¡ãã«åºè»¢
ç§»é µçŽ âå šå®¹é0.45ml é µçŽ æº¶æ¶²ã®èçœæ¿åºŠã¯15ã40mgïŒmlãšããã溶
液ã«ã¯ãªã³é žå¡©ç·©è¡å€ãã°ã«ã¿ããªã³åã³ãžããª
ã¹ã¬ã€ããŒã«ããå«ããã ïŒ åæ¢æ¶²âå šå®¹éïŒml 1Næ°Žé žåãããªãŠã äžã®800ããªã¢ã«ã®ç¡Œé žãš
80ããªã¢ã«ã®EDTAäºãããªãŠã ãïŒããªã¢ã«ã®
DLâã¡ã¿ãããªã³ïŒHClãïŒããªã¢ã«ã®DLâã
ã«ã¡ã¿ãããªã³ïŒHClãåã³ïŒããªã¢ã«ã®ã¡ãã
ã·ãã©ãã³ïŒHClãå«ããã ïŒ ã¡ã¿éãšãŠé žå¡©ãããªãŠã ïŒïœïŒïœïŒïŒ 溶液
âå šå®¹éïŒml ïŒ ã°ãªã»ããŒã«10ïŒïœïŒïœïŒïŒ 溶液âå šå®¹éïŒ
ml  åºä¹³åç©ç³»ã®èª¿è£œ 人è¡æ¶²ã®ãµã³ãã«ãæ£è ããæ¡è¡ããããã®è¡
液ããEGTAïŒ250ããªã¢ã«ïŒãšã°ã«ã¿ããªã³
ïŒ200ããªã¢ã«ïŒãšã®æ··åç©ãå«ã管ã«éãããå®
å®å溶液ã®PHã¯ïŒãïŒã«ããŠããããæ¡éå šè¡ã®
ïŒmlåœãã20ÎŒã®å®å®å溶液ãå ãããã€ã
ã§ãè¡æ¶²ãµã³ãã«ãé å¿åé¢æäœã«ä»ããŠè¡æŒ¿ã
åŸããè¡æŒ¿ãåçµãããããµã³ãã«ã«ãã€ããªã³
åã³ä»ã®ç²ç¶ç©å³ã¡æ¿ãããªãããã«æ³šæãæã€
ãã  è©Šè¬æ··åç© ïŒ¢ã§åŸã次ã®æåãã次ã®é äœãšå²åãšã§çšã
ãŠè©Šè¬æ··åç©ã調補ããã æº¶æ¶²ïŒ 10ÎŒ æº¶æ¶²ïŒ 10ÎŒ æº¶æ¶²ïŒ ïŒã20ÎŒ èžçæ°Žâ» å šéã40ÎŒã«ããé â»ïŒè±ã€ãªã³ãã¬ã©ã¹èžçïŒ é µçŽ æ·»å åã«æ··åç©ã軜ã枊åãããåè©Šè¬æ··
åç©å®æåŸã«è»œã枊åããããæ§ã ãª40ÎŒåå¿
æ··åç©ã調補ããã  æšæºæº¶æ¶²ãšå®å®å溶液 溶液ïŒã®ã¢ãªã³ãŒããå·èžçæ°Žã§ïŒïŒ10000ã®
æ¯ã§åžéããŠæ°·æµŽäžã«è²¯èµãããããã«ãã10ÎŒ
åœãã100pïœã®åã«ãã³ãŒã«ã¢ãã³ãå«ã
âå¯äœ¿æšæºç©âãæäŸããã 溶液ïŒã®ã¢ãªã³ãŒããåæ§ã«åžéããã  ã€ã³ããŠããŒã·ãšã³ 50ÎŒã®è¡æž ã®å ¥ã€ã管ã«10ÎŒã®æº¶æ¶²ïŒãšã
40ÎŒã®å·¥çšïŒ€ã®è©Šè¬æ··åç©ãšãå ããã 空詊éšãµã³ãã«ãåç §æšæºãæ¢ç¥æ¿åºŠã®ã«ãã³
ãŒã«ã¢ãã³ãå«ãè¡æŒ¿ãµã³ãã«ã®åæãæªç¥ãµã³
ãã«ã®åæãšå ±ã«åæ§ã«è¡ã€ããåç §æšæºã¯æ°Žäž
ã§ãåºä¹³åç©ç³»ãååšããªãå Žåã®é µçŽ ã®ïŒ¯âã¡
ãã«ååã枬å®ããããã«å«ãããæ¢ç¥æ¿åºŠã®ã«
ãã³ãŒã«ã¢ãã³ãå«ãè¡æŒ¿ãµã³ãã«ã¯åæã®å質
å¶åŸ¡ã枬å®ããããã«å«ããã 空詊éšãµã³ãã«ã¯50ÎŒã®èžçæ°Žã10ÎŒã®æº¶
液ïŒã40ÎŒã®è©Šè¬æ··åç©ãã調補ããã åç §æšæºã¯50ÎŒã®èžçæ°Žã10ÎŒã®å·¥çšïŒ¥ã®
å¯äœ¿æšæºç©ã40ÎŒã®è©Šè¬æ··åç©ãã調補ããã ã«ãã³ãŒã«ã¢ãã³å«éãæ¢ç¥ã®è¡æŒ¿ãµã³ãã«ã¯
50ÎŒã®è¡æŒ¿ã10ÎŒã®å·¥çšïŒ¥ã®å¯äœ¿æšæºç©ã40
ÎŒã®è©Šè¬æ··åç©ãã調補ããã æªç¥ãµã³ãã«ãå«ãäžèšãµã³ãã«ç®¡ãšä»ã®æº¶æ¶²
管ãšããåæãéããŠåäžã«åŠçãããåŸã€ãŠã
次äžã®å·¥çšã«ãããŠã¯æªç¥ãµã³ãã«ç®¡ã«ã®ã¿èšå
ããã ãµã³ãã«ç®¡ã軜ã枊éããã37âã§60åéæ¯å
氎济å ã§ã€ã³ããŠããŒã·ãšã³ãããã€ã³ããŠããŒ
ã·ãšã³çµäºåŸã«ç®¡ã氷济ã«æ»ãã50ÎŒã®æº¶æ¶²ïŒ
ãå ããã  æœåº ïŒmlã®ãã«ãšã³ïŒã€ãœã¢ãã«ã¢ã«ã³ãŒã«ïŒïŒïŒ
ïŒãïœïŒïœïŒããåæ¢ãããã€ã³ããŠããŒãã«å
ãããçææ··åç©ãæ¿ãã枊åãããé å¿åé¢æ
äœã«ä»ããïŒ2000rpmã§ïŒåéïŒã以åŸã®é å¿å
é¢æäœãåäžæ¹æ³ã§è¡ã€ããïŒã€ã®æçã«ç°ãªã
å±€ãççããã管ããã©ã€ã¢ã€ã¹âãšã¿ããŒã«æµŽ
ã«å ¥ããæ°Žå±€ãåçµããããææ©çžããã«ã³ããŒ
ã·ãšã³ã«ããã0.1mlã®0.1Né ¢é žãå«ã管ã«å ¥ã
ãã管ãšå 容ç©ãšã枊巻æ¹æããé å¿åé¢æäœã«
ä»ããåèšãšåäžã®æ¹æ³ã§åçµããããææ©çžã
åçµæ°ŽçžããåžãåºããŠæšãŠããåçµæ°Žçžã解å
ããïŒmlã®ãã«ãšã³ïŒã€ãœã¢ãã«ã¢ã«ã³ãŒã«
ïŒïŒïŒïŒãïœïŒïœïŒãå ãã管ãšå 容ç©ãšãæ¿ã
ã枊åããé å¿åé¢æäœã«ä»ãããæ°Žçžãåçµã
ãããã®äžåŽã®ææ©çžãåžãåºããŠæšãŠãã  åé¢ ïŒ§ã®é ¢é žçžã®å šãŠããAnaltech IncããåŸãã·
ãªã«ã²ã«GFæ¿ïŒ2.5Ã10cmã250ãã¯ãã³å±€ïŒã®
åºéšã«å¡åžãããæ°Žæ§ã¹ãããããã¹ãããã«å
ç«ã€ãŠç®¡ã«0.15mlç¡æ°Žãšã¿ããŒã«ãå ããå枩颚
ãæµãããšã«ãã也ç¥ããããã¹ããããããæ¿
ããçŽãå 匵ããããäºå平衡åèå±€ã¯ãããã°
ã©ãã€ãŒå±éçšã¿ã³ã¯å ã«å ¥ãããæ¿ãã€ãœãã
ãã«ã¢ã«ã³ãŒã«ïŒïœâããã«ã¢ã«ã³ãŒã«ïŒæ°ŽïŒã®
é žïŒ60ïŒ20ïŒ19ïŒïŒïŒã®æº¶åªç³»ã§å±éãããã溶
åªãæ¿ã®é é ã«åããŠçŽïŒæé移åããããæ¿ã
åãåºããŠå®å šã«ä¹Ÿç¥ãããã垯è²ãŸãŒã³ã
254nm玫å€å ã§å¯èŠåãããäžåŽã®ãŸãŒã³ã¯
NMNãšMEOTãšãå«ãã§ãããäžåŽã®ãŸãŒã³ã¯
MNãå«ãã§ãããåãŸãŒã³ã®ã·ãªã«ã²ã«ããã¬
ãŒãããèœãšããå¥ã®ç®¡ã«å ¥ããã  NMNã®é žå NMNãšMEOTãšãå«ã管ã«ïŒmlã®1Næ°Žé žåã¢
ã³ã¢ããŠã ãå ããŠã¢ãã³é¡ãã·ãªã«ã²ã«ãã溶
é¢ããæ¿ãã枊åãããã50ÎŒã®æº¶æ¶²ïŒãå
ããç®¡å šäœã枊åãããã溶液ïŒãæ·»å ããŠïŒå
åŸã«50ÎŒã®æº¶æ¶²ïŒãå ããŠæžŠåãããã  NMNããã®ãããªã³ã®æœåºãšèšæ° 100ÎŒã®æ°·é ¢é žã管ã«å ããŠæžŠåãããã10
mlã®ãã«ãšã³ïŒãªã¯ã€ãã©ã¯ãŒïŒLiguiflour
ïŒã管ã«å ¥ããŠã管ã30ç§éæ¿ããæ¯ãšãã
ãã管ã2000rpmã§ïŒåéé å¿åé¢æäœã«ä»ããŠ
å±€ãåé¢ãããæ°Žå±€ãåçµããããäžã®ææ©å±€ã
ãã«ã³ããŒã·ãšã³ã«ãããïŒmlã®0.1Né ¢é žãå«
ãã·ã³ãã¬ãŒã·ãšã³ãã€ã¢ã«ã«å ¥ããããã®ãã€
ã¢ã«ã«ãã€ãããããæ¿ããæ¯ãšããã液äœã·ã³
ãã¬ãŒã·ãšã³èšæ°ç®¡å ã§èšæ°ããããã€ã¢ã«å ã®
æŸå°èœã¯ãµã³ãã«äžã®NEã®éã«åå ããã  MEOTã®æœåºãšèšæ° ã®åçµæ°Žå±€ã解åããïŒmlã®ãã«ãšã³ãå ã
ãã管ãšå 容ç©ãšã枊åããã2000pmã§ïŒåé
é å¿åé¢æäœã«ä»ããæ°Žå±€ãåçµããããäžã®æ
æ©çžãåžãåºããŠæšãŠãã0.3mlã®æ¿æ°Žé žåã¢ã³
ã¢ããŠã ãå ãã管ã枊åããããæ°Žçžã®PHã¯
9.8ã10.1ã§ãã€ãã10mlã®ãã«ãšã³ïŒã€ãœã¢ã
ã«ã¢ã«ã³ãŒã«ïŒïŒïŒ2vïŒïœïŒãå ããã管ãæ¿
ããæ¯ãšãããã2000rpmã§ïŒåéé å¿åé¢æäœ
ã«ä»ããæ°Žå±€ãåçµããããäžã®ææ©çžã10mlã®
ãžãªããŒã«ãDiotolïŒãã«ãã€ã㯠ãã³ã
ãžã€ã¯ãœã³ïŒBurdick and JacksonïŒããåŸã
液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªããå«ãã·ã³ãã¬ãŒã·
ãšã³ãã€ã¢ã«äžã«ãã«ã³ããŒã·ãšã³ããããã€ã¢
ã«ãæ¯ãšããã液äœã·ã³ãã¬ãŒã·ãšã³èšæ°ç®¡å ã§
èšæ°ããããã€ã¢ã«å ã®æŸå°èœã¯ãµã³ãã«äžã®
DAã®éã«åå ããã  MNã®é žåãMNããã®ãããªã³ã®æœåºãšèš
æ° äžåŽãŸãŒã³ããåã€ãã·ãªã«ã²ã«ããšåäžã®
æ¹æ³ã§åŠçãããæœåºãšèšæ°ãšã¯ïŒªãšåäžã®æ¹æ³
ã§è¡ã€ãããã€ã¢ã«å ã®æŸå°èœã¯ãµã³ãã«äžã®ãš
ããããªã³ã®éã«åå ããã å®æœäŸ ïŒ NEãšïŒ¥ãšã®åèšéãç¥ãããã®é瀺差çåæ
ãè¡ãããã«ãåé¢å·¥çšãé€ããç¹ä»¥å€ã¯å®æœäŸ
ïŒãšåäžã®åææ³ãè¡ã€ããã€ã³ããŠããŒã·ãšã³
ãåæ¢ãããã€ã³ããŠããŒãã®ãã«ãšã³ïŒã€ãœã¢
ãã«ã¢ã«ã³ãŒã«ïŒïŒïŒïŒãïœïŒïœïŒæœåºç©ããåŸ
ãé ¢é žçžãã空æ°æµäžãæžå§äžã§ä¹Ÿç¥ãããïŒml
ã®1Næ°Žé žåã¢ã³ã¢ããŠã ã也ç¥æ®æž£ã«å ãã管
ãšå 容ç©ãšã枊åããããã€ãã§ãå®æœäŸïŒã®å·¥
çšïŒ©ïŒïŒªã«ãããéãã«ç®¡ã®å 容ç©ããããªã³ã«
é žåããæœåºããèšæ°ããããã€ã¢ã«å ã®æŸå°èœ
ã¯ããµã³ãã«äžã®ïŒ¥ãšNEãšã®æªç€ºå·®ååèšéã«
åå ããã å®æœäŸ ïŒ å®æœäŸïŒãšïŒã®åææ¹æ³ãã人尿ãµã³ãã«ãè±
èçœçµç¹åç質ã®äžæŸã¿ã§è¡ã€ããå®æœäŸïŒïŒïŒ
ãšåæ§ãªåæçµæãåŸãããã å®æœäŸïŒïŒïŒïŒïŒã®åã ã«ãããŠãããŒããã³
éã®æŽã«åçŸæ§ããããã€æ£ç¢ºãªåæã確å®ã«ã
ãããã«DOPAã«ã«ããã·ã«åºåè§£é µçŽ é»å®³å€ã
ã€ã³ããŠããŒã·ãšã³æ··åç©äžã«ååšãããã
DOPAã«ã«ããã·ã«åºåè§£é µçŽ ãé»å®³ããååç©
ãäŸç€ºãããšããã³ãžã«ãªãã·ã¢ãã³é¡åã³æ°Žæº¶
æ§ããã©ãžã³é¡ã®äžå¡ã§ããããã³ãžã«ãªãã·ã¢
ãã³é¡ã®äŸã瀺ããšãã³ãžã«ãªãã·ã¢ãã³ãïŒâ
ããããã·âïŒâããã ãã³ãžã«ãªãã·ã¢ãã³å
ã³ãããã®é žä»å å¡©ãäŸãã°ç¡«é žããªã³ã³é žãå¡©
é žã®ä»å å¡©ã§ããã氎溶æ§ããã©ãžã³ã®äŸã¯ããš
ãã«ããã©ãžã³ã§ããã æ¬çºæã®æŽã«å¥ã®æ æ§ã¯ãåæã«å¿ é ã®æåã
æ€æ»å®€ã§å©çšã§ãããããã«éæããããšã§ã
ããåã«è¿°ã¹ãæ§ã«ãã«ãã³ãŒã«ã¢ãã³éãç¥ã
ããšã¯ãå€æ°ã®çç¶ã®èšºæã«ãããŠææ矩ã§ã
ããåæ¥çãªæ€æ»å®€ãç é¢ãã¯ãªããã¯ã¯ãã®å
æã«å¯ŸããŠçžåœã®å¿ èŠæ§ãæã€ããããå¿ èŠæ§
ã¯ãåæã«é¢ããé©åãªæ瀺ãšå ±ã«ãå©çšå¯èœãª
å€æ°ã®å¿ èŠè©Šéšãæã€ããšã«ããæé«ã«å 足ãã
ãããããããããã¯åæ¥ç茞éã«ãã容æã«å ¥
æãããŠæ€æ»å®€ãç é¢ãã¯ãªããã¯ã®å¿ èŠæ§ãæº
足ãããããšãã§ãããæ¬çºæã«ãããå€æ°ã®å°
容åšãšå 容ç©ãšãå èµãã容åšãæäŸãããã該
å 容ç©ã¯ãã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ ïŒ
æªæšèåã¡ãã«åºäŸäžäœãæ¬è³ªäžå«ãŸãªãæšæºå
ã¡ãã«åºäŸäžäœã§ããâã¢ããã·ã«ââã¡ã
ãªãã³ïŒ 3HïŒã¡ãã«ïŒã«ãã³ãŒã«ã¢ãã³ã®ã«ã
ã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ 觊åªïŒ¯âã¡ãã«å
ãé²åãããé žåæ°ïŒïŒã®ã«ããªã³ïŒé µçŽ âåºè³ª
ç³»ã§ããã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ âã«
ãã³ãŒã«ã¢ãã³ãå®å®åãããååç©ïŒåã³ãã«
ãã³ãŒã«ã¢ãã³ã®ã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»
é µçŽ è§ŠåªïŒ¯âã¡ãã«åã劚害ãããªãããã«ã«ã«
ã·ãŠã ã€ãªã³ãéžæé€å»ããè¬å€ïŒãããªããäœ
ããâã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒã¡
ãã«ãå ¥ã€ãå°å®¹åšã«ã¯ä»æåã¯å ¥ãããååæ
åã¯ãè±èçœçµç¹åç質ãè¡æž åã¯è¡æŒ¿ãåã³ç
ç©åŠçæµåäœãããªã矀ããéžæãããåºä¹³åç©
ç³»ããã®ã«ãã³ãŒã«ã¢ãã³ãµã³ãã«ã®ååšäžãé©
åœãªPHãšæž©åºŠãšã§å šæåãäžç·ã«ããããšã«ãã
éå§ãããã¡ãã«åºã®æšèåäŸäžäœããã«ãã³ãŒ
ã«ã¢ãã³ãžã®é µçŽ 觊åªè»¢ç§»ã該ãµã³ãã«äžã®ã«ã
ã³ãŒã«ã¢ãã³ã®å®è³ªäžå šãŠãâã¡ãã«ïŒ 3HïŒ
åãããããšã®ã§ããéã§ååšããã å°å®¹åšãä¿æãã倧容åšã¯ããªãã®èè¡ææ§ã§
ããã¹ããããªãŒã ãã®ä»ã®ãããã®ææã§ãäœ
ãããšãã§ããããã®ã¹ããããªãŒã ãã®ä»ã®æ
æã¯ãå°å®¹åšïŒæ®éã¯ç°åœ¢ãã€ã¢ã«ïŒãå å¯åµå
ãããã®é éšã«åã貫éããŠããåºäœã§ãããå°
容åšã®å éšã«ã¯å 容ç©ãååšããããã¯åæã€ã³
ããŠããŒãäžã«å ¥ããæšèåã¡ãã«åºäŸäžäœãå ¥
ã€ã容åšã«ã¯ãããã®ä»ã®æåãå«ããŠã¯ãªããª
ããé µçŽ ãã«ããªã³ãé µçŽ âåºè³ªç³»å®å®ååå
ç©ãã«ã«ã·ãŠã ã€ãªã³ãéžæé€å»ããè¬å€ã¯åèª
ã®å°å®¹åšã«å ¥ããããšããåãããªãçµåãã§ã
ã€ãŠãåäžå°å®¹åšã«å ¥ããããšãã§ãããåæã«
圹ç«ã€ä»è©Šè¬ããããäžã«å«ããããšãã§ããäŸ
ãã°ç·©è¡æ¶²ç³»ã䜿çšããŠã€ã³ããŠããŒãåã³ã€ã³
ããŠããŒã·ãšã³åæ¢æ¶²ã®PHãç¶æããããšãã§ã
ããã€ã³ããŠããŒã·ãšã³åæ¢æ¿ã¯æããã«ããã®
å 容ç©ãã€ã³ããŠããŒãæåã§ãããããªãå°å®¹
åšã«ãååšãããŠã¯ãªããªããå°å®¹åšãä¿æãã
倧容åšã¯è¢«ãã§äžéšãªããå šäœã被ãããããã®
被ãã¯å€§å®¹åšããèªç±ã«é€ãããåã¯ãã³ãžã«ã
ãçã®äœããã®æ¹æ³ã§ããã«åãä»ããããåæ
æ¹æ³ã«é¢ããæ瀺ãäžããæ段ã容åšã被ãã®å
éšãåã¯å®¹åšã被ãã«åãä»ããããŠããããã®
æ段ã¯ãåæãè¡ãããã®é©åãªæ¹æ³ã«é¢ããæ
å ±ãäŒããå°å·çŽãèšé²ããŒããã®ä»ãããã®æ
段ã®åœ¢ã§ãã€ãŠãããã è©Šè¬ã®ãã¡ã®å¹Ÿã€ãã¯æ¯èŒçäžå®å®ãªã®ã§ãã
ããã¯äœ¿çšäžã§ãªãæã«ã¯äœæž©ã奜ãŸããã¯â20
âã«ä¿æãã¹ãã§ããã åææåã«é©çšãããäŸç€ºãéžææ§ãåæã«äœ¿
çšããããããæåã«ãçããåæ§ã«é©çšããã
ããšãç¹èšããã æ¬æ现æžã«ã¯ãââã¡ãã«ïŒ 3HïŒåããã
ãšããããªã³ãšãã«ãšããããªã³âãšããè¡šçŸã
ããããã®è¡šçŸã«ãããŠã¯ãã«ãšããããªã³ã
âã¡ãã«ïŒ 3HïŒåãããŠãããšç解ããããã
ïŒ 3HïŒãååšããªãæã«ãåæ§ãªè§£éãšããŠç
解ããããã ã€ã³ããŠããŒã·ãšã³ã§äžè¬ã«äœ¿çšãããé µçŽ ã®
æ¿åºŠã¯ãäžå®éã®ã¡ãã«åºäŸäžäœãšã«ãã³ãŒã«ã¢
ãã³ãšã§æ倧é床ãåŸãã®ã«å¿ èŠãªéã§ããã æ¬æ现æžã®åãã«ãããŠã¯ãã¯ãããã°ã©ãã€
ãŒåé¢ã«ãããŠã¯é žæ§æº¶åªç³»ã奜ãŸãããšææã
ããä»ã¯ãå¡©åºæ§æº¶åªç³»ãç¹ã«å®¹éæ¯ã§ïŒéšã®ïœ
âã¢ãã«ã¢ã«ã³ãŒã«ãšïŒéšã®ãã³ãŒã³ãšïŒéšã®ã¡
ãã«ã¢ãã³æº¶æ¶²ãããªã溶åªç³»ã奜ãŸããããšã
確ç«ãããã åºä¹³åç©çµç¹ãµã³ãã«ãåŠçããæã«ã¯ãåæ
ã§äœ¿çšããã«å ç«ã€ãŠãããç²ç ããè±èçœããª
ããã°ãªããªããããã¯å質åãè¶ é³æ³¢åŠçåã¯
çµç¹å§æŸã®æ§ãªæ段ã«ããè¡ãããšãã§ãããé
å¿åé¢æäœã«ããåºäœå¡ã液äœããåé¢ãããå
æã«ãããŠäžæŸã¿æ¶²ãçšãããæ¬æ现æžã«ãããŠ
çšèªâè±èçœçµç¹åç質ã®äžæŸã¿âã¯ãå質åæ
è¡ã®ã¿ãªãããäœããã®æ段ã«ããç²ç ãããçµ
ç¹ã®äžæŸã¿ãæå³ããã âããªã¹âç·©è¡å€ã¯ãããªã¹ïŒããããã·ã¡ã
ã«ïŒã¢ããã¡ã¿ã³ç·©è¡å€ã§ããããããç·©è¡å€ã
䜿çšããŠã€ã³ããŠããŒãã®PHãç¶æããã æ¬æ现æžã«ãããŠãâã¡ãã«ïŒ 3HïŒåã«ã
ã³ãŒã«ã¢ãã³ãæœåºãã溶åªãšããŠã®ãã·ã¬ã³ã
æ瀺ãããæã«ã¯ãïœâãã·ã¬ã³åã³ïœâãã·ã¬
ã³ã®ä»ã«ïœâãã·ã¬ã³ãå«ãŸããã æ¬æ现æžã«ãããŠãåæã€ã³ããŠããŒãã®äžæ
åã¯âé µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã
ã€ãªã³ãåªå é€å»ããè¬å€âã§ããããããè¬å€
ã®äœçšã¯ãã«ã«ã·ãŠã ã€ãªã³ãé µçŽ åå¿ãé»å®³ã
ãã®ãæ¢ããããããšã§ããããã°ãã·ãŠã ãã³
ãã«ãåã³ãã³ã¬ã³ã®æ§ãªé žåæ°ïŒïŒã®é µçŽ 賊掻
ã«ããªã³ãé µçŽ æŽ»æ§ã«ãšãå¿ èŠãªã®ã§ãEGTAã®
æ§ãªãé µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã
ã€ãªã³ãéžæé€å»ããè¬å€ã䜿çšããŠãé µçŽ è³ŠæŽ»
ã«ããªã³æ¿åºŠãé µçŽ æŽ»æ§ãçããå€ã«ããããšã
åœç¶ã«å¥œãŸããã é µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã ã€ãª
ã³ãé€å»ããè¬å€ã¯åæã«ãããŠãçšåªå çã«å¿
èŠãšããããã®ã§ã¯ãªããã䜿çšã§ãããäŸã
ã°ãå€ãã®ãã¬ãŒãå€ã¯ã«ã«ã·ãŠã ã®ä»ã«ææé
ã®ãã°ãã·ãŠã ãé€å»ãããã®ã§ã¯ãããåæã§
䜿çšã§ãããã€ã³ããŠããŒãäžã®å©çšå¯èœé µçŽ 賊
掻ã«ããªã³ã®æ倱ã¯ãå®è³ªçãªå³ã¡éžæçã«ã¯æ
é©ã®é µçŽ 掻æ§ãäžããã®ã«å åãªéã§è¶ 賊掻ã«ã
ãªã³ãæ·»å ããããšã«ããè£å ã§ããã é µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã ã€ãª
ã³ãé€ããã®âééžæçâã¿ã€ãã®è¬å€ãäŸç€ºã
ããšãšãã¬ã³ïŒãžãããªãïŒåé ¢é žïŒEDTAïŒ
ïŒæ®éã¯ãããªãŠã å¡©ãšããŠäœ¿çšãããïŒïŒïŒïŒ
ïŒâãžã¢ããã·ã¯ããããµã³âïŒïŒ®ïŒNâ²ïŒ
Nâ²âåé ¢é žïŒåã³Nâ²âïŒïŒâããããã·ãšã
ã«ïŒãšãã¬ã³ãžã¢ãã³âïŒïŒ®ïŒNâ²âäžé ¢é žïŒ
ã§ãããåæã«ããããã®è¬å€ã®æ¿åºŠã¯çŽïŒã50
ããªã¢ã«ã奜ãŸããã¯çŽïŒã20ããªã¢ã«ã§ããã
ãšãã¬ã³ïŒãžãããªãïŒåé ¢é žïŒEDTAïŒããã®
ã«ããŽãªãŒã«å«ãŸãã奜ãŸããã¯ååç©ã§ããã å®è³ªçãªããæ倧ã®é µçŽ 賊掻åãéæãããã
ã«ã€ã³ããŠããŒãäžã«å¿ èŠãšãããè¶ è³ŠæŽ»ã€ãªã³
ã®æ¿åºŠã¯ãçšããããåã ã®è¬å€ã®çµååãç¥ã
ããšã«ãããæã¯ç°¡åãªå®éšã«ãã容æã«èšç®ã§
ããã é µçŽ ãšçžäºäœçšãããªãããã«ã«ã«ã·ãŠã ã€ãª
ã³ãé€ããæŽã«é µçŽ 賊掻ã€ãªã³ããé€ããã®ééž
æçè¬å€ããæ¬çºæã®åææ³ã«ãããŠã¯ãâé µçŽ
åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã ã€ãªã³ãåª
å é€å»ããè¬å€âã®ä»£ããã«äœ¿çšã§ããããšãç
解ããããããã®çœ®ãæãã¯ãç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒé ã®ç¬ç«é èšèŒã®çºæã§è¡ãããšãã§ã
ããæ¬çºæã®ãã®æ æ§ã®äžäŸã¯ãã«ãã³ãŒã«â
âã¡ãã«åºè»¢ç§»é µçŽ ïŒæªæšèåã¡ãã«åºäŸäžäœã
æ¬è³ªäžå«ãŸãªãããªããŠã æšèåã¡ãã«åºäŸäžäœ
ã§ããâã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒ
ã¡ãã«ïŒè©²ã¡ãã«åºè»¢ç§»ãé²è¡ãããé žåæ°ãïŒ
ïŒã®ã«ããªã³ïŒé µçŽ åºè³ªç³»ãå®å®åãããåå
ç©ãé µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã ã€
ãªã³ãé€å»ããè¬å€ïŒåã³ãè±èçœçµç¹åç質ã®
äžæŸã¿ãè¡æž åã¯è¡æŒ¿ãåã³çç©åŠçæµåäœãã
ãªã矀ããéžæãããåºä¹³åç©ç³»ïŒãããªãã該
è»¢ç§»é µçŽ ã該ã«ããªã³ã該å®å®åååç©ã該ã¡ã
ã«åºäŸäžäœãåã³ã«ã«ã·ãŠã ã€ãªã³ãé€å»ãã該
è¬å€ãã該åºä¹³åç©ç³»äžã«ååšãããšããããª
ã³ããã«ãšããããªã³åã³ããŒããã³ã®å®è³ªäžå š
ãŠãâã¡ãã«ïŒ 3HïŒåãããéã§ååšããçµ
æç©ã§ããã
ã§ããååç©ã以åŸDAãšç§°ãïŒã§ãããããã
ã®ã«ãã³ãŒã«ã¢ãã³ã¯ããšãããè¡æ¶²ãå°¿ãé«æ¶²
åã³è³çµç¹ãå«ãèªäœã®æ§ã ãªçµç¹äžã«èŠãåºã
ããããããååç©ã®éã¯æ¥µåºŠã«å°ãªããäŸã
ã°ãè¡æž äžã«ïŒ¥ãšNEãšã¯pgïŒ10-12ïœïŒåäœã®é
ã§ååšããã æè¿ã§ã¯åºä¹³åç©ç³»äžã®ã«ãã³ãŒã«ã¢ãã³éã
枬å®ããããšã«çžåœã®èå³ããããã«ãã³ãŒã«ã¢
ãã³éã¯å¥œã¯ããŒã æ§çŽ°èè «ãååšããæã«ã¯æ
æã«å¢å ããããã®ã«ãã³ãŒã«ã¢ãã³éã¯ãäžæ¢
ç¥çµç³»ã«åœ±é¿ãäžããä»è «çãäŸãã°ç¥çµèœçŽ°è
è «ãã®åœ±é¿ãåãããã«ãã³ãŒã«ã¢ãã³éãç¥ã
ããšã¯ãé«è¡å§çãå ç¶åèçŸæ£ãçå¿çãæ¥æ§
å¿çæ¢å¡çåã³çæ§ç³å°¿ç ã®èšºæåã³åŠçœ®ã«ãã
ãŠææ矩ã§ããããµããã¯ãïœåã«éããã«å å
ã«æåæ§ã§ãããåºä¹³åç©ç³»äžã®ã«ãã³ãŒã«ã¢ã
ã³éã枬å®ããããã®åæã®æ¹æ³ã¯Von Eulerãš
Flodingãšã®èå åå åææ³ïŒActa Physiol.
Scand.33ïŒå¢è£çïŒ118ïŒ1955幎ïŒã§ãã€ããã
ã®åææ³ã¯ãé«èå çºå æ§ã®ãã«ã¢ãã¬ãã«ãã³
åã¯ã¢ãã¬ãã«ãã³ãã¢ã«ã«ãªæ§æº¶æ¶²äžã«ãããŠ
çæãã察å¿ããªããããã·ã€ã³ããŒã«ã«NEå
ã³ïŒåã¯ïŒ¥ããããšãªã·ã¢ããåã¯ãšãŠçŽ ãçšã
ãŠé žåããããšã«åºã¥ãããã®åæãè¡ãåã«ã
NEåã¯ïŒ¥ããåºä¹³åç©ç³»ãäŸãã°è¡æž åã¯è¡
挿ãè±èçœçµç¹åç質åã¯é«æ¶²ããããŸãåé¢ã
ãªããã°ãªããªããDAããšãŠçŽ ã«ããé žåããŠ
ãžããããã·ã€ã³ããŒã«ã圢æããããã®ããã
ãã·ã€ã³ããŒã«ã®èªå°äœã®èå å£ã¯NEåã¯ïŒ¥ã®
èªå°äœã®èå å£ãšã¯ç°ããèå åæã®åºç€ã§ãã
ïŒCarlsonãšWaldeckã®å ±èãActa.Physinol.
Scand.44ïŒ293ïŒ1958幎ïŒãNEåã³ïŒ¥ãšåæ§ã«ã
DAãåãã®åæã«å ç«ã€ãŠåºä¹³åç©ç³»ããåé¢
ãããªããã°ãªããªãã è±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž ãè¡æŒ¿åã¯ç
ç©åŠçæµåäœããã®ã«ãã³ãŒã«ã¢ãã³ã®åé¢ã¯äž
è¬ã«ãïŒã€ã®æè¡ã®ãã¡ã®ïŒã€ã«ããè¡ãããã
第ïŒã®ãæãå¹ åºã䜿çšãããŠããåé¢æè¡ã¯ã
ã«ãã³ãŒã«ã¢ãã³ãPH8.4ã8.6ã®äžæ§ã¢ã«ããã«
åžçãããããšã§ãããã«ãã³ãŒã«å«æååç©ã¯
ã¢ã«ããã«ããåžçãããéã«ãã³ãŒã«ååç©ã¯
æšãŠããããã«ãã³ãŒã«ã¯é žã«ãã溶åºã«ããã
ã®ã¢ã«ããããåãåºãããã 第ïŒã®åé¢æè¡ã§ã¯ã«ããªã³äº€æã¯ãããã°ã©
ãã€ãŒãçšãããNEïŒïŒ¥åã³DAã¯é žæ§PHã§ã¯ã€
ãªã³åããã®ã§äº€ææš¹èã«çµåãããã€ãã§é žåŒ·
床ãé«ããããšã«ããåªå 溶åºãããããšãã§ã
ãã ãããåé¢æ³ã¯å ±ã«æ¥µããŠé·æéããããåç¹
å®ã«ãã³ãŒã«ã¢ãã³ã«å¯ŸããŠç§»ç°çãªãã©ã¯ã·ãš
ã³ãäžè¬ã«ã¯çæããªãããã®äžãèå åå åæ
ç³»ã¯ç 究è ã®èŠæ±åºŠããèããã°æ¯èŒçã«éæå
æ§ã§ãããNEãšïŒ¥ãšã®å Žåã«ã¯çŽ50ã500nïœã®
æ床ãåŸãããããã®æ¹æ³ã®æ¹è¯ã«ããïŒã3n
ïœãšããå°éã«å¯ŸããŠãæåæ§ã§ããæè¡ãéçº
ããããããã®æ床ã¬ãã«ã§ã®åæ粟床ã¯æªã
ãEngelmançèâAm.J.Med.Sci.âïŒ255ïŒ259
ïŒ1962幎ïŒãåç §ããããããDAã®å Žåã®æ床ã¯
çŽ500nïœã§ããããã®åææ³ã¯æ¯èŒçã«éæå
æ§ã§ã¯ããããïŒç®æãé€ãã°å šãŠã®åæ¥çæ€æ»
宀ã§ã¯ãã«ãã³ãŒã«ã¢ãã³ã枬å®ããããã«ãã®
èå åææ³åã¯ãã®æ¹è¯æ³ã䜿çšããŠããã åæ¥çã«ã«ãã³ãŒã«ã¢ãã³éã枬å®ããããã®
ããïŒã€ã®æ¹æ³ãããããå©çšå¯èœã§ããã AxelrodãšTomchickãšã«ããåããŠå ±åã
ããç¹æ§åãããã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»
é µçŽ ïŒä»¥åŸCOMTãšç§°ãïŒã¯ãã¡ãã«åºããã®
äŸäžäœååããã«ãã³ãŒã«æ žã«è»¢ç§»ããããã«ã
ãã次åŒã«ãã瀺ãããïŒâã¡ããã·ååç©ã圢
æããé µçŽ ã§ããã ïŒåŒäžãã¯ã¢ãã³å®èœåºã§ããïŒ æŸå°æ§ãã¬ãŒãµãŒãšãã¯ãããã°ã©ãã€ãŒçã®
ä»æè¡ãšã䜿çšããåŸã®ç 究è ã¯ãã¡ã¿ãããªã³
ïŒä»¥åŸMNãšç§°ãïŒããã«ã¡ã¿ãããªã³ïŒä»¥åŸNMN
ãšç§°ãïŒåã³ã¡ããã·ãã©ãã³ïŒä»¥åŸMEOTãš
称ãïŒã®æŸå°æ§æšèåéããåºä¹³åç©ç³»äžã®ïŒ¥ã
NEåã³DAã®åæéã«é¢é£ã¥ãããMNïŒNMNå
ã³METOã®ååŠæ§é ã次ã«ç€ºãã 1968幎ãEngelmançã¯COMTãçšããäºéåž
éèªå°äœæ³ïŒdouble isotope dilution derivative
technigueïŒãå©çšããŠçç©åŠçæ€äœäžã®ã«ãã³
ãŒã«ã¢ãã³ãå³ã¡ãšããããªã³ãšãã«ãšããããª
ã³ããåæãããå åå ãã¬ãŒãµãŒã§ããïŒâ
3Hâãã«ãšããããªã³ãã¡ãã«åºäŸäžäœãšããŠ
ã®ïŒ³âã¢ããã·ã«ââã¡ããªãã³ã¡ãã«â14C
ãšå ±ã«çšãããåæã«å ç«ã€ãŠå°¿ãµã³ãã«ãšè¡æ¶²
ãµã³ãã«ãšãååŠçããŠã«ãã³ãŒã«ã¢ãã³ãåé¢
ãããå°¿ãµã³ãã«ã¯ã¢ã«ããã§ã¯ãããã°ã©ãã€
ãŒããè¡æ¶²ãµã³ãã«ã¯ã«ããªã³äº€ææš¹èã§ã¯ãã
ãã°ã©ãã€ãŒãããã¯ãããã°ã©ãã€ãŒããããµ
ã³ãã«ãé µçŽ ç³»äžã§ã€ã³ããŠããŒã·ãšã³ããåŸã«
ã€ã³ããŠããŒã·ãšã³ãåæ¢ãããçæ溶液ãåŠç
ããã«ããªã³äº€ææš¹èã§ã¯ãããã°ã©ãã€ãŒã
ããã¡ã¿ãããªã³ã溶åºãããéãšãŠçŽ é žå¡©ã§ã
ããªã³ã«é žåããããã®ãããªã³ãæœåºãã粟補
ãã液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªäžã§èšæ°ãããã«
ãã³ãŒã«ã¢ãã³ã®ååšéãå€æãããã®ã«ã¯å žå
çãªè€éãªããã«ã¢ã€ãœããŒã枬å®ãèšç®ãšãå¿
èŠã ã€ãã Engelmannã¯åœŒã®åæã®ç 究ãç¶ãããã®çµ
æãå¥ã®åè¡ç©ã§ããEngelmannçè
âCirculation Researchâ26ïŒ53ïŒ1970幎ïŒã«çº
è¡šããã圌ã®åæã®ç 究ã®æ¹è¯ã«ããä»ããïŒã
10mlã®äººè¡æŒ¿ã®åäžãµã³ãã«äžã®ïŒ¥ãšNEãšã®ç€º
å·®ç枬å®ãå¯èœã«ãªã€ããNHãšNMNãšãèå±€ã¯
ãããã°ã©ãã€ãŒã«ããåé¢ããããšããç¹ãé€
ããŠã¯åèšåè¡ç©èšèŒã®ãã®ãšåäžã®äºéåžéæ³
ãçšãããããªããŠã æšèåãã¬ãŒãµãŒéã®ïŒ¥ãš
NEãšã100ÎŒïœã®MNãšNMNãšå ±ã«å ãããåæ
ã«å ç«ã€ãŠãè¡æŒ¿ãµã³ãã«ãšå°¿ãµã³ãã«ãšã¯å ±
ã«ãã«ããªã³äº€ææš¹èã¯ãããã°ã©ãã€ãŒãã
ããã¯ãããã°ã©ãã€ãŒå·¥çšã«å ç«ã€ãŠãšãã¬ã³
ãžã¢ãã³åé ¢å¡©ãè¡æŒ¿ãµã³ãã«ã«å ããããã®å
æã®æ床ã¯ã空詊éšå€ã®ïŒåã®å€ã«ãã枬å®ãã
ãšããã§ã¯250pïœã ã€ããè¡æŒ¿ïŒ¥å€ã¯æ£åžžåã®
äžéå€ã§ã¯ããã»ã©æ£ç¢ºã«ã¯æž¬å®ã§ããªãã€ãã PassonãšPeulerãšã®å ±èâAnalytical
BiochemistryâïŒ51ïŒ618ïŒ1973幎ïŒã«ãããŠ
ã¯ããšNEãšããCOMTã䜿çšããã€ãã§MN
ãšNMNãšãã¯ãããã°ã©ãã€ãŒã«ããåé¢ãã
ãã®åŸã«ãããªã³ã«é žåããããšã«ããåæãã
ãŠãããè¡æž åã¯è¡æŒ¿ã¯ããã®åæã«å ç«ã€ãŠã¯
ãããã°ã©ãã€ãŒã«ä»ãããããšãªãçŽæ¥ã«äœ¿çš
ããããåªïŒã€ã®ã¢ã€ãœããŒããšããŠïŒ³âã¢ãã
ã·ã«âã¡ããªãã³ïŒ 3HïŒã¡ãã«ã䜿çšãããã
ããªããŠã åã¡ãã«åºäŸäžäœãéæŸå°æ§ã¡ãã«åº
äŸäžäœã§åžéããããã¬ãŒãµãŒãšããŠæšèå 14C
ååç©ãè©Šçšããããåºè³ªã§ããã«ãã³ãŒã«ã¢ã
ã³ã®æ£ç¢ºãªååççã«ä¿ãåé¡ç¹ãå°ãããã®ã«
ã¯åœ¹ç«ããªãã€ããéæŸå°æ§ïŒ³âã¢ããã·ã«ã¡ã
ãªãã³ã®æ¿åºŠã10ÎŒïŒããäœããšãã©ã³ã¯ã瀺ã
ãµã³ãã«ãå®è³ªäžå¢å ããããã®ä»ã®ç¹ã§ã¯åæ
æè¡ã¯Engelmançåã³ä»ã®è ã«ãã䜿çšããã
æè¡ã«äŒŒãŠãããåææ床NEãšïŒ¥ã®å Žåã«170p
ïœã§ããããã®ããïŒmlæªæºã®äººè¡æž äžã®NEãš
ãšã枬å®ã§ãããšäž»åŒµãããã CoyleãšHenryãšã¯COMTãšïŒ³âã¢ããã·ã«â
ã¡ããªãã³ïŒ 3HïŒã¡ãã«ãšã䜿çšããããšã«ã
ãè±èçœè³çµç¹åç質ã«ãããŠãã«ãšããããªã³
ãããŒããã³ããåé¢ããããJ.of
NeurocheistryïŒ21ïŒ61ïŒ1973幎ïŒããéæŸå°ç·æ§
æ äœéã®NMNãšMEOTãšãæ·»å ããåŸã«ã€ã³ã
ãŠããŒãïŒã€ã³ããŠããŒã·ãšã³æ··åç©ïŒãææ©æº¶
液ã«ããæœåºããæœåºç©ãå¡©é žæ°Žæº¶æ¶²äžã«ååé
ããããæ°Žçžãåèšãšåäžã®ææ©æº¶åªã§æŽã€ãã
ãããªã³âïŒ 3HïŒãNMNâïŒ 3HïŒã®éãšãŠçŽ
é žå¡©éè£ã«ããçæããããããªã³âïŒ 3HïŒã
ææ©æº¶åªäžã«æœåºããæåŸã«æ¶²äœã·ã³ãã¬ãŒã·ãš
ã³åªè³ªäžã§èšæ°ãããMEOTãç·©è¡å€ã§ããã
ãŠé žå¡©ãšïŒïŒïŒïŒïœïŒïœïŒãã«ãšã³ïŒã€ãœã¢ãã«
ã¢ã«ã³ãŒã«æº¶åªç³»ãšãçšããŠéãšãŠçŽ é žå¡©æ°Žæº¶æ¶²
çžããæœåºãã液äœã·ã³ãã¬ãŒã¿ãŒãçšããŠèšæ°
ããã Christensenã¯COMTæ³ãå©çšããäºéåžéæ³
ã«ããè¡æŒ¿äžã®DAéã枬å®ãããScand.J.Clin.
Lad.Invest.ïŒ31ïŒ343ïŒ1973幎ïŒããé µçŽ äœçšã«ã
ãã¡ãã«åºè»¢ç§»åã«ãã¢ã«ãããŠã ãå©çšããŠã«
ãã³ãŒã«ã¢ãã³ãè¡æŒ¿ããåé¢ãããCOMTãš
被æ€ãµã³ãã«ãšãâã¢ããã·ã«ã¡ããªãã³âã¡
ãã«ïŒ 14CïŒãšãã¬ãŒãµãŒéã®ããªããŠã æšèå
DAãšå ±ã«ã€ã³ããŠããŒã·ãšã³ãããNMãšNMN
ãšãéãšãŠçŽ é žå¡©ã§ãããªã³ã«é žåããåŸã«
MEOTãåé¢ãã液äœã·ã³ãã¬ãŒã¿ãŒäžã§åæ
ãããDAæ¿åºŠã 14Cãš 3Hãšã®èšæ°ããã³ã³ã
ãŠãŒã¿ã§èšç®ããã Cuelloã¯1973幎ãNEã®ååšäžã§è±èçœè³çµç¹
æœåºç©äžã®DAãåæãããCOMTãšããªããŠã
æšèåâã¢ããã·ã«ã¡ããªãã³ãéæŸå°æ§ïŒ³â
ã¢ããã·ã«ã¡ããã³å㯠14CSâã¢ããã·ã«ã¡ã
ãªãã³ãšå ±ã«æ··åãããã€ã³ããŠããŒããææ©æº¶
åªã§æœåºããåŸã«ãã®ææ©æº¶åªãå¡©é žäžã«éæœåº
ããã€ãã§ã¯ãããã°ã©ãã€ãŒããã 1975幎ã«å±±å£çã¯è¡æ¶²äžã®å å æ§ã«ãã³ãŒã«ã¢
ãã³ãããšãã¬ã³ã°ãªã³ãŒã«ãã¹âïŒã¢ãããšã
ã«ãšãŒãã«ïŒâïŒNâ²âåé ¢é žïŒä»¥åŸEGTAãšç§°
ãïŒãã€ã³ããŠããŒã·ãšã³æ··åç©äžã«ååšãããŠ
åæãããCirculation ResearchïŒ36ïŒ662
ïŒ1975幎ïŒãã Champlainçã¯ãAxelrodãšTomchikãšã«ãã
ãªãããç 究ããã«ã«ã·ãŠã ã€ãªã³ãCOMTã®
åå¿ãé»æ¢ããããšãç¥ãããããšã
Circulation ResearchïŒ38ïŒ109ïŒ1976幎ïŒã«é
瀺ãããEGTAã¯ãã°ãã·ãŠã ã§ã¯ãªãã«ã«ã·ãŠ
ã ã®éžæçãã¬ãŒãå€ã§ãããé µçŽ ã®æŽ»æ§ãå埩
ãããããããããã®åŸã®åè¡ç©ã§ãã
WeinshilboumçèâBiochemical
PharmacolcgyâïŒ25ïŒ573ïŒ1976ïŒã«ã¯ãã«ã«ã·
ãŠã ã€ãªã³ä»¥å€ã®ã«ããªã³ãæé©æ¿åºŠã®ãã°ãã·
ãŠã ã®ååšäžã§COMTåå¿ãé»æ¢ããå¯èœæ§ã¯
ä»æ¥ãŸã§ç 究ãããŠããªããšè¿°ã¹ãããŠããã åŸæ¥ã®å¡©åºæ§COMTç³»ãå©çšãããã«ãã³ãŒ
ã«ã¢ãã³ãåæããããã®æ°èŠãªç³»ãä»ãéçºã
ãããåºä¹³åç©ç³»ã®ã«ãã³ãŒã«ã¢ãã³å«éã¯ä»
ããNEãšïŒ¥ã®å Žåã§5pïœã®ãDAã®å Žåã§12pïœ
ã®æ床ã«ãŸã§åæã§ããããã®åæã¯ç²Ÿç¢ºã§ã
ããåç°åžžã«éžæçã§ãããæŽã«ããã®åææ³ã¯
æå°ã®é«çæè¡èšç·Žãåããæ€æ»å¡ã«ããæ¥éã«
å±¥è¡ã§ããããã®åææ³ã¯çŸåšãã¢ãããžãšã³ã«
ã³ãããŒã®æ€æ»æ¹æ³éšéã«ããåæ¥çããŒã¹ã§æ
åããŠäœ¿çšãããŠããã æ¬çºæã«ããã ïœ è±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž åã¯è¡æŒ¿ã
åã¯çç©åŠçæµåäœã®ã¢ãªã³ãŒãããã«ãã³ãŒ
ã«ââã¡ãã«åºè»¢ç§»é µçŽ ãæªæšèåã¡ãã«åº
äŸäžäœãå®è³ªäžå«ãŸãªãããªããŠã æšèåã¡ã
ã«åºäŸäžäœã§ããâã¢ããã·ã«ââã¡ããª
ãã³ïŒ 3HïŒã¡ãã«ã該ã¡ãã«åºè»¢ç§»ãé²è¡ã
ããé žåæ°ïŒïŒã®ã«ããªã³ãé µçŽ âåºè³ªç³»ãå®
å®åãããååç©ãåã³é µçŽ åå¿ã劚害ãããª
ãããã«ã«ã«ã·ãŠã ã€ãªã³ãåªå çã«é€å»ãã
è¬å€ãšäžç·ã«ãïŒ ïœ å®è³ªäžå šãŠã®ãšããããªã³ãšãã«ãšããããª
ã³ãšãâã¡ãã«ïŒ 3HïŒåããã®ã«å åãªæ
éãšæž©åºŠãšPHã§âïœâã®æåãäžç·ã«ã€ã³ããŠ
ããŒã·ãšã³ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããããšããããªã³ãš
ãã«ãšããããªã³ãšãåªå çã«æº¶è§£ããææ©æº¶
åªã§ãâã¡ãã«ïŒ 3HïŒåããããšããããª
ã³ãšãã«ãšããããªã³ãšãæœåºãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããããšããããªã³ãš
ãã«ãšããããªã³ãšãããããã«ãããã³ãäŸ
äžããã®ã«å åãªåŒ·åºŠã®é žã®æ°Žæº¶æ¶²äžã«ååé
ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããããšããããªã³ãš
ãã«ãšããããªã³ãšããããªã³â 3Hã«é žå
ãïŒ ïœ ãããªã³â 3Hãåªå çã«æº¶è§£ããææ©æº¶åª
ã§ãããªã³â 3Hã氎溶液ããæœåºãïŒ ïœ ãããªã³â 3HããæŸåºãããæŸå°ç·ãèšæ°
ããïŒ ããšãããªããè±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž
åã¯è¡æŒ¿ãåã³çç©åŠçæµåäœãããªã矀ããéž
æãããåºä¹³åç©ç³»äžã®å å æ§ã®æªç€ºå·®åãšãã
ããªã³ãšãã«ãšããããªã³ãšã®éãåæãããã
ã®æ¹æ³ãæäŸãããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãäžèšãšåäžã®åæå·¥çš
ããã¯ãããã°ã©ãã€ãŒæ段ã«ããâã¡ãã«å
ãšããããªã³ãšïŒ¯âã¡ãã«åãã«ãšããããªã³ãš
ãåé¢ããããã®è¿œå å·¥çšãšå ±ã«è¡ãããšãããª
ããè±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž åè¡æŒ¿ãå
ã³çç©åŠçæµåäœãããªã矀ããéžæãããåºä¹³
åç©ç³»ããåŸããããšããããªã³åã³ïŒåã¯ãã«
ãšããããªã³ã®éã瀺差çã«åæããããã®æ¹æ³
ã§ããããã®åé¢å·¥çšã¯ãâã¡ãã«ïŒ 3HïŒå
ããããšããããªã³åã³ïŒåã¯ãã«ãšããããªã³
ãååé ãããåŸããããããããªã³â 3Hã«é ž
åããåã«è¡ãã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ã被æ€ãµã³ãã«äžã«ååš
ããããŒããã³éã®åææ¹æ³ã§ãããæªç€ºå·®åãš
ããããªã³ãšãã«ãšããããªã³ãšã®åæã«ãããŠ
ã¯ããããªã³ã®æœåºåŸã«æ®ã€ãæ°Žæ§é žåçžãææ©
溶åªãçšããŠå¡©åºæ§PHã§æœåºããMEOTïŒ 3HïŒ
ãèšæ°ããããšããããªã³ãšãã«ãšããããªã³ãš
ã®ç€ºå·®çåæã«ãããŠã¯ãâã¡ãã«ïŒ 3HïŒå
ãšããããªã³ãšïŒ¯âã¡ãã«ïŒ 3HïŒåãã«ãšãã
ããªã³ãšãåé¢ããã®ã«äœ¿çšããã溶åªç³»ãé žæ§
ã§ããæã«ã¯é瀺差çåææ³ãšåäžã®æ¹æ³ã§ããŒ
ããã³ãåæãããâã¡ãã«ïŒ 3HïŒåãšãã
ããªã³ãâã¡ãã«ïŒ 3HïŒåãã«ãšããããªã³
ããåé¢ããããã®æº¶åªç³»ãå¡©åºæ§ã§ãããªã
ã°ãMEOTïŒ 3HïŒãåã¯ãããã°ã©ãã€ãŒç³»äž
ã«åé¢ããããMEOTïŒ 3HïŒã溶åºããèšæ°ã
ãã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãCOMTé µçŽ åå¿ã劚
害ãããªãããã«ã«ã«ã·ãŠã ã€ãªã³ãéžæé€å»ã
ãè¬å€ã®äœ¿çšã§ããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãEGTAãCOMTãšçµ
ã¿åããŠäœ¿çšããããšã«ããCOMTã®åºæ掻æ§
ãé«ããæ¹æ³ã§ããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãç¡«é žã¢ã³ã¢ããŠã åå¥
æ³ãå©çšããŠã©ããèCOMTã粟補ããæ¹æ³ã§
ããããã®ç²Ÿè£œã«ããåŸãããæ°èŠãªCOMTçµ
æç©ã¯æ¬çºæã®å¥ã®æ æ§ã§ããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãé žæŽæ¶²ãçšããŠã®ã·ã³
ãã¬ãŒã·ãšã³ãã€ã¢ã«å ã®ãããªã³â 3Hã®ç²Ÿè£œ
ãšãããããã€ã¢ã«ã§ãã®æŸå°èœãåæããæ¹æ³
ãšã§ããã æ¬çºæã®ç¬¬ïŒã®æ æ§ã¯ãã·ãªã«ã²ã«ã®ååšäžã§
éãšãŠçŽ é žå¡©ãçšããŠã¡ã¿ãããªã³â 3Hã«é žå
ããããšãšããããã®æåãããªãçµæç©ãšã§ã
ãã æ¬çºæã®ç¬¬10ã®æ æ§ã¯ãèå±€ã¯ãããã°ã©ãã€
ãŒã§äœ¿çšãããæ°èŠãªå¡©åºæ§æº¶åªç³»ã§ããã æ¬çºæã®ç¬¬11ã®æ æ§ã¯ãè³éŠæâã¢ãã³é žã
ç¹ã«DOPAã§ãããã«ã«ããã·ã«åºåè§£é µçŽ ã®é µ
çŽ æŽ»æ§ã®é»æ¢å€ãã€ã³ããŠããŒãäžã«ååšããã
ãšã§ããããã®ã¿ã€ãã®ååç©ã¯ãã®ã€ã³ããŠã
ãŒã·ãšã³æéäžã®ããŒããã³ã®çæãé»æ¢ããã æ¬çºæã®ç¬¬12ã®æ æ§ã¯ãåæå¿ é æåãæ€æ»å¡
ã䜿çšã§ãããããã«éæããããšã§ããã æ¬çºæã®ãã®ä»ã®æ æ§ã¯ãæ¬çºæã«ã€ããŠã®èš
è¿°ãç¶ãã«ã€ããŠæçœã«ãªãã§ãããã ã«ãã³ãŒã«ã¢ãã³ã¯æ§ã ãªåºä¹³åç©ç³»äžã«çºèŠ
ããããåã«è¿°ã¹ãéãããããååç©ã¯ã«ãã³
ãŒã«æ žãšã¢ãã³å®èœåºãšãå ±éããŠæãããã«ã
ã³ãŒã«ã¢ãã³ãåæã§ããæ§ã ãªåºä¹³åç©ã®äŸ
ã¯ã人éã銬ãçãç¬ãç«ãã©ãããããŠã¹ããŠ
ãµã®ãåã³è¡æ¶²åŸªç°åé¡ãšå¿çåé¡ãšã®ç 究ã®ã
ãã«ç§åŠå®éšå®€ã«ãããŠäžè¬ã«äœ¿çšãããä»åç©
ã§ãããã«ãã³ãŒã«ã¢ãã³ã¯åºä¹³åç©ã®æ§ã ãªç³»
äžã«çºèŠãããã埪ç°éã®ã«ãã³ãŒã«ã¢ãã³ãè¡
液äžã«çºèŠããããäœå ã®ä»ã®çç©åŠçæµåäœã
äŸãã°å°¿ãé«æ¶²åã³ãªã³ã液ãåææéã®ã«ãã³
ãŒã«ã¢ãã³ãå«ããåæç³»äžã«çšããããšã®ã§ã
ãçµç¹ãµã³ãã«ã¯ãè¡ç®¡çµç¹ãèèãå¯è åã³è
èã®æ§ãªäº€æç¥çµã®æ¯é ãåããå šãŠã®çµç¹ïŒè³
çµç¹ïŒè «çã®ããçµç¹ïŒçã§ãããçµç¹ãåæã
ãããšããæã«ã¯ãã®ãµã³ãã«ããå質åãçµç¹
ã®å§æŸåã³è¶ é³æ³¢åŠçã®æ§ãªäžè¬æè¡ã®ãããã
ã«ããç²ç ãããåæã«çšããããã®ã¯ãã®åç
質ã®äžæŸã¿ã§ãããç³»ã®çµ±åæ§ãç¶æããããã«
ã¯é žæ§PHãçšããã¹ãã§ãããè¡æ¶²ãã©ã¯ã·ãšã³
ãã®ä»ã®çç©åŠçæµåäœã®æ§ãªæ¶²äœç³»ãçšããæ
ã«ã¯ã¢ã«ããã¯ãããã°ã©ãã€ãŒåã¯ã«ããªã³äº€
æã¯ãããã°ã©ãã€ãŒã®æ§ãªäºååé¢æ³ãçšãã
å¿ èŠã¯å šããªããæµå液äœãµã³ãã«èªäœãçšãã
ããšãã§ããã 被åæãµã³ãã«ã®ãµã€ãºã¯ã«ãã³ãŒã«ã¢ãã³ã®
ååšéã«äŸåããŠçžåœã«å€åãããåææ床ãé«
ãã®ã§10ÎŒãªããããæªæºãšããå°éã®è¡æž å
ã¯è¡æŒ¿ã®ãµã³ãã«ã容æã«åæã§ãããå°¿äžã«å
åšããã«ãã³ãŒã«ã¢ãã³ã®éã¯è¡æ¶²äžã®ååšéã
ããææã«å€ãã®ã§å°¿ãµã³ãã«ã¯äžè¬ã«ã¯åžéã
ãªããã°ãªããªãã奜ã¯ããŒã æ§çŽ°èè «ãå«ãçµ
ç¹ãµã³ãã«ã¯çžåœã«å€éã®ã«ãã³ãŒã«ã¢ãã³ãå«
ããšããããšãç¹èšãããã¹ãã§ããã被åæåº
ä¹³åç©ç³»ã®å®¹éã®äžéã¯ææãªãã°ïŒmlãšå€ããŠ
ããããå¿ èŠå®¹éã¯äžè¬ã«ã¯éåžžã«ããããªã®
ã§ãå°ããªå®éšåç©ãéèŠãªåé¡ãªã容æã«åæ
ã§ãããåãµã³ãã«ã¢ãªã³ãŒãäžã«ååšããã«ã
ã³ãŒã«ã¢ãã³ã®éã¯ãåã¯NEã®é瀺差çåæ
ã«ãããŠçŽ20ã10000pïœãïŒNEåã³DAã®ç€º
å·®çåæã«ãããŠçŽïŒã5000pïœã§ããã被åæ
ç³»ã®äžè¬çãµã³ãã«ã¢ãªã³ãŒãã¯ïœïœæ¿åºŠã«äŸå
ããŠçŽ10ã50ÎŒã§ããã åèšããéããCOMTã¯ã«ãã³ãŒã«æ žãâ
ã¡ãã«åããäžè¬ç掻æ§ãæã€ãæ¬çºæã®åææ³
ã¯å å æ§ã«ãã³ãŒã«ã¢ãã³ã«å¯ŸããŠæ¥µããŠç¹ç°ç
ã§ã¯ãããããã®ã«ãã³ãŒã«æ žãå€å æ§ã®ã«ãã³
ãŒã«æ žããèå¥ããªããäŸãã°ãåºä¹³åç©ãç¹ã«
人éãã«æäžãããå€æ°ã®è¬ç©ã¯ã«ãã³ãŒã«æ žã
æã€ããã«ãã³ãŒã«æ žãæã€ä»£è¬ç£ç©ã®åé§äœã§
ããããããè¬ç©åã³ïŒåã¯ä»£è¬ç£ç©ã®äŸã¯Î±â
ã¡ãã«ãã«ãšããããªã³ãαâã¡ãã«ããŒãã
ã³ãã€ãœãããã¬ããŒã«ãαâã¡ãã«ããŒããå
ã³ä»ã®åé¡ååç©ã§ãããåºä¹³åç©ããããè¬ç©
ã§ã®åŠçœ®ãåããŠãããªãã°ãCOMTãå©çšã
ãåæã®çµæã¯é床ã«é«ããªãã§ããããåŸã€
ãŠããããååç©ãæçšããåºä¹³åç©ã¯äžé©åœãª
被åæ察象ã§ããã é µçŽ COMTã¯æ§ã ãªåºä¹³åç©ã§çºèŠãããã
ãããåºä¹³åç©ã®äŸã¯ã©ãããä¹³çãè±ãããŠ
ã¹ãã¢ã«ã¢ãããç«ããŠãµã®ã人éã§ãããè©²é µ
çŽ ã¯ç³»ãäŸãã°èèãè èãèŸèãå°è žãè³çã
äžã«åºãååžããŠããã奜ãŸããã®ã¯ã©ããã§ã
ããè©²é µçŽ ãåé¢ããã®ã«å¥œãŸããåšå®ã¯èèã§
ããããã®åé¢æ³ã¯åœæ¥çã§ç¥ãããŠãããæŽã«
ç¡«é žã¢ã³ã¢ããŠã åå¥æ³ãçšãããšããç¹ãé€ã
ã°ãè©²é µçŽ ã®åé¢ã«ãããŠã¯æ®éã®å·¥çšãé²è¡ã
ãã該åå¥æ³ã¯ä»è¿åœæ¥çã«ãããŠè¡ãããŠããª
ããã30ã50ïŒ ãªãã55ïŒ ã®ç¡«é žã¢ã³ã¢ããŠã æ²
殿ç©ãç¡«é žã¢ã³ã¢ããŠã 55ïŒ æº¶æ¶²ãšããŠåæžæ¿ã
ããçžãåé¢ãã以åŸã¯æ®éã®åé¢å·¥çšãšããŠé²
è¡ããããã®ã§ããããã®ç¹å¥ã®åå¥å·¥çšã®è¿œå
ã«ãã空詊éšå€ãçžåœã«äœäžããã âã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒã¡ã
ã«ã¯ãé µçŽ ã«ããâã¡ãã«åã§çšããããæšè
åã¡ãã«åºäŸäžäœã§ããããã®ããªããŠã æšèå
ã¡ãã«åºäŸäžäœã¯åœæ¥çã§ç¥ãããŠããæŸå°ååŠ
æ³ã«ãã補é ã§ããåã¢ã¡ãªã«ã®ããŠãŒã€ã³ã°ã©
ã³ãã®ããŠãŒã¯ã¬ã¢ã³ãŒãã¬ãŒã·ãšã³ïŒNuclear
CorpïŒãšã¢ããŒã·ã€ã ãŒãµãŒã¬ïŒAmershamâ
ïŒSearleïŒãšããåžè²©ãããŠãããããªããŠã æš
èã¯ã¡ãã«åºéšäœã«ããããã®ã¡ãã«åºäŸäžäœ
ã¯ãã«ãã³ãŒã«ã¢ãã³ã®æ倧掻æ§ãåŸãåã«ãã³
ãŒã«ã¢ãã³ãâã¡ãã«åé床ã決å®ããæ¿åºŠãš
ããŠç¶æããããã«ã¯çŽïŒÎŒïŒä»¥äžã®æ¿åºŠã§ã€ã³
ããŠããŒã·ãšã³æ··åç©äžã«ååšãããã¹ãã§ãã
ããšãä»ãçºèŠããããããããåææ床ãåŸã
ããã«ã¯ãæšèåã¡ãã«åºäŸäžäœã¯ãæªæšèåé
æŸå°æ§ã¡ãã«åºäŸäžäœã§ããâã¢ããã·ã«â
âã¡ããªãã³ãæ¬è³ªäžå«ãã§ã¯ãªããªããæªæšè
åéæŸå°æ§ã¡ãã«åºäŸäžäœã®æ·»å ã¯ãã«ãã³ãŒã«
ã¢ãã³ã«å¯Ÿããåææ床ãäœããããæ床ã®äœã
åææ³ãææãªãã°ãããã¯ãæªæšèåéæŸå°æ§
âã¢ããã·ã«ââã¡ããªãã³ãåæã€ã³ããŠ
ããŒãã«å ããããšã«ããéæã§ãããæé«åæ
æ床ãåŸãããã«ã¯æ倧æŸå°èœãæã€ããªããŠã
æšèåâã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒ
ã¡ãã«ã補é ãã¹ãã§ãããïŒããŠãªãŒïŒããªã¢
ã«ã«çããããããã倧ããæŸå°èœãçšããããš
ãã§ããã奜ãŸããæŸå°èœã¯çŽ10ã15ããŠãªãŒïŒ
ããªã¢ã«ã§ããã é µçŽ ç³»ã掻æ§ã«ããããã«ã¯ãé žåæ°ãïŒïŒã§
ããå€æ°ã®ã«ããªã³ã®ãã¡ã®å°ããšãïŒçš®ãã€ã³
ããŠããŒãäžã«ååšãããã°ãªããªãã䜿çšã§ã
ãé žåæ°ãïŒïŒã®ã«ããªã³ã¯ãã°ãã·ãŠã ãã³ã
ã«ãåã³ãã³ã¬ã³ã§ããããã°ãã·ãŠã ã奜ãŸã
ãããã®éå±ã¯å¡©ãäŸãã°å¡©åãã°ãã·ãŠã ããš
ããŠååšã§ãããã«ããªã³ã¯çŽ10ã100ããªã¢ã«
ã®ã奜ãŸããã¯çŽ25ã35ããªã¢ã«ã®æ¿åºŠã§ã€ã³ã
ãŠããŒã·ãšã³æ··åç©äžã«ååšããã é µçŽ âåºè³ªç³»ãå®å®åãããååç©ãã€ã³ããŠ
ããŒãäžã«ååšããããã®ååç©ã¯ã«ãã³ãŒã«ã¢
ãã³ã®é žåã劚害ããããšã«ããç³»ã®çµ±åæ§ãç¶
æããåã€ã³ããŠããŒã·ãšã³äžã®é µçŽ 掻æ§ã®æç¶
ãå©ãããé µçŽ âåºè³ªç³»ãå®å®åãããããã«æ
å¹ã«çšããããšã®ã§ããååç©ã¯ã°ã«ã¿ããªã³ã
ãžããªã¹ã¬ã€ããŒã«ãã¢ã¹ã³ã«ãã³é žãã¡ã¿éäº
ç¡«é žãããªãŠã ãã¡ã«ã«ãããšã¿ããŒã«ãã·ã¹ã
ã€ã³çã§ãããã°ã«ã¿ããªã³ã奜ãŸãããã€ã³ã
ãŠããŒãäžã®ãã®å®å®å€ã®æ¿åºŠã¯çŽïŒã10ããªã¢
ã«ã奜ãŸããã¯çŽïŒãïŒããªã¢ã«ã§ãããã¢ã¹ã³
ã«ãã³é žãçšããæã«ã¯ãé µçŽ æŽ»æ§ã®æå¶ãçã
ãããšãããã®ã§ã泚æããŠéå°éã®äœ¿çšãé¿ã
ãªããã°ãªããªãã ã€ã³ããŠããŒãã®å¥ã®æåã¯ãé µçŽ äœçšã«ãã
転åã劚害ãããªãããã«ã«ã«ã·ãŠã ã€ãªã³ãåª
å é€å»ããè¬å€ã§ãããã«ã«ã·ãŠã ã€ãªã³ã¯ãã°
ãã·ãŠã ãã³ãã«ãããã³ã¬ã³ã®æ§ãªè³ŠæŽ»ã€ãªã³
ã®ååšäžã§ã®é µçŽ äœçšã«ããâã¡ãã«åãæå¶
ãããåŸã€ãŠãé µçŽ äœçšã«ãã転ååå¿ã«åå ã
ããªãããã«ã賊掻ã€ãªã³ã§ã¯ãªãã«ã«ã·ãŠã ã€
ãªã³ãéžæé€å»ããè¬å€ãã€ã³ããŠããŒãäžã«å
åšãããããšã極ããŠæçã§ããããã®æ©èœãæ
ããè¬å€ãäŸç€ºãããšEGTAïŒã±ã¬ãã¯ã¹
ChelexïŒãã€ãªã©ã ã©ãã©ããªãŒãº
ïŒBiorad LaboratoriesïŒããåŸãããšã®ã§ããæš¹
èç¶ç©è³ªãïŒèé žãããªãŠã ïŒã«ã«ã·ãŠã ã€ãªã³
ãéžæçã«ãã¬ãŒãããææãäŸãã°ã ã¬ãªãã·
ãïŒMureoxideïŒïŒåã³ä»ã®åé¡è¬å€ã§ã
ããEGTAã奜ãŸããããããè¬å€ã¯è³ŠæŽ»ã€ãªã³
åŠäœã«ãã€ãŠã¯ã«ã«ã·ãŠã ã€ãªã³ã«å¯Ÿããéžææ§
ãç°ãããšãããã®ã§ãç¹å¥ã®è³ŠæŽ»ã€ãªã³ãå¿ èŠ
ãšãããããšããããåå¿ èŠãªãã°æ·»å ãã¹ãã§
ããããããè¬å€ã¯é µçŽ äœçšã«ãã転åãå¯èœãª
éãæ¥éãã€å¹çããé²è¡ãããã®ã«å åãªéã§
ååšããããäŸãã°ãçŽïŒã25ããªã¢ã«ã®æ¿åºŠã§
EGTAãã€ã³ããŠããŒã·ãšãšã³æ··åç©äžã«äœ¿çšã§
ããã EGTAãCOMTã®åºæ掻æ§ã®å¢åŒ·ã®åå ãšãª
ãããšãçºèŠãããã空詊éšã€ã³ããŠããŒããå³
ã¡åºä¹³åç©ç³»ä»¥å€ã®å šæåãå«ãã€ã³ããŠããŒã
ã«æ·»å ããããšEGTAã¯ãâã¡ãã«ïŒ 3HïŒã«
ãã³ãŒã«ã¢ãã³ã®åœ¢æéã«ããå€æãããéãã
COMTã®é µçŽ 掻æ§ãé«ããã ã€ã³ããŠããŒãã®åæåã¯å šãŠãã«ãã³ãŒã«ã¢
ãã³æ¿åºŠãåŸéå åãšãªãéã§ååšããããé µ
çŽ ãã¡ãã«åºäŸäžäœãã«ããªã³ãå®å®åååç©ã
åã³ã«ã«ã·ãŠã ã€ãªã³ãéžæé€å»ããè¬å€ã¯ãã«
ãã³ãŒã«ã¢ãã³ãâã¡ãã«ïŒ 3HïŒåã«ãã³ãŒ
ã«ã¢ãã³ã«é©æ転åããã®ã«å¿ èŠãªéãè¶ éãã
éã§ååšãããã被åæåºä¹³åç©ç³»äžã«ååšãã
ã«ãã³ãŒã«ã¢ãã³ã®å šãŠãªããæ¬è³ªäžå šãŠã¯ã€ã³
ããŠããŒã·ãšã³æéäžã«è»¢åãããã é µçŽ äœçšã«ããã€ã³ããŠããŒã·ãšã³ã¯ãé µçŽ äœ
çšã«ãã転åãå®äºãããæéãšPHãšæž©åºŠã§æšæº
ã®æ€æ»è£ 眮ã§å®æœãããããã®ã€ã³ããŠããŒã·ãš
ã³ã®PHã¯çŽïŒãšçŽ10ãšã®éã«ç¶æãã¹ãã§ããã
奜ãŸããPHåã¯çŽïŒãïŒã§ããããã®ã€ã³ããŠã
ãŒã·ãšã³ã«ãšãé©åœãªç·©è¡å€ã¯äžãªã³é žå¡©åã¯ã°
ãªã·ã³ïŒNaOHã§ãããã€ã³ããŠããŒã·ãšã³æž©åºŠ
ã¯çŽ25ã45âã奜ãŸããã¯çŽ35ã40âã§ãããã€
ã³ããŠããŒã·ãšã³ã¯çŽ15åããçŽïŒæéã奜ãŸã
ãã¯çŽ40ã60åã®éé²è¡ãããã ã€ã³ããŠããŒã·ãšã³ã¯æ§ã ãªæšæºæ段ã®ããã
ã«ãã€ãŠãåæ¢ããããäŸãã°æž©åºŠãäžãããäž
ããåã¯PHãäžãããäžããããšãã§ããã枩床
ãäžãããã€ãã°ãã·ãŠã ãã³ãã«ããåã¯ãã³
ã¬ã³ã®çµåå€ã®æ·»å ã«äŒŽãé«PHã®å°å ¥ã«ããã€ã³
ããŠããŒã·ãšã³ãåæ¢ãããããšã奜ãŸãããçµ
æžçãæéçå åãåã¯å人ç奜ã¿ã«ãããææ
ãªãã°ãâã¡ãã«ïŒ 3HïŒåã«ãã³ãŒã«ã¢ãã³
ãã€ã³ããŠããŒãããéžæé€å»ããåã«ã€ã³ããŠ
ããŒã·ãšã³ãåæ¢ãããå¿ èŠã¯ãªãã åæ¢æ¶²ã«ã¯æ äœéã®MNïŒNMNåã³MEOTã
ãå«ããããšãã§ãããã«ãã³ãŒã«ã¢ãã³ã¯è¢«æ€
ãµã³ãã«äžã«ã¯éåžžã«å°éã§ããååšããªãã®
ã§ããããã®æ äœååç©ãå ããŠãåæäžã®è¢«æ€
ãµã³ãã«äžã®ã«ãã³ãŒã«ã¢ãã³ã®èªèãšåé ãšã
容æã«ãããšæå©ã§ããã該æ äœååç©ã¯äžè¬ç
ã«ã¯ãããå¡©é žä»å å¡©ãšããŠååšããããã®åœ¢ã®
æ¹ãå®å®ã§ããããã§ããã次ã®åæå·¥çšã«ãã
ãŠãã®éé¢å¡©åºã圢æãããã該æ äœååç©ã¯ã€
ã³ããŠããŒãã®ææ©æº¶åªæœåºã«å ç«ã€ãŠåæ¢æ¶²äž
ã«æ·»å ããããšã奜ãŸããããCOMT転移ã«ã
ãã平衡ã«äŸåããŠåãã«ã€ã³ããŠããŒãã«å ã
ãããšãã§ãããã€ã³ããŠããŒã·ãšã³ãåæ¢ããª
ããªãã°æ äœéã®MNïŒNMNåã³MEOTãæŽ
ã«ãåªå çææ©æº¶åªã§ã®æœåºã«å ç«ã€ãŠã€ã³ããŠ
ããŒãã«æ·»å ãã¹ãã§ãããçŽïŒãïŒããªã¢ã«ã®
æ äœæ¿åºŠãçšããããšãã§ããã ä»ããâã¡ãã«ïŒ 3HïŒåã«ãã³ãŒã«ã¢ãã³
ã¯æº¶åªæœåºã«ããã€ã³ããŠããŒãããéžæé€å»ã
ãããMNïŒNMNåã³MEOTãã€ã³ããŠããŒã
ããæœåºããææ©æº¶åªãçšããããã¡ãããâ
ã¡ãã«åã«ãã³ãŒã«ã¢ãã³ãåªå 溶解ãããå³ã¡
ã€ã³ããŠããŒãæåãåå¿å¯çç©ãã®ä»ã®ç°ç©ã®
ã§ããã ãå€ããæ°Žæ§ã€ã³ããŠããŒãäžã«æ®ãæ
æ©æº¶åªã䜿ãããšã奜ãŸãããæ°Žãšã¯å®è³ªäžéæ··
ååæ§ã®ææ©æº¶åªã䜿çšã§ãããçšããããšã®ã§
ããææ©æº¶åªã®äŸã¯ããã¿ããŒã«ãã€ãœã¢ãã«ã¢
ã«ã³ãŒã«ããããµããŒã«ã®æ§ãªé«çŽã¢ã«ã³ãŒã«ïŒ
é ¢é žãšãã«ã®æ§ãªãšã¹ãã«ïŒãžãšãã«ãšãŒãã«ã
ããã©ããããã©ã³ããžãªããµã³ã®æ§ãªãšãŒã
ã«ïŒãã³ãŒã³ããã«ãšã³ããã·ã¬ã³é¡ã®æ§ãªè³éŠ
æååç©ïŒã§ããã奜ãŸããææ©æº¶åªã¯ã€ãœã¢ã
ã«ã¢ã«ã³ãŒã«ããã¿ããŒã«ããã«ãšã³åã³ãã·ã¬
ã³é¡ã§ãããæŽã«å¥œãŸããã®ã¯ææ©æº¶åªã®ç¹å®æ··
åç©ãç¹ã«35ïŒ75vïŒïœïŒ ã®ãã«ãšã³ïŒã€ãœã¢ã
ã«ã¢ã«ã³ãŒã«æ··åç©ã奜ãŸããã¯ã¯50ã65ïŒ ã®ã
ã«ãšã³ãå«ããã«ãšã³ïŒã€ãœã¢ãã«ã¢ã«ã³ãŒã«æ··
åç©ã§ããã ææ©æº¶åªæœåºãããâã¡ãã«ïŒ 3HïŒåã«ã
ã³ãŒã«ã¢ãã³ããã«ãã³ãŒã«ã¢ãã³ã®ã¢ãã³å®èœ
åºã«ãããã³ãä»äžããã®ã«å åãªåŒ·åºŠãæã€é ž
ã®æ°Žæº¶æ¶²äžã«ååé ãããããããé žã®äŸã¯ã®
é žãé ¢é žãããããªã³é žãå¡©é žãç¡«é žããªã³é žç
ã§ãããæªç€ºå·®åãšNEã®åèšéãåæããã
ãã®åæãè¡ãã«ã¯ãããã®é žã®ããããã䜿çš
ã§ããããããããšNEãšã®ç€ºå·®åæãè¡ãæ
ã«ã¯ãæ¯èŒçäœã沞ç¹ãæã¡ããã€èžçºã«éããŠ
æ®æž£ãæ¬è³ªçã«ã¯å šãæ®ããªãé žãäŸãã°ã®é žã
é ¢é žãããããªã³é žã奜ãŸããã¯é ¢é žã䜿çšãã
ããšã奜ãŸããããã®ç€ºå·®åæã§ã¯NMNãMNã
ãåé¢ããããã®ã¯ãããã°ã©ãã€ãŒå·¥çšãå¿ èŠ
ãšããããMNåã¯NMNã®é žä»å å¡©ã®ååšãã
NMNããã®MNã®åé¢ã被æ€ãµã³ãã«äžã®ä»æå
ããã®åã«ãã³ãŒã«ã¢ãã³ã®åé¢ã劚害ãããå
é å¹æãé«ããããã«ååé ãæ°åºŠããè¿ãããš
ãã§ããã æ°Žçžãææ©çžããé«å¯åºŠã§ãããªãã°ãäºçžã®
åé¢ã¯æ°Žçžã®åçµã«ãã容æã«ãªãããšãçºèŠã
ãããåçµã«ããåææéãççž®ãããåæ°Žçžã
ãã®ææ©çžã®åé¢ãäžå±€æçœãã€æ£ç¢ºãšãªãã ãšNEãšã®æªç€ºå·®ååèšéãç¥ãããšãææ
ãªãã°ãMNãNMNããåé¢ããå·¥çšã¯è¡ããª
ãããã®ä»£ããã«é žæ°Žæº¶æ¶²æœåºç©ãåªå çã«ä¹Ÿç¥
ãããå¡©åºæ§æº¶æ¶²ã«å ¥ããMNãšNMNãšããããª
ã³ã«é žåããã ãšNEãšã®ç€ºå·®åææ³ãè¡ãæã«ã¯ãã®æç¹
ã§MNãšNMNããåé¢ãããâã¡ãã«åã«ãã³
ãŒã«ã¢ãã³ãåé¢ããæ®éã®æ段ã¯ã¯ãããã°ã©
ãã€ãŒãäŸãã°ããŒããŒã¯ãããã°ã©ãã€ãŒãšè
å±€ã¯ãããã°ã©ãã€ãŒã§ããã奜ãŸããã¯èå±€ã¯
ãããã°ã©ãã€ãŒã§ãããâã¡ãã«åã«ãã³ãŒ
ã«ã¢ãã³ãå«ãé žæ°Žæº¶æ¶²æœåºç©ã也ç¥ããã95ïŒ
ãšã¿ããŒã«ã®æ§ãªææ©æº¶åªã«æº¶è§£ãããããã®ãš
ã¿ããŒã«æº¶æ¶²ããåžçå€ãäŸãã°çªé žè³ªæãã®è
å±€ã«ãã被ãããã¯ãããã°ã©ãã€ãŒæ¿ã«å¡ãã
åžçå€ã®å±€åã¯åœæ¥çã§äžè¬çã«äœ¿çšãããŠãã
ãã®ã§ãããäŸãã°50ã750ÎŒã奜ãŸããã¯200ã
300ÎŒã§ãããåžçå€ã¯ã·ãªã«ã²ã«ã奜ãŸããã
åé¢ã«äœ¿çšããã溶åªç³»ã¯MNãNMNããåé¢ã
ãããšãç¥ãããŠããç³»ã®ãããã§ãããããã
ããã·ãªã«ã²ã«ãšå ±ã«ã¯ãïœïŒïœïŒ ã§60ã®ã€ãœã
ããã«ã¢ã«ã³ãŒã«ã20ã®ïœâãã¿ããŒã«ã19ã®
æ°Žãåã³ïŒã®ã®é žãšããçµæãæã€æº¶åªç³»ã䜿çš
ããããšã奜ãŸããããã®æº¶åªç³»ã䜿çšããæã«
ã¯MNã¯çŽ0.59ã®Rfå€ãNMNçŽ0.7ã®Rfå€ã瀺
ããMEOTã¯NMNããåé¢ããªããNMNããã®
MNã®åé¢ã¯æ¥éãã€é¡èã«èµ·ãããå¥ã®æº¶åªç³»
ãã·ãªã«ã²ã«ãšçµã¿åããŠäœ¿çšããæã«ã¯
MEOTãNMNããåé¢ãããã容éæ¯ã§ïŒéšã®
ïœâã¢ãã«ã¢ã«ã³ãŒã«ãšïŒéšã®ãã³ãŒã³ãšïŒéšã®
ã¡ãã«ã¢ãã³ãããªãå¡©åºæ§æº¶åªç³»ã¯ã·ãªã«ã²ã«
äžã§MEOTãNMNããåé¢ããããã®å Žåã
MEOTãåç¹ïŒæº¶åªç³»å¡åžå°ç¹ïŒããæãé¢ã
ãŠãããMNãMEOTããã¯åç¹ã«è¿ããNMN
ãåç¹ã«æãè¿ããããã®åŸè ã®æº¶åªç³»ã«ããã
åé¢ãããMEOTã®æŸå°ç·æŸåºãå©çšããŠã®DA
ã®å®¹æãªåæãå¯èœãšãªãã äžèšèå±€ã¯ãããã°ã©ãã€ãŒå·¥çšã§çšãããã
å¡©åºæ§æº¶åªç³»ã¯æ°èŠã§ããããã®ç³»ã®å¿ é æåã¯
容éæ¯ãçŽïŒïŒïŒããçŽïŒïŒïŒã§ããã¢ã«ã³ãŒã«
ãšã¡ãã«ã¢ãã³ãšã§ãããã¡ãã«ã¢ãã³ã¯40ïŒ æ°Ž
溶液ãšããŠäœ¿çšããããã¢ã«ã³ãŒã«ã¯ïœâã¢ãã«
ã¢ã«ã³ãŒã«ãã€ãœã¢ãã«ã¢ã«ã³ãŒã«ãïœâãã¿ã
ãŒã«çã®æ§ãªé«çŽã¢ã«ã³ãŒã«ã§ãããç¡æ¥µæ§ã§èŠª
æ²¹æ§ã®ææ©ååç©ããã®æº¶åªç³»äžã«ååšãããã
ãšãã§ãããããã溶åªã®ååšã«ãã移åé床ãš
ã¹ãããåé¢é床ãšãäžæãããããã¯äžçžæº¶åª
ç³»ãä¹±ããªãéãå€éã«ååšãããããšãã§ã
ããçšããããšãã§ããç¡æ¥µæ§ã»èŠªæ²¹æ§ææ©æº¶åª
ã®äŸã¯ããã³ãŒã³ããã«ãšã³ãïœâãã·ã¬ã³åã³
ïœâãã·ã¬ã³ã§ããã åæã®ãã®æç¹ã§MNãå«ãã¹ããããæ°Žé žå
ã¢ã³ã¢ããŠã ã®æ§ãªæº¶åªãçšããŠã·ãªã«ã²ã«ãã
溶é¢ãããã€ãã§ãã€ã³ããŠããŒãã®æœåºã®ãšã
ãã§æ¢ã«é瀺ããææ©æº¶åªåã¯ææ©æº¶åªç³»ã§æœåº
ããã ã€ãã§æŸå°æ§æšèåååç©ãèšæ°ãããã¯ãã
ãã°ã©ãã€ãŒåé¢ã«ãããŠå¡©åºæ§æº¶åªç³»ã䜿çšã
ãæã«ã¯ãMEOTãšNMNãšã¯åäžæ¹æ³ã§åæã§
ãããããããé žæ§ãå¡©åºæ§ãã®ããããã®æº¶åª
åé¢ç³»ããåŸãããMNãšNMNãšããããªã³ã«é ž
åããããšã奜ãŸãããβâããããã·ã«ãã³ãŒ
ã«ã¢ãã³ã®ã¿ããã®é žåãåããã®ã§ãã®é žåã«
ããåæç¹ç°æ§ã¯å€§ãããªãããã®å·¥çšã«ããã
βâããããã·åºãæããªãä»ã®æšèåã«ãã³ãŒ
ã«æ žååç©ã¯åé¢ããããæŽã«ãé žæ§æº¶åªç³»ã«ã
ããŠã¯ãNMNãšMEOTãšã¯åé¢ãããªãã®ã§ã
NMNããããªã³ã«é žåããããšãå¿ èŠã§ããã
æªç€ºå·®åãšNEãšã®åèšéãåæããã ãã®æ
ã§ããMEOTãMNåã³NMNããåé¢ããã«ã¯
ãã®é žåãå¿ èŠã§ããã βâããããã·ââã¡ãã«åã«ãã³ãŒã«ã¢ã
ã³ã®é žåã¯æšæºã®è©Šè¬ãšæ¡ä»¶ãšãçšããŠéæãã
ããMNåã¯NMNãåžçå€ãã溶é¢ãããåŸã«
MNãšNMNãšããçŽïŒã12ã®PHãçŽïŒã50âã®æž©
床ã§çŽïŒã30åéãã¡ã¿éãšãŠçŽ é žå¡©ãããªãŠã
ã®æ§ãªé žåå€ãšæ¥è§ŠããããMNãšNMNãšã¯ãã
ãªã³ã«å®éçã«é žåãããªããã°ãªããªããåå¿
枩床ã¯çŽïŒã40âã奜ãŸãããåå¿æéã¯ïŒã10
ã奜ãŸããã ä»ããéãšãŠçŽ é žå¡©ã«ããé žåã¯ã·ãªã«ã²ã«ã®
æ¥è§Šååšäžã§å®æœã§ããããšãçºèŠãããããã
ã«ããåæã®æ床ãæ£ç¢ºåºŠã粟床ãé«ãŸããé žå
å·¥çšãåäžå®¹åšå ã§å®æœã§ããããã§ãããMN
åã¯NMNãå«ãã·ãªã«ã²ã«åž¯ãæ¿ããåãã管
ã«å ¥ããMNåã¯NMNãæ°Žé žåã¢ã³ã¢ããŠã ã®æ§
ãªå¡©åºæ§æº¶åªã§æº¶åºããã¡ã¿éãšãŠçŽ é žãããªãŠ
ã ãå ããããããªã³ãžã®é žåã¯ã·ãªã«ã²ã«ã®æ¥
觊ååšäžã§ã¹ã ãŒãºã«ãåäœã®å°é£ããªãèµ·ã
ãã é žåã¯å®äºããããåæ¢ããããåæ¢å€ã¯äžè¬
çã«ã¯ã°ãªã»ããŒã«æº¶æ¶²ã§ãããç³»ã®PHãæªã ïŒ
ãªãããã以äžã§ãªããªãã°ãç³»ã®PHãé žã«ãã
ïŒãªãããã以äžã«äžãããçšããããé žã®æ§è³ª
ã¯é倧ã§ã¯ãªããå¡©é žãç¡«é žããªã³é žãã®é žãé ¢
é žãããããªã³é žãçšããããšã®ã§ããé žã®äŸã§
ããã ãããªã³ããæ°Žæ§ãã©ã¯ã·ãšã³ãšå®è³ªäžéæ··å
æ§ã®ææ©æº¶åªäžã«æœåºããããã®ææ©æº¶åªã¯ãã
ããªã³ãšçžå¯Ÿçã«æ¥µæ§ã®å¯çç©ãšãååã«åé¢ã
ããããã«ã¯çžå¯Ÿçã«ç¡æ¥µæ§ã§ããããšã奜ãŸã
ããããã溶åªã®äŸã瀺ããšãã³ãŒã³ããã«ãš
ã³ãïœâãã·ã¬ã³ãïœâãã·ã¬ã³ããšãã«ãã³ãŒ
ã³ãã€ãœãããã«ãã³ãŒã³ïŒé ¢é žãšãã«ãé ¢é žã€
ãœãããã«ã®æ§ãªãšã¹ãã«ïŒãžãšãã«ãšãŒãã«ã
ïŒïŒïŒâãžãªããµã³ã®æ§ãªãšãŒãã«ïŒã§ãããæ°Ž
çžãææ©çžããé«å¯åºŠã§ããæã«ã¯æ°Žçžãåçµã
ããææ©çžãé€ãããšã«ããïŒçžã®åé¢ã¯å®¹æã«
ãªãã ãããªã³â 3Hãèšæ°ããããã©ã³ã·ãã
ïŒplanchetïŒèšæ°ã®æ§ãªæ§ã ãªæŸå°ç·èšæ°æè¡ã
çšããããšãã§ãããã液äœã·ã³ãã¬ãŒã·ãšã³èš
æ°æè¡ã奜ãŸãããçšããããåã ã®æ¶²äœã·ã³ã
ã¬ãŒã¿ãŒãäœã§ãããã¯ããããããªããŠã ãã
æŸåºãããβç·ã«æé²ãããæã«äžå®éã®å ãæŸ
åºããéãé倧ã§ã¯ãªããé©åœãªã·ã³ãã¬ãŒã¿ãŒ
ã®äŸã¯ïœâãã«ããšãã«ïŒïŒïŒïŒâãžããšãã«ãª
ããµãŸãŒã«ïŒïŒâããšãã«âïŒâïŒïŒâãããšã
ãªã«ïŒâïŒïŒïŒïŒïŒâãªããµãžã¢ãŸãŒã«ïŒïŒïŒïŒ
âãã¹âïŒâïŒïŒâïœâããã«ãã³ãŸããµãŸãª
ã«ïŒâããªããšã³ïŒ2.5âãžããšãã«âïŒïŒïŒïŒ
ïŒâãªããµãžã¢ãŸãŒã«ïŒïŒâïŒ4â²âãããšãã«ïŒ
âïŒâããšãã«ãã³ãŸããµãŸãŒã«ïŒïŒïŒïŒâãã¹
âïŒâïŒïŒâããšãã«ãªããµãŸãªã«ïŒâãã³ãŒ
ã³ïŒã§ããããã®ã·ã³ãã¬ãŒã¿ãŒã¯ææ©æº¶åªã«æº¶
解ããããã·ã³ãã¬ãŒã¿ãŒãšæº¶åªãšã®çµåãã以
åŸã液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªãšåŒã¶ããããªã³
ãå«ãææ©æº¶åªããã®æ¶²äœã·ã³ãã¬ãŒã·ãšã³åªè³ª
ã«å ããèšæ°ããã奜ãŸãããããªã³â3Hæœåº
æ³ã¯ãæœåºçšæº¶åªãšããŠæ¶²äœã·ã³ãã¬ãŒã·ãšã³åª
質ã䜿çšããããšã§ãããåæç¹ç°æ§ã¯ããããª
ã³å«æææ©æº¶åªãé žæ°Žæº¶æ¶²ãšæ¥è§Šãããããã«ã
ã氎溶æ§äžçŽç©ãæŽã«é€å»ããããšã«ããæŽã«é«
ããããšãã§ããããã®æœåºã¯ããããªã³å«ææ
æ©æº¶åªã液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªã«æ·»å ãã以
åã«è¡ãããšãã§ããããé žæ°Žæº¶æ¶²çžã液äœã·ã³
ãã¬ãŒã·ãšã³åªè³ªãšæ¥è§Šãããããšã奜ãŸããã
ãã®æ¹æ³ã«ãããŠåé¢è»¢ç§»ãšçžåé¢ãšã®æ°ãæå°
ã«ãªãããããªã³ã液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªã«
å ããæã«ã¯ãããªã³ã¯ææ©å±€äžã«çãŸããã·ã³
ãã¬ãŒã¿ãŒã«ããèšæ°ããããããããã·ã³ãã¬
ãŒã¿ãŒã¯ææ©çžã«ååšããåããªããŠã ããã®Î²
ç·æŸåºã¯æ°Žçžãšçé¢ãšã«ããåæ¢ãããã®ã§ãé ž
氎溶液çžäžã«æœåºããããããã®ããªããŠã æšè
å借éç©ãèšæ°ãããªãã液äœã·ã³ãã¬ãŒã·ãšã³
åªè³ªã¯ãã·ã³ãã¬ãŒã¿ãŒãæ°Žçžã«ã»ãšãã©ãªãã
å šã溶解ããŠããªããã®ãéžæããªããã°ãªããª
ãã DAãåæ§ã«ããŠåæããããšãææãªãã°ã
éãšãŠçŽ é žå¡©æ°Žæº¶æ¶²çžã®PHãïŒãã倧ããã奜ãŸ
ããã¯9.8ã10.1ã«äžãããããªã³æœåºã§äœ¿çšã
ããæ§ãªææ©æº¶åªã§MEOTãæœåºãããMEOT
â 3Hããã®æŸå°ç·ã®èšæ°ã¯ããããªã³â 3Hã®
å Žåãšåæ§ãªæ¹æ³ã§è¡ãã æªç¥éã®ã«ãã³ãŒã«ã¢ãã³ãå«ãåºä¹³åç©ç³»ãš
åæã«ãåºä¹³åç©ç³»ä»¥å€ã®ã€ã³ããŠããŒãæåã®
å šãŠãå«ã空詊éšãµã³ãã«ãåäžã®æ¹æ³ã§åæã
ãããã®åææ床ã¯ã空詊éšãµã³ãã«ã®èšæ°å€ã®
ïŒåã®å€ã瀺ãã«ãã³ãŒã«éãšããŠå®ãããåæ
æšæºæ²ç·ããæªç¥ãµã³ãã«ã空詊éšãµã³ãã«ãšå ±
ã«æ¢ç¥éã®ïŒ¥ïŒNEåã¯DAãåæããããšã«ãã
åŸããæ¢ç¥æ¿åºŠã®ïŒ¥ïŒNEåã¯DAã§åŸãããèšæ°
å€ããã®æ¿åºŠã«å¯ŸããŠãããããããã€ãã§ãæš
æºæ²ç·ãåç §ããããšã«ãããæªç¥æ¿åºŠã®ã«ãã³
ãŒã«ã¢ãã³ãæŸåºãããæŸå°ç·ã®æ°ããæ±ããã ãã®æ¹æ³ã«ãããŠãã§3pïœïŒNEã§5pïœïŒ
DAã§12pïœãæªç€ºå·®åãšNEãšã®åèšéã§5pïœ
ã®æ床ã«éããããšãã§ããã極ããŠå°ãããµã³
ãã«ãµã€ãºã®åºä¹³åç©ç³»ããå€ç°ä¿æ°ãïŒã12ïŒ
ã§ãããšãã粟床ãåŸããããæšæºæ²ç·ã¯çŽ3p
ïœããå°ããšã3000pïœã®ç¯å²å ã§äžæ¬¡åå¿é床
ã瀺ããæ¬çºæã®åæç³»ã¯å€ç®çã«äœ¿çšã§ããæ¥
éã§ãååæ¥çã«æçšã§ããã 以äžã¯æ¬çºæã®åæç³»ããããå©çšããåææ¹
æ³ã®ç¹å®å®æœäŸã§ãããå®æœäŸã¯æ¬çºæã®æŠå¿µã
äŸç€ºããããšã®ã¿ãç®çãšãããããéå®ããã
ã®ã§ã¯ãªãã å®æœäŸ ïŒ ïŒ¡ ã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ ã®èª¿è£œ ãã®é µçŽ 調補ã¯äžè¬çã«ã¯Axelrodãš
Tomchickãšã®æ¹æ³ïŒJ.Biol.Chem.233ïŒ702ïŒ
1958幎ïŒã«åŸãã ã©ãããç æ§ã«ãããèèãåãåºããå·ç匵
KClïŒ1.15ïŒ ïŒäžã§ãªã³ã¹ããåžåçŽã䜿ã€ãŠä¹Ÿ
ç¥ãããéããéããïŒå容éã®ç匵KClã«å ¥ã
ãŠå質åãããåŸãããåç質ã78000ïœã§30å
éé å¿åé¢æäœã«ä»ãããäžæŸã¿ããã«ã³ããŒã·
ãšã³ã«ããåãåºãããã®PHããæ¹æããªãã
1Né ¢é žã滎äžããããšã«ããPHïŒã«èª¿æŽããã
å·æã«æŸçœ®ããåŸã«é å¿åé¢æäœã«ä»ããŠã圢æ
ãããæµ®é液ãé€å»ããã åŸãããäžæŸã¿ããã«ã³ããŒã·ãšã³ã«ããååº
ããããã«ç¡«é žã¢ã³ã¢ããŠã ïŒAmSO4ïŒããã€ã
ããšå ããŠAmSO4æ¿åºŠã30ïŒ ã«ãããé å¿åé¢
æäœåŸã«äžæŸã¿ããã«ã³ããŒã·ãšã³ã«ããåãåº
ããããã«AmSO4ãå ããŠãã®æ¿åºŠã55ïŒ ã«äž
ãããçæ溶液ãé å¿åé¢æäœã«ä»ããŠ30ã55ïŒ
AmSO4ãã©ã¯ã·ãšã³ãçæããã ãã®30ã55ïŒ AmSO4æ®æž£ãã0.1ããªã¢ã«ã®ãž
ããªã¹ã¬ã€ããŒã«ïŒåã¯0.2ããªã¢ã«ã®ã°ã«ã¿ã
ãªã³ïŒãå«ãPH7.4ã®ïŒããªã¢ã«ãªã³é žå¡©
ïŒPO4ïŒç·©è¡æ¶²ã«æº¶è§£ããã€ãã§AmSO4ãåã³ã
ã€ãããšå ããŠAmSO4æ¿åºŠã55ïŒ ã«ããããã®
è¿œå ã®AmSO4åå¥æ³ã«ãããäœã空詊éšå€ã瀺
ãé µçŽ èª¿è£œç©ãæäŸããããé å¿åé¢æäœåŸã«æ®
枣ãåã³äžèšãšåäžã®PO4ç·©è¡æ¶²ã«æº¶è§£ããåäž
ç·©è¡æ¶²ãïŒåºŠãããŠéæããããã®éæãè¡ãã«
ã¯æ®é14ã18æéããã€ãã é µçŽ èª¿è£œç©ã®æŽ»æ§ã枬å®ãããã®å®¹éããã«ã
ã³ãŒã«ã¢ãã³ã®åæã§æé©ã«äœ¿çšã§ããæ§ã«èª¿æŽ
ãããé µçŽ èª¿è£œç©ã®èçœæ¿åºŠã枬å®ããã ãã®èª¿è£œç©äžã«ã¯è³éŠæâã¢ãã³é žã«ã«ãã
ã·ã«åºåè§£é µçŽ æŽ»æ§ãååšããã®ã§ãå¡©é žãã³ãž
ã«ãªãã·ã¢ãã³åã¯ãªã³é žïŒâããããã·âïŒâ
ããã ãã³ãžã«ãªãã·ã¢ãã³ã®æ§ãªã«ã«ããã·ã«
åºåè§£é µçŽ é»å®³å€ã10-3ã¢ã«æ¿åºŠã§é µçŽ 調補ç©äž
ã«å«ãããã€ã³ããŠããŒãé»å®³å€æ¿åºŠã¯10-3ã
10-5ã¢ã«ã ã€ãã  溶液 以äžã®æº¶æ¶²ã調補ããã ïŒ å®å®å溶液âå šå®¹é0.5ml 10ããªã¢ã«ã®éå æ§ã°ã«ã¿ããªã³ã0.01NHCl
ã«æº¶è§£ããã ïŒ æšæºæº¶æ¶²âå šå®¹é0.5ml ãã«ãšããããªã³ããšããããªã³åã³ããŒãã
ã³ãå®å®å溶液ã«æº¶è§£ããŠåå¡©åºã®æçµæ¿åºŠã
100ÎŒïœïŒmlã«ããã ïŒ ç·©è¡æ¶²âå šå®¹éïŒml 1000ããªã¢ã«ã®ããªã¹ïŒããããã·ã¡ãã«ïŒã¢
ããã¡ã¿ã³ãš100ããªã¢ã«ã®EGTAãš300ããªã¢ã«
ã®å¡©åãã°ãã·ãŠã ãšãå«ã溶液ã ïŒ ïŒ³âã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒã¡
ãã«âå šå®¹é0.4ml ç¹ç°æŽ»æ§ãïŒ8CiïŒããªã¢ã«ã§ããïŒÎŒCiïŒ10
ÎŒã®3Hãåžç¡«é žïŒãšã¿ããŒã«å ¥ããã ïŒ ã©ããèããã®ã«ãã³ãŒã«ââã¡ãã«åºè»¢
ç§»é µçŽ âå šå®¹é0.45ml é µçŽ æº¶æ¶²ã®èçœæ¿åºŠã¯15ã40mgïŒmlãšããã溶
液ã«ã¯ãªã³é žå¡©ç·©è¡å€ãã°ã«ã¿ããªã³åã³ãžããª
ã¹ã¬ã€ããŒã«ããå«ããã ïŒ åæ¢æ¶²âå šå®¹éïŒml 1Næ°Žé žåãããªãŠã äžã®800ããªã¢ã«ã®ç¡Œé žãš
80ããªã¢ã«ã®EDTAäºãããªãŠã ãïŒããªã¢ã«ã®
DLâã¡ã¿ãããªã³ïŒHClãïŒããªã¢ã«ã®DLâã
ã«ã¡ã¿ãããªã³ïŒHClãåã³ïŒããªã¢ã«ã®ã¡ãã
ã·ãã©ãã³ïŒHClãå«ããã ïŒ ã¡ã¿éãšãŠé žå¡©ãããªãŠã ïŒïœïŒïœïŒïŒ 溶液
âå šå®¹éïŒml ïŒ ã°ãªã»ããŒã«10ïŒïœïŒïœïŒïŒ 溶液âå šå®¹éïŒ
ml  åºä¹³åç©ç³»ã®èª¿è£œ 人è¡æ¶²ã®ãµã³ãã«ãæ£è ããæ¡è¡ããããã®è¡
液ããEGTAïŒ250ããªã¢ã«ïŒãšã°ã«ã¿ããªã³
ïŒ200ããªã¢ã«ïŒãšã®æ··åç©ãå«ã管ã«éãããå®
å®å溶液ã®PHã¯ïŒãïŒã«ããŠããããæ¡éå šè¡ã®
ïŒmlåœãã20ÎŒã®å®å®å溶液ãå ãããã€ã
ã§ãè¡æ¶²ãµã³ãã«ãé å¿åé¢æäœã«ä»ããŠè¡æŒ¿ã
åŸããè¡æŒ¿ãåçµãããããµã³ãã«ã«ãã€ããªã³
åã³ä»ã®ç²ç¶ç©å³ã¡æ¿ãããªãããã«æ³šæãæã€
ãã  è©Šè¬æ··åç© ïŒ¢ã§åŸã次ã®æåãã次ã®é äœãšå²åãšã§çšã
ãŠè©Šè¬æ··åç©ã調補ããã æº¶æ¶²ïŒ 10ÎŒ æº¶æ¶²ïŒ 10ÎŒ æº¶æ¶²ïŒ ïŒã20ÎŒ èžçæ°Žâ» å šéã40ÎŒã«ããé â»ïŒè±ã€ãªã³ãã¬ã©ã¹èžçïŒ é µçŽ æ·»å åã«æ··åç©ã軜ã枊åãããåè©Šè¬æ··
åç©å®æåŸã«è»œã枊åããããæ§ã ãª40ÎŒåå¿
æ··åç©ã調補ããã  æšæºæº¶æ¶²ãšå®å®å溶液 溶液ïŒã®ã¢ãªã³ãŒããå·èžçæ°Žã§ïŒïŒ10000ã®
æ¯ã§åžéããŠæ°·æµŽäžã«è²¯èµãããããã«ãã10ÎŒ
åœãã100pïœã®åã«ãã³ãŒã«ã¢ãã³ãå«ã
âå¯äœ¿æšæºç©âãæäŸããã 溶液ïŒã®ã¢ãªã³ãŒããåæ§ã«åžéããã  ã€ã³ããŠããŒã·ãšã³ 50ÎŒã®è¡æž ã®å ¥ã€ã管ã«10ÎŒã®æº¶æ¶²ïŒãšã
40ÎŒã®å·¥çšïŒ€ã®è©Šè¬æ··åç©ãšãå ããã 空詊éšãµã³ãã«ãåç §æšæºãæ¢ç¥æ¿åºŠã®ã«ãã³
ãŒã«ã¢ãã³ãå«ãè¡æŒ¿ãµã³ãã«ã®åæãæªç¥ãµã³
ãã«ã®åæãšå ±ã«åæ§ã«è¡ã€ããåç §æšæºã¯æ°Žäž
ã§ãåºä¹³åç©ç³»ãååšããªãå Žåã®é µçŽ ã®ïŒ¯âã¡
ãã«ååã枬å®ããããã«å«ãããæ¢ç¥æ¿åºŠã®ã«
ãã³ãŒã«ã¢ãã³ãå«ãè¡æŒ¿ãµã³ãã«ã¯åæã®å質
å¶åŸ¡ã枬å®ããããã«å«ããã 空詊éšãµã³ãã«ã¯50ÎŒã®èžçæ°Žã10ÎŒã®æº¶
液ïŒã40ÎŒã®è©Šè¬æ··åç©ãã調補ããã åç §æšæºã¯50ÎŒã®èžçæ°Žã10ÎŒã®å·¥çšïŒ¥ã®
å¯äœ¿æšæºç©ã40ÎŒã®è©Šè¬æ··åç©ãã調補ããã ã«ãã³ãŒã«ã¢ãã³å«éãæ¢ç¥ã®è¡æŒ¿ãµã³ãã«ã¯
50ÎŒã®è¡æŒ¿ã10ÎŒã®å·¥çšïŒ¥ã®å¯äœ¿æšæºç©ã40
ÎŒã®è©Šè¬æ··åç©ãã調補ããã æªç¥ãµã³ãã«ãå«ãäžèšãµã³ãã«ç®¡ãšä»ã®æº¶æ¶²
管ãšããåæãéããŠåäžã«åŠçãããåŸã€ãŠã
次äžã®å·¥çšã«ãããŠã¯æªç¥ãµã³ãã«ç®¡ã«ã®ã¿èšå
ããã ãµã³ãã«ç®¡ã軜ã枊éããã37âã§60åéæ¯å
氎济å ã§ã€ã³ããŠããŒã·ãšã³ãããã€ã³ããŠããŒ
ã·ãšã³çµäºåŸã«ç®¡ã氷济ã«æ»ãã50ÎŒã®æº¶æ¶²ïŒ
ãå ããã  æœåº ïŒmlã®ãã«ãšã³ïŒã€ãœã¢ãã«ã¢ã«ã³ãŒã«ïŒïŒïŒ
ïŒãïœïŒïœïŒããåæ¢ãããã€ã³ããŠããŒãã«å
ãããçææ··åç©ãæ¿ãã枊åãããé å¿åé¢æ
äœã«ä»ããïŒ2000rpmã§ïŒåéïŒã以åŸã®é å¿å
é¢æäœãåäžæ¹æ³ã§è¡ã€ããïŒã€ã®æçã«ç°ãªã
å±€ãççããã管ããã©ã€ã¢ã€ã¹âãšã¿ããŒã«æµŽ
ã«å ¥ããæ°Žå±€ãåçµããããææ©çžããã«ã³ããŒ
ã·ãšã³ã«ããã0.1mlã®0.1Né ¢é žãå«ã管ã«å ¥ã
ãã管ãšå 容ç©ãšã枊巻æ¹æããé å¿åé¢æäœã«
ä»ããåèšãšåäžã®æ¹æ³ã§åçµããããææ©çžã
åçµæ°ŽçžããåžãåºããŠæšãŠããåçµæ°Žçžã解å
ããïŒmlã®ãã«ãšã³ïŒã€ãœã¢ãã«ã¢ã«ã³ãŒã«
ïŒïŒïŒïŒãïœïŒïœïŒãå ãã管ãšå 容ç©ãšãæ¿ã
ã枊åããé å¿åé¢æäœã«ä»ãããæ°Žçžãåçµã
ãããã®äžåŽã®ææ©çžãåžãåºããŠæšãŠãã  åé¢ ïŒ§ã®é ¢é žçžã®å šãŠããAnaltech IncããåŸãã·
ãªã«ã²ã«GFæ¿ïŒ2.5Ã10cmã250ãã¯ãã³å±€ïŒã®
åºéšã«å¡åžãããæ°Žæ§ã¹ãããããã¹ãããã«å
ç«ã€ãŠç®¡ã«0.15mlç¡æ°Žãšã¿ããŒã«ãå ããå枩颚
ãæµãããšã«ãã也ç¥ããããã¹ããããããæ¿
ããçŽãå 匵ããããäºå平衡åèå±€ã¯ãããã°
ã©ãã€ãŒå±éçšã¿ã³ã¯å ã«å ¥ãããæ¿ãã€ãœãã
ãã«ã¢ã«ã³ãŒã«ïŒïœâããã«ã¢ã«ã³ãŒã«ïŒæ°ŽïŒã®
é žïŒ60ïŒ20ïŒ19ïŒïŒïŒã®æº¶åªç³»ã§å±éãããã溶
åªãæ¿ã®é é ã«åããŠçŽïŒæé移åããããæ¿ã
åãåºããŠå®å šã«ä¹Ÿç¥ãããã垯è²ãŸãŒã³ã
254nm玫å€å ã§å¯èŠåãããäžåŽã®ãŸãŒã³ã¯
NMNãšMEOTãšãå«ãã§ãããäžåŽã®ãŸãŒã³ã¯
MNãå«ãã§ãããåãŸãŒã³ã®ã·ãªã«ã²ã«ããã¬
ãŒãããèœãšããå¥ã®ç®¡ã«å ¥ããã  NMNã®é žå NMNãšMEOTãšãå«ã管ã«ïŒmlã®1Næ°Žé žåã¢
ã³ã¢ããŠã ãå ããŠã¢ãã³é¡ãã·ãªã«ã²ã«ãã溶
é¢ããæ¿ãã枊åãããã50ÎŒã®æº¶æ¶²ïŒãå
ããç®¡å šäœã枊åãããã溶液ïŒãæ·»å ããŠïŒå
åŸã«50ÎŒã®æº¶æ¶²ïŒãå ããŠæžŠåãããã  NMNããã®ãããªã³ã®æœåºãšèšæ° 100ÎŒã®æ°·é ¢é žã管ã«å ããŠæžŠåãããã10
mlã®ãã«ãšã³ïŒãªã¯ã€ãã©ã¯ãŒïŒLiguiflour
ïŒã管ã«å ¥ããŠã管ã30ç§éæ¿ããæ¯ãšãã
ãã管ã2000rpmã§ïŒåéé å¿åé¢æäœã«ä»ããŠ
å±€ãåé¢ãããæ°Žå±€ãåçµããããäžã®ææ©å±€ã
ãã«ã³ããŒã·ãšã³ã«ãããïŒmlã®0.1Né ¢é žãå«
ãã·ã³ãã¬ãŒã·ãšã³ãã€ã¢ã«ã«å ¥ããããã®ãã€
ã¢ã«ã«ãã€ãããããæ¿ããæ¯ãšããã液äœã·ã³
ãã¬ãŒã·ãšã³èšæ°ç®¡å ã§èšæ°ããããã€ã¢ã«å ã®
æŸå°èœã¯ãµã³ãã«äžã®NEã®éã«åå ããã  MEOTã®æœåºãšèšæ° ã®åçµæ°Žå±€ã解åããïŒmlã®ãã«ãšã³ãå ã
ãã管ãšå 容ç©ãšã枊åããã2000pmã§ïŒåé
é å¿åé¢æäœã«ä»ããæ°Žå±€ãåçµããããäžã®æ
æ©çžãåžãåºããŠæšãŠãã0.3mlã®æ¿æ°Žé žåã¢ã³
ã¢ããŠã ãå ãã管ã枊åããããæ°Žçžã®PHã¯
9.8ã10.1ã§ãã€ãã10mlã®ãã«ãšã³ïŒã€ãœã¢ã
ã«ã¢ã«ã³ãŒã«ïŒïŒïŒ2vïŒïœïŒãå ããã管ãæ¿
ããæ¯ãšãããã2000rpmã§ïŒåéé å¿åé¢æäœ
ã«ä»ããæ°Žå±€ãåçµããããäžã®ææ©çžã10mlã®
ãžãªããŒã«ãDiotolïŒãã«ãã€ã㯠ãã³ã
ãžã€ã¯ãœã³ïŒBurdick and JacksonïŒããåŸã
液äœã·ã³ãã¬ãŒã·ãšã³åªè³ªããå«ãã·ã³ãã¬ãŒã·
ãšã³ãã€ã¢ã«äžã«ãã«ã³ããŒã·ãšã³ããããã€ã¢
ã«ãæ¯ãšããã液äœã·ã³ãã¬ãŒã·ãšã³èšæ°ç®¡å ã§
èšæ°ããããã€ã¢ã«å ã®æŸå°èœã¯ãµã³ãã«äžã®
DAã®éã«åå ããã  MNã®é žåãMNããã®ãããªã³ã®æœåºãšèš
æ° äžåŽãŸãŒã³ããåã€ãã·ãªã«ã²ã«ããšåäžã®
æ¹æ³ã§åŠçãããæœåºãšèšæ°ãšã¯ïŒªãšåäžã®æ¹æ³
ã§è¡ã€ãããã€ã¢ã«å ã®æŸå°èœã¯ãµã³ãã«äžã®ãš
ããããªã³ã®éã«åå ããã å®æœäŸ ïŒ NEãšïŒ¥ãšã®åèšéãç¥ãããã®é瀺差çåæ
ãè¡ãããã«ãåé¢å·¥çšãé€ããç¹ä»¥å€ã¯å®æœäŸ
ïŒãšåäžã®åææ³ãè¡ã€ããã€ã³ããŠããŒã·ãšã³
ãåæ¢ãããã€ã³ããŠããŒãã®ãã«ãšã³ïŒã€ãœã¢
ãã«ã¢ã«ã³ãŒã«ïŒïŒïŒïŒãïœïŒïœïŒæœåºç©ããåŸ
ãé ¢é žçžãã空æ°æµäžãæžå§äžã§ä¹Ÿç¥ãããïŒml
ã®1Næ°Žé žåã¢ã³ã¢ããŠã ã也ç¥æ®æž£ã«å ãã管
ãšå 容ç©ãšã枊åããããã€ãã§ãå®æœäŸïŒã®å·¥
çšïŒ©ïŒïŒªã«ãããéãã«ç®¡ã®å 容ç©ããããªã³ã«
é žåããæœåºããèšæ°ããããã€ã¢ã«å ã®æŸå°èœ
ã¯ããµã³ãã«äžã®ïŒ¥ãšNEãšã®æªç€ºå·®ååèšéã«
åå ããã å®æœäŸ ïŒ å®æœäŸïŒãšïŒã®åææ¹æ³ãã人尿ãµã³ãã«ãè±
èçœçµç¹åç質ã®äžæŸã¿ã§è¡ã€ããå®æœäŸïŒïŒïŒ
ãšåæ§ãªåæçµæãåŸãããã å®æœäŸïŒïŒïŒïŒïŒã®åã ã«ãããŠãããŒããã³
éã®æŽã«åçŸæ§ããããã€æ£ç¢ºãªåæã確å®ã«ã
ãããã«DOPAã«ã«ããã·ã«åºåè§£é µçŽ é»å®³å€ã
ã€ã³ããŠããŒã·ãšã³æ··åç©äžã«ååšãããã
DOPAã«ã«ããã·ã«åºåè§£é µçŽ ãé»å®³ããååç©
ãäŸç€ºãããšããã³ãžã«ãªãã·ã¢ãã³é¡åã³æ°Žæº¶
æ§ããã©ãžã³é¡ã®äžå¡ã§ããããã³ãžã«ãªãã·ã¢
ãã³é¡ã®äŸã瀺ããšãã³ãžã«ãªãã·ã¢ãã³ãïŒâ
ããããã·âïŒâããã ãã³ãžã«ãªãã·ã¢ãã³å
ã³ãããã®é žä»å å¡©ãäŸãã°ç¡«é žããªã³ã³é žãå¡©
é žã®ä»å å¡©ã§ããã氎溶æ§ããã©ãžã³ã®äŸã¯ããš
ãã«ããã©ãžã³ã§ããã æ¬çºæã®æŽã«å¥ã®æ æ§ã¯ãåæã«å¿ é ã®æåã
æ€æ»å®€ã§å©çšã§ãããããã«éæããããšã§ã
ããåã«è¿°ã¹ãæ§ã«ãã«ãã³ãŒã«ã¢ãã³éãç¥ã
ããšã¯ãå€æ°ã®çç¶ã®èšºæã«ãããŠææ矩ã§ã
ããåæ¥çãªæ€æ»å®€ãç é¢ãã¯ãªããã¯ã¯ãã®å
æã«å¯ŸããŠçžåœã®å¿ èŠæ§ãæã€ããããå¿ èŠæ§
ã¯ãåæã«é¢ããé©åãªæ瀺ãšå ±ã«ãå©çšå¯èœãª
å€æ°ã®å¿ èŠè©Šéšãæã€ããšã«ããæé«ã«å 足ãã
ãããããããããã¯åæ¥ç茞éã«ãã容æã«å ¥
æãããŠæ€æ»å®€ãç é¢ãã¯ãªããã¯ã®å¿ èŠæ§ãæº
足ãããããšãã§ãããæ¬çºæã«ãããå€æ°ã®å°
容åšãšå 容ç©ãšãå èµãã容åšãæäŸãããã該
å 容ç©ã¯ãã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ ïŒ
æªæšèåã¡ãã«åºäŸäžäœãæ¬è³ªäžå«ãŸãªãæšæºå
ã¡ãã«åºäŸäžäœã§ããâã¢ããã·ã«ââã¡ã
ãªãã³ïŒ 3HïŒã¡ãã«ïŒã«ãã³ãŒã«ã¢ãã³ã®ã«ã
ã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ 觊åªïŒ¯âã¡ãã«å
ãé²åãããé žåæ°ïŒïŒã®ã«ããªã³ïŒé µçŽ âåºè³ª
ç³»ã§ããã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ âã«
ãã³ãŒã«ã¢ãã³ãå®å®åãããååç©ïŒåã³ãã«
ãã³ãŒã«ã¢ãã³ã®ã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»
é µçŽ è§ŠåªïŒ¯âã¡ãã«åã劚害ãããªãããã«ã«ã«
ã·ãŠã ã€ãªã³ãéžæé€å»ããè¬å€ïŒãããªããäœ
ããâã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒã¡
ãã«ãå ¥ã€ãå°å®¹åšã«ã¯ä»æåã¯å ¥ãããååæ
åã¯ãè±èçœçµç¹åç質ãè¡æž åã¯è¡æŒ¿ãåã³ç
ç©åŠçæµåäœãããªã矀ããéžæãããåºä¹³åç©
ç³»ããã®ã«ãã³ãŒã«ã¢ãã³ãµã³ãã«ã®ååšäžãé©
åœãªPHãšæž©åºŠãšã§å šæåãäžç·ã«ããããšã«ãã
éå§ãããã¡ãã«åºã®æšèåäŸäžäœããã«ãã³ãŒ
ã«ã¢ãã³ãžã®é µçŽ 觊åªè»¢ç§»ã該ãµã³ãã«äžã®ã«ã
ã³ãŒã«ã¢ãã³ã®å®è³ªäžå šãŠãâã¡ãã«ïŒ 3HïŒ
åãããããšã®ã§ããéã§ååšããã å°å®¹åšãä¿æãã倧容åšã¯ããªãã®èè¡ææ§ã§
ããã¹ããããªãŒã ãã®ä»ã®ãããã®ææã§ãäœ
ãããšãã§ããããã®ã¹ããããªãŒã ãã®ä»ã®æ
æã¯ãå°å®¹åšïŒæ®éã¯ç°åœ¢ãã€ã¢ã«ïŒãå å¯åµå
ãããã®é éšã«åã貫éããŠããåºäœã§ãããå°
容åšã®å éšã«ã¯å 容ç©ãååšããããã¯åæã€ã³
ããŠããŒãäžã«å ¥ããæšèåã¡ãã«åºäŸäžäœãå ¥
ã€ã容åšã«ã¯ãããã®ä»ã®æåãå«ããŠã¯ãªããª
ããé µçŽ ãã«ããªã³ãé µçŽ âåºè³ªç³»å®å®ååå
ç©ãã«ã«ã·ãŠã ã€ãªã³ãéžæé€å»ããè¬å€ã¯åèª
ã®å°å®¹åšã«å ¥ããããšããåãããªãçµåãã§ã
ã€ãŠãåäžå°å®¹åšã«å ¥ããããšãã§ãããåæã«
圹ç«ã€ä»è©Šè¬ããããäžã«å«ããããšãã§ããäŸ
ãã°ç·©è¡æ¶²ç³»ã䜿çšããŠã€ã³ããŠããŒãåã³ã€ã³
ããŠããŒã·ãšã³åæ¢æ¶²ã®PHãç¶æããããšãã§ã
ããã€ã³ããŠããŒã·ãšã³åæ¢æ¿ã¯æããã«ããã®
å 容ç©ãã€ã³ããŠããŒãæåã§ãããããªãå°å®¹
åšã«ãååšãããŠã¯ãªããªããå°å®¹åšãä¿æãã
倧容åšã¯è¢«ãã§äžéšãªããå šäœã被ãããããã®
被ãã¯å€§å®¹åšããèªç±ã«é€ãããåã¯ãã³ãžã«ã
ãçã®äœããã®æ¹æ³ã§ããã«åãä»ããããåæ
æ¹æ³ã«é¢ããæ瀺ãäžããæ段ã容åšã被ãã®å
éšãåã¯å®¹åšã被ãã«åãä»ããããŠããããã®
æ段ã¯ãåæãè¡ãããã®é©åãªæ¹æ³ã«é¢ããæ
å ±ãäŒããå°å·çŽãèšé²ããŒããã®ä»ãããã®æ
段ã®åœ¢ã§ãã€ãŠãããã è©Šè¬ã®ãã¡ã®å¹Ÿã€ãã¯æ¯èŒçäžå®å®ãªã®ã§ãã
ããã¯äœ¿çšäžã§ãªãæã«ã¯äœæž©ã奜ãŸããã¯â20
âã«ä¿æãã¹ãã§ããã åææåã«é©çšãããäŸç€ºãéžææ§ãåæã«äœ¿
çšããããããæåã«ãçããåæ§ã«é©çšããã
ããšãç¹èšããã æ¬æ现æžã«ã¯ãââã¡ãã«ïŒ 3HïŒåããã
ãšããããªã³ãšãã«ãšããããªã³âãšããè¡šçŸã
ããããã®è¡šçŸã«ãããŠã¯ãã«ãšããããªã³ã
âã¡ãã«ïŒ 3HïŒåãããŠãããšç解ããããã
ïŒ 3HïŒãååšããªãæã«ãåæ§ãªè§£éãšããŠç
解ããããã ã€ã³ããŠããŒã·ãšã³ã§äžè¬ã«äœ¿çšãããé µçŽ ã®
æ¿åºŠã¯ãäžå®éã®ã¡ãã«åºäŸäžäœãšã«ãã³ãŒã«ã¢
ãã³ãšã§æ倧é床ãåŸãã®ã«å¿ èŠãªéã§ããã æ¬æ现æžã®åãã«ãããŠã¯ãã¯ãããã°ã©ãã€
ãŒåé¢ã«ãããŠã¯é žæ§æº¶åªç³»ã奜ãŸãããšææã
ããä»ã¯ãå¡©åºæ§æº¶åªç³»ãç¹ã«å®¹éæ¯ã§ïŒéšã®ïœ
âã¢ãã«ã¢ã«ã³ãŒã«ãšïŒéšã®ãã³ãŒã³ãšïŒéšã®ã¡
ãã«ã¢ãã³æº¶æ¶²ãããªã溶åªç³»ã奜ãŸããããšã
確ç«ãããã åºä¹³åç©çµç¹ãµã³ãã«ãåŠçããæã«ã¯ãåæ
ã§äœ¿çšããã«å ç«ã€ãŠãããç²ç ããè±èçœããª
ããã°ãªããªããããã¯å質åãè¶ é³æ³¢åŠçåã¯
çµç¹å§æŸã®æ§ãªæ段ã«ããè¡ãããšãã§ãããé
å¿åé¢æäœã«ããåºäœå¡ã液äœããåé¢ãããå
æã«ãããŠäžæŸã¿æ¶²ãçšãããæ¬æ现æžã«ãããŠ
çšèªâè±èçœçµç¹åç質ã®äžæŸã¿âã¯ãå質åæ
è¡ã®ã¿ãªãããäœããã®æ段ã«ããç²ç ãããçµ
ç¹ã®äžæŸã¿ãæå³ããã âããªã¹âç·©è¡å€ã¯ãããªã¹ïŒããããã·ã¡ã
ã«ïŒã¢ããã¡ã¿ã³ç·©è¡å€ã§ããããããç·©è¡å€ã
䜿çšããŠã€ã³ããŠããŒãã®PHãç¶æããã æ¬æ现æžã«ãããŠãâã¡ãã«ïŒ 3HïŒåã«ã
ã³ãŒã«ã¢ãã³ãæœåºãã溶åªãšããŠã®ãã·ã¬ã³ã
æ瀺ãããæã«ã¯ãïœâãã·ã¬ã³åã³ïœâãã·ã¬
ã³ã®ä»ã«ïœâãã·ã¬ã³ãå«ãŸããã æ¬æ现æžã«ãããŠãåæã€ã³ããŠããŒãã®äžæ
åã¯âé µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã
ã€ãªã³ãåªå é€å»ããè¬å€âã§ããããããè¬å€
ã®äœçšã¯ãã«ã«ã·ãŠã ã€ãªã³ãé µçŽ åå¿ãé»å®³ã
ãã®ãæ¢ããããããšã§ããããã°ãã·ãŠã ãã³
ãã«ãåã³ãã³ã¬ã³ã®æ§ãªé žåæ°ïŒïŒã®é µçŽ 賊掻
ã«ããªã³ãé µçŽ æŽ»æ§ã«ãšãå¿ èŠãªã®ã§ãEGTAã®
æ§ãªãé µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã
ã€ãªã³ãéžæé€å»ããè¬å€ã䜿çšããŠãé µçŽ è³ŠæŽ»
ã«ããªã³æ¿åºŠãé µçŽ æŽ»æ§ãçããå€ã«ããããšã
åœç¶ã«å¥œãŸããã é µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã ã€ãª
ã³ãé€å»ããè¬å€ã¯åæã«ãããŠãçšåªå çã«å¿
èŠãšããããã®ã§ã¯ãªããã䜿çšã§ãããäŸã
ã°ãå€ãã®ãã¬ãŒãå€ã¯ã«ã«ã·ãŠã ã®ä»ã«ææé
ã®ãã°ãã·ãŠã ãé€å»ãããã®ã§ã¯ãããåæã§
䜿çšã§ãããã€ã³ããŠããŒãäžã®å©çšå¯èœé µçŽ 賊
掻ã«ããªã³ã®æ倱ã¯ãå®è³ªçãªå³ã¡éžæçã«ã¯æ
é©ã®é µçŽ 掻æ§ãäžããã®ã«å åãªéã§è¶ 賊掻ã«ã
ãªã³ãæ·»å ããããšã«ããè£å ã§ããã é µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã ã€ãª
ã³ãé€ããã®âééžæçâã¿ã€ãã®è¬å€ãäŸç€ºã
ããšãšãã¬ã³ïŒãžãããªãïŒåé ¢é žïŒEDTAïŒ
ïŒæ®éã¯ãããªãŠã å¡©ãšããŠäœ¿çšãããïŒïŒïŒïŒ
ïŒâãžã¢ããã·ã¯ããããµã³âïŒïŒ®ïŒNâ²ïŒ
Nâ²âåé ¢é žïŒåã³Nâ²âïŒïŒâããããã·ãšã
ã«ïŒãšãã¬ã³ãžã¢ãã³âïŒïŒ®ïŒNâ²âäžé ¢é žïŒ
ã§ãããåæã«ããããã®è¬å€ã®æ¿åºŠã¯çŽïŒã50
ããªã¢ã«ã奜ãŸããã¯çŽïŒã20ããªã¢ã«ã§ããã
ãšãã¬ã³ïŒãžãããªãïŒåé ¢é žïŒEDTAïŒããã®
ã«ããŽãªãŒã«å«ãŸãã奜ãŸããã¯ååç©ã§ããã å®è³ªçãªããæ倧ã®é µçŽ 賊掻åãéæãããã
ã«ã€ã³ããŠããŒãäžã«å¿ èŠãšãããè¶ è³ŠæŽ»ã€ãªã³
ã®æ¿åºŠã¯ãçšããããåã ã®è¬å€ã®çµååãç¥ã
ããšã«ãããæã¯ç°¡åãªå®éšã«ãã容æã«èšç®ã§
ããã é µçŽ ãšçžäºäœçšãããªãããã«ã«ã«ã·ãŠã ã€ãª
ã³ãé€ããæŽã«é µçŽ 賊掻ã€ãªã³ããé€ããã®ééž
æçè¬å€ããæ¬çºæã®åææ³ã«ãããŠã¯ãâé µçŽ
åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã ã€ãªã³ãåª
å é€å»ããè¬å€âã®ä»£ããã«äœ¿çšã§ããããšãç
解ããããããã®çœ®ãæãã¯ãç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒé ã®ç¬ç«é èšèŒã®çºæã§è¡ãããšãã§ã
ããæ¬çºæã®ãã®æ æ§ã®äžäŸã¯ãã«ãã³ãŒã«â
âã¡ãã«åºè»¢ç§»é µçŽ ïŒæªæšèåã¡ãã«åºäŸäžäœã
æ¬è³ªäžå«ãŸãªãããªããŠã æšèåã¡ãã«åºäŸäžäœ
ã§ããâã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒ
ã¡ãã«ïŒè©²ã¡ãã«åºè»¢ç§»ãé²è¡ãããé žåæ°ãïŒ
ïŒã®ã«ããªã³ïŒé µçŽ åºè³ªç³»ãå®å®åãããåå
ç©ãé µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·ãŠã ã€
ãªã³ãé€å»ããè¬å€ïŒåã³ãè±èçœçµç¹åç質ã®
äžæŸã¿ãè¡æž åã¯è¡æŒ¿ãåã³çç©åŠçæµåäœãã
ãªã矀ããéžæãããåºä¹³åç©ç³»ïŒãããªãã該
è»¢ç§»é µçŽ ã該ã«ããªã³ã該å®å®åååç©ã該ã¡ã
ã«åºäŸäžäœãåã³ã«ã«ã·ãŠã ã€ãªã³ãé€å»ãã該
è¬å€ãã該åºä¹³åç©ç³»äžã«ååšãããšããããª
ã³ããã«ãšããããªã³åã³ããŒããã³ã®å®è³ªäžå š
ãŠãâã¡ãã«ïŒ 3HïŒåãããéã§ååšããçµ
æç©ã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ è±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž åã¯è¡æŒ¿ã
åã³çç©åŠçæµåäœãããªã矀ããéžæãããåº
ä¹³åç©ç³»ããåŸãããããŒããã³ã®éãåæãã
æ¹æ³ã«ãããŠã ïœ è±èçœçµç¹åç質ã®äžæŸã¿ãè¡æž åã¯è¡æŒ¿ã
åã³çç©åŠçæµåäœãããªã矀ããéžæããã
åºä¹³åç©ç³»ã®ã¢ãªã³ãŒãããã«ãã³ãŒã«ââ
ã¡ãã«åºè»¢ç§»é µçŽ ãæªæšèåã¡ãã«åºäŸäžäœã
å®è³ªäžå«ãŸãªãããªããŠã æšèåã¡ãã«åºäŸäž
äœã§ããâã¢ããã·ã«ââã¡ããªãã³ïŒ
3HïŒã¡ãã«ã該ã¡ãã«åºè»¢ç§»ãé²è¡ãããé ž
åæ°ïŒïŒã®ã«ããªã³ãé µçŽ âåºè³ªç³»ãå®å®åã
ããååç©ãåã³é µçŽ åå¿ã劚害ãããªããã
ã«ã«ã«ã·ãŠã ã€ãªã³ãåªå çã«é€å»ããè¬å€ãš
äžç·ã«ãïŒ ïœ ãšããããªã³ããã«ãšããããªã³åã³ããŒã
ãã³ã®å®è³ªäžå šãŠãâã¡ãã«ïŒ 3HïŒåãã
ã®ã«å åãªæéãšæž©åºŠãšPHã§âïœâã®æåãäž
ç·ã«ã€ã³ããŠããŒã·ãšã³ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåãšããããªã³ãâã¡
ãã«ïŒ 3HïŒåãã«ãšããããªã³åã³ïŒ¯âã¡ã
ã«ïŒ 3HïŒåããŒããã³ãããããâã¡ãã«
åååç©ãåªå çã«æº¶è§£ããææ©æº¶åªã§æœåº
ãïŒ ïœ è©²ïŒ¯âã¡ãã«ïŒ 3HïŒåååç©ãã該âã¡
ãã«ïŒ 3HïŒåååç©ã«ãããã³ãäŸäžããã®
ã«å åãªåŒ·åºŠãæã€é žã®æ°Žæº¶æ¶²ã§ãããèžçºã«
éããŠæ¬è³ªäžæ®æž£ãæ®ããªã氎溶液äžã«ååé
ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããŒããã³ãâã¡ã
ã«ïŒ 3HïŒåãšããããªã³ããåé¢ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåãã«ãšããããªã³ãšïŒ¯
âã¡ãã«ïŒ 3HïŒããŒããã³ãšãå«ã溶液ãé
ãšãŠçŽ é žå¡©ã§é žåããŠãããªã³â 3Hã圢æ
ãïŒ ïœ ãããªã³â 3Hãææ©æº¶åªäžã«æœåºãïŒ ïœ éãšãŠçŽ é žå¡©æ°Žæº¶æ¶²çžã®PHãïŒãã倧ãã
ãïŒ ïœ éãšãŠçŽ é žå¡©æ°Žæº¶æ¶²çžããâã¡ãã«ïŒ
3HïŒåããŒããã³ãææ©æº¶åªã«ããæœåºãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããŒããã³ããæŸåºã
ããæŸå°ç·ãèšæ°ããïŒ ããšãããªãæ¹æ³ã ïŒ åºä¹³åç©ç³»ã人éã®è¡æž åã¯è¡æŒ¿ã§ãããé ž
åæ°ïŒïŒã®ã«ããªã³ããã°ãã·ãŠã ãã³ãã«ãå
ã³ãã³ã¬ã³ãããªã矀ããéžæãããé µçŽ âåºè³ª
ç³»ãå®å®åãããååç©ãã°ã«ã¿ããªã³ã§ããã
é µçŽ ç³»ã劚害ãããªãããã«ã«ã«ã·ãŠã ãåªå ç
ã«é€å»ããè¬å€ããšãã¬ã³ã°ãªã³ãŒã«ãã¹âïŒã¢
ãããšãã«ãšãŒãã«ïŒâïŒNâ²âåé ¢é žã§ã
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ ã«ããªã³ããã°ãã·ãŠã ã§ãããã€ã³ããŠã
ãŒãã®PHãïŒã10ã§ãããã€ã³ããŠããŒã·ãšã³ã
åªå çææ©æº¶åªã§ã®æœåºä»¥åã«åæ¢ãããâã¡
ãã«ïŒ 3HïŒåããŒããã³ããã·ãªã«ã²ã«è¢«èŠè
å±€ã¯ãããã°ã©ãã€ãŒæ¿ã§é žæ§æº¶åªç³»ã§å±éãã
ãã¯ãããã°ã©ãã€ãŒã«ããâã¡ãã«ïŒ 3HïŒ
åãšããããªã³ããåé¢ããããç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®æ¹æ³ã ïŒ ã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ ãèèçµ
ç¹ããæœåºããããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
æ¹æ³ã ïŒ èèçµç¹ãã©ããã®ãã®ã§ãããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ æå¹éã®è³éŠæâã¢ããé žã§ãããã«ã«ã
ãã·ã«åºåè§£é µçŽ ã®é µçŽ 掻æ§ã®é»æ¢å€ãã€ã³ããŠ
ããŒãäžã«ååšãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®æ¹æ³ã ïŒ æå¹éã®è³éŠæâã¢ããé žã§ãããã«ã«ã
ãã·ã«åºåè§£é µçŽ ã®é µçŽ 掻æ§ã®é»æ¢å€ãã€ã³ããŠ
ããŒã·ãšã³æ··åç©äžã«ååšãããç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®æ¹æ³ã ïŒ é»æ¢å€ããã³ãžã«ãªãã·ã¢ãã³ãïŒâããã
ãã·âïŒâããã ãã³ãžã«ãªãã·ã¢ãã³åã³ãã
ãã®é žä»å å¡©ãããªã矀ããéžæããããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ è±èçœçµç¹åç質ãè¡æž åã¯è¡æŒ¿ãåã³çç©
åŠçæµåäœãããªã矀ããéžæãããåºä¹³åç©ç³»
ããåŸãããããŒããã³ã®éãåæããæ¹æ³ã«ã
ããŠã ïœ è±èçœçµç¹åç質ãè¡æž åã¯è¡æŒ¿ãåã³çç©
åŠçæµåäœãããªã矀ããéžæãããåºä¹³åç©
ç³»ã®ã¢ãªã³ãŒãããã«ãã³ãŒã«ââã¡ãã«åº
è»¢ç§»é µçŽ ãæªæšèåã¡ãã«åºäŸäžäœãå®è³ªäžå«
ãŸãªãããªããŠã æšèåã¡ãã«åºäŸäžäœã§ãã
âã¢ããã·ã«ââã¡ããªãã³ïŒ 3HïŒã¡ã
ã«ã該ã¡ãã«åºè»¢ç§»ãé²è¡ãããé žåæ°ïŒïŒã®
ã«ããªã³ãé µçŽ âåºè³ªç³»ãå®å®åãããåå
ç©ãåã³é µçŽ åå¿ã劚害ãããªãããã«ã«ã«ã·
ãŠã ã€ãªã³ãåªå çã«é€å»ããè¬å€ãšäžç·ã«
ãïŒ ïœ ãšããããªã³ããã«ãšããããªã³åã³ããŒã
ãã³ã®å®è³ªäžå šãŠãâã¡ãã«ïŒ 3HïŒåãã
ã®ã«å åãªæéãšæž©åºŠãšPHã§âïœâã®æåãäž
ç·ã«ã€ã³ããŠããŒã·ãšã³ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåãšããããªã³ãâã¡
ãã«ïŒ 3HïŒåãã«ãšããããªã³åã³ïŒ¯âã¡ã
ã«ïŒ 3HïŒåããŒããã³ãããããâã¡ãã«
ïŒ 3HïŒåååç©ãåªå çã«æº¶è§£ããææ©æº¶åª
ã§æœåºãïŒ ïœ è©²ïŒ¯âã¡ãã«ïŒ 3HïŒåååç©ãã該âã¡
ãã«ïŒ 3HïŒåååç©ã«ãããã³ãäŸäžããã®
ã«å åãªåŒ·åºŠãæã€é žã®æ°Žæº¶æ¶²ã§ãããèžçºã«
éããŠæ¬è³ªäžæ®æž£ãæ®ããªã氎溶液äžã«ååé
ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããŒããã³ãã¯ããã
ã°ã©ãã€ãŒæ段ã«ããâã¡ãã«ïŒ 3HïŒåãš
ããããªã³åã³ïŒ¯âã¡ãã«ïŒ 3HïŒåãã«ãšã
ãããªã³ããåé¢ãïŒ ïœ åé¢ãããâã¡ãã«ïŒ 3HïŒåããŒããã³
ã溶åºãïŒ ïœ åé¢ãããâã¡ãã«ïŒ 3HïŒåããŒããã³
ãå¡©åºæ§PHã«ãã溶åºæ¶²ããææ©æº¶åªã§æœåº
ãïŒ ïœ ïŒ¯âã¡ãã«ïŒ 3HïŒåããŒããã³ããæŸåºã
ããæŸå°ç·ãèšæ°ããïŒ ããšãããªãæ¹æ³ã ïŒïŒ åºä¹³åç©ç³»ã人éã®è¡æž åã¯è¡æŒ¿ã§ããã
é žåæ°ïŒïŒã®ã«ããªã³ããã°ãã·ãŠã ãã³ãã«ã
åã³ãã³ã¬ã³ãããªã矀ããéžæãããé µçŽ âåº
質系ãå®å®åãããååç©ãã°ã«ã¿ããªã³ã§ã
ããé µçŽ ç³»ã劚害ãããªãããã«ã«ã«ã·ãŠã ãåª
å çã«é€å»ããè¬å€ããšãã¬ã³ã°ãªã³ãŒã«ãã¹â
ïŒã¢ãããšãã«ãšãŒãã«ïŒâïŒNâ²âåé ¢é žã§ã
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒïŒ ã«ããªã³ããã°ãã·ãŠã ã§ãããã€ã³ããŠ
ããŒãã®PHãïŒã10ã§ãããã€ã³ããŠããŒã·ãšã³
ãåªå ç溶åªã§ã®æœåºä»¥åã«åæ¢ãããâã¡ã
ã«ïŒ 3HïŒåããŒããã³ãã·ãªã«ã²ã«è¢«èŠèå±€ã¯
ãããã°ã©ãã€ãŒæ¿ã§å¡©åºæ§æº¶åªç³»ã«ããå±éã
ããã¯ãããã°ã©ãã€ãŒã«ããâã¡ãã«ïŒ
3HïŒåãšããããªã³åã³ïŒ¯âã¡ãã«ïŒ 3HïŒåã
ã«ãšããããªã³ããåé¢ããããç¹èš±è«æ±ã®ç¯å²
第ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ ã«ãã³ãŒã«ââã¡ãã«åºè»¢ç§»é µçŽ ãèè
çµç¹ããæœåºããããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èš
èŒã®æ¹æ³ã ïŒïŒ èèçµç¹ãã©ããã®ãã®ã§ãããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ æå¹éã®è³éŠæâã¢ããé žã§ãããã«ã«
ããã·ã«åºåè§£é µçŽ ã®é µçŽ 掻æ§ã®é»æ¢å€ãã€ã³ã
ãŠããŒãäžã«ååšãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®æ¹æ³ã ïŒïŒ æå¹éã®è³éŠæâã¢ããé žã§ããã«ã«ã
ãã·ã«åºåè§£é µçŽ ã®é µçŽ 掻æ§ã®é»æ¢å€ãã€ã³ããŠ
ããŒã·ãšã³æ··åç©äžã«ååšãããç¹èš±è«æ±ã®ç¯å²
第ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ é»æ¢å€ããã³ãžã«ãªãã·ã¢ãã³ãïŒâãã
ããã·âïŒâããã ãã³ãžã«ãªãã·ã¢ãã³åã³ã
ããã®é žä»å å¡©ãããªã矀ããéžæããããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68199976A | 1976-04-30 | 1976-04-30 | |
| US681999 | 1976-04-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6037998A JPS6037998A (ja) | 1985-02-27 |
| JPS6258720B2 true JPS6258720B2 (ja) | 1987-12-07 |
Family
ID=24737774
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5062877A Granted JPS52133292A (en) | 1976-04-30 | 1977-04-30 | Analytical method of catechol amine |
| JP620684A Granted JPS6037998A (ja) | 1976-04-30 | 1984-01-17 | ããŒããã³ã®å®éæ¹æ³ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5062877A Granted JPS52133292A (en) | 1976-04-30 | 1977-04-30 | Analytical method of catechol amine |
Country Status (5)
| Country | Link |
|---|---|
| JP (2) | JPS52133292A (ja) |
| CA (1) | CA1072426A (ja) |
| DE (1) | DE2717306A1 (ja) |
| FR (1) | FR2361656A1 (ja) |
| GB (1) | GB1555872A (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02146334U (ja) * | 1989-05-16 | 1990-12-12 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120214180B (zh) * | 2025-05-28 | 2025-08-19 | çŸåº·çç©ç§æè¡ä»œæéå ¬åž | äžç§ä»å°¿æ¶²äžæå8ç§å¿è¶é èºåå ¶ä»£è°¢ç©çæ ·æ¬åå€çæ¹æ³åè¯åç |
-
1977
- 1977-03-29 CA CA275,051A patent/CA1072426A/en not_active Expired
- 1977-04-19 DE DE19772717306 patent/DE2717306A1/de not_active Withdrawn
- 1977-04-21 GB GB1658077A patent/GB1555872A/en not_active Expired
- 1977-04-29 FR FR7713039A patent/FR2361656A1/fr active Granted
- 1977-04-30 JP JP5062877A patent/JPS52133292A/ja active Granted
-
1984
- 1984-01-17 JP JP620684A patent/JPS6037998A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02146334U (ja) * | 1989-05-16 | 1990-12-12 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1555872A (en) | 1979-11-14 |
| JPS52133292A (en) | 1977-11-08 |
| FR2361656A1 (fr) | 1978-03-10 |
| CA1072426A (en) | 1980-02-26 |
| JPS6129720B2 (ja) | 1986-07-08 |
| DE2717306A1 (de) | 1977-11-10 |
| JPS6037998A (ja) | 1985-02-27 |
| FR2361656B1 (ja) | 1983-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Knowles et al. | Measurement of NOS activity by conversion of radiolabeled arginine to citrulline using ion-exchange separation | |
| Holly et al. | The estimation of catecholamines in human plasma | |
| David-Pfeuty et al. | Effect of antimitotic drugs on tubulin GTPase activity and self-assembly. | |
| Mudd et al. | Transsulfuration in mammals: microassays and tissue distributions of three enzymes of the pathway | |
| Levy et al. | Studies on the biosynthesis of cholesterol. 10. Mevalonic kinase and phosphomevalonic kinase from liver | |
| Sole et al. | A simple specific radioenzymatic assay for the simultaneous measurement of picogram quantities of norepinephrine, epinephrine, and dopamine in plasma and tissues | |
| JP2870704B2 (ja) | ãã¢ã·ã¹ãã€ã³ã¢ãã»ã€ | |
| Tipton et al. | Assay of monoamine oxidase | |
| Mannervik et al. | Inhibition of choline acetyltransferase from bovine caudate nucleus by sulfhydryl reagents and reactivation of the inhibited enzyme | |
| Kodavanti et al. | Biochemical methods of studying hepatotoxicity | |
| Hussain et al. | Radioenzymatic microassay for simultaneous estimations of dopamine, norepinephrine, and epinephrine in plasma, urine, and tissues. | |
| Shoup et al. | Determination of catechol-O-methyltransferase activity in various tissues by liquid chromatography | |
| Lovenberg et al. | Assay of serotonin, related metabolites and enzymes | |
| US4288542A (en) | Radioenzymatic assay of catecholamines | |
| Hooff et al. | Isoprenoid quantitation in human brain tissue: a validated HPLCâfluorescence detection method for endogenous farnesyl-(FPP) and geranylgeranylpyrophosphate (GGPP) | |
| US4284587A (en) | Radioenzymatic assay of catecholamines | |
| JPS6129720B2 (ja) | ||
| US4242456A (en) | Radioenzymatic assay of catecholamines | |
| Holdiness | Chromatographic analysis of glutamic acid decarboxylase in biological samples | |
| US4287368A (en) | Method for preparing vanillin and composition therefor | |
| US4242222A (en) | Radioenzymatic assay of catecholamines | |
| Hammerman et al. | Phorbol ester-stimulated phosphorylation of basolateral membranes from canine kidney | |
| US4423144A (en) | Radioenzymatic assay of catecholamines | |
| Lindstedt et al. | Studies on the metabolism of lysine and 5-hydroxylysine | |
| Welsch | Choline acetyltransferase in aneural tissue: Evidence for the presence of the enzyme in the placenta of the guinea pig and other species |